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Abstract
Hydrogels have emerged as an invaluable class of materials for biomedical applications, owing in part to
their utility as structural, bioinstructive, and cell-laden implants that mimic many aspects of native
tissues. Despite their many positive attributes, conventional hydrogels face numerous challenges toward
translational therapies, including difficulty in delivery (i.e., invasive implantation) as well as limited control
over biophysical properties (i.e., porosity, degradation, and strength). To address these challenges, the
overall goal of this dissertation was the development of a class of supramolecular hydrogels that can be
implanted in vivo by simple injection and that have tunable properties — either innate to the system or
achieved through additional modifications. Toward this, we developed guest-host (GH) hydrogels that
undergo supramolecular assembly through complexation of hyaluronic acid (HA) separately modified by
adamantane (Ad-HA, guest) and β-cyclodextrin (CD-HA, host).
Modular modifications were made to GH hydrogels to enable tuning of biophysical properties, including
the incorporation of matrix-metalloproteinase cleavable peptides between HA and Ad to form
enzymatically degradable assemblies. Additionally, dual-crosslinking (DC) of methacrylated CD-HA (CDMeHA) and thiolated Ad-HA (Ad-HA-SH) by Michael addition subsequent to GH assembly was explored to
stiffen hydrogels in vivo following injection. Finally, injectable and tough double network (DN) hydrogels
were fabricated, where GH hydrogels were formed in the presence of an interpenetrating covalent network
(methacrylated HA, MeHA) crosslinked by Michael addition with a dithiol under cytocompatible
conditions.
Both GH and DC hydrogels were further explored in vivo, with application to attenuate the maladaptive left
ventricular (LV) remodeling that occurs following myocardial infarction (MI) that can result in heart failure.
DC hydrogels reduced stress within the infarct region, prevented early ventricular expansion and thereby
ameliorated progressive LV remodeling. Moreover, the preservation of myocardial geometry reduced
incidence and severity of ischemic mitral regurgitation — an undesirable and devastating consequence of
LV remodeling. Overall, the body of work represents a novel approach to engineer biomaterials with
unique properties toward biomedical therapies.
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ABSTRACT

DEVELOPMENT OF SHEAR-THINNING AND SELF-HEALING HYDROGELS
THROUGH GUEST-HOST INTERACTIONS FOR BIOMEDICAL
APPLICATIONS
Christopher B. Rodell
Jason A. Burdick, Ph.D.

Hydrogels have emerged as an invaluable class of materials for biomedical
applications, owing in part to their utility as structural, bioinstructive, and cell-laden
implants that mimic many aspects of native tissues. Despite their many positive
attributes, conventional hydrogels face numerous challenges toward translational
therapies, including difficulty in delivery (i.e., invasive implantation) as well as
limited control over biophysical properties (i.e., porosity, degradation, and
strength). To address these challenges, the overall goal of this dissertation was
the development of a class of supramolecular hydrogels that can be implanted in
vivo by simple injection and that have tunable properties — either innate to the
system or achieved through additional modifications. Toward this, we developed
guest-host (GH) hydrogels that undergo supramolecular assembly through
complexation of hyaluronic acid (HA) separately modified by adamantane (Ad-HA,
guest) and β-cyclodextrin (CD-HA, host).
Modular modifications were made to GH hydrogels to enable tuning of
biophysical properties, including the incorporation of matrix-metalloproteinase
v

cleavable peptides between HA and Ad to form enzymatically degradable
assemblies. Additionally, dual-crosslinking (DC) of methacrylated CD-HA (CDMeHA) and thiolated Ad-HA (Ad-HA-SH) by Michael addition subsequent to GH
assembly was explored to stiffen hydrogels in vivo following injection. Finally,
injectable and tough double network (DN) hydrogels were fabricated, where GH
hydrogels were formed in the presence of an interpenetrating covalent network
(methacrylated HA, MeHA) crosslinked by Michael addition with a dithiol under
cytocompatible conditions.
Both GH and DC hydrogels were further explored in vivo, with application
to attenuate the maladaptive left ventricular (LV) remodeling that occurs following
myocardial infarction (MI) that can result in heart failure. DC hydrogels reduced
stress within the infarct region, prevented early ventricular expansion and thereby
ameliorated progressive LV remodeling. Moreover, the preservation of myocardial
geometry reduced incidence and severity of ischemic mitral regurgitation — an
undesirable and devastating consequence of LV remodeling. Overall, the body of
work represents a novel approach to engineer biomaterials with unique properties
toward biomedical therapies.
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CHAPTER 1

Introduction: Material Design for Biomedical Applications

Adapted from: Rodell CB, Tibbett MW, Burdick JA, Anseth KS. Progress in Material
Design for Biomedical Applications. Proceedings of the National Academy of
Sciences (PNAS) 112, 14444-14451 (2015).

1.1 Introduction
Biomaterials have been used to augment tissue function and treat diseases
and injuries for thousands of years – whether selecting coral or wood for dental
implants or fabric for sutures, implant materials historically originated by evaluating
potential materials in our surroundings that could be used for a specific biomedical
application. Many times this selection process simply involved consideration of the
mechanical properties of the material to restore basic function at the implant site;
typically, the materials themselves were never originally designed to interface with
living tissues. Today, this is no longer the case, as we now have an advanced
toolbox of synthetic and processing techniques to rationally create, design, and
process materials with specific properties in mind. These advancements have
come hand in hand with the integration of theory with experiments, materials
chemistry and biology with engineering, and basic science with application. As
highlighted by the announcement of the Materials Genome Initiative1, biomaterial
1

science is often the stealth technology that enables breakthroughs in medical
devices that improve health care and save lives.
In fact, the last few decades of research have led to the emergence of
numerous biomaterial options, along with an increasing sophistication in the ability
to tune and manipulate complex physical and biological properties. Such advances
in biomaterial science have not only driven and enabled new medical products, but
have served as new tools for investigation of important biological questions. The
modern biomaterial evolution initiated with the design of materials – including hard
materials like metals and ceramics – that focused on outcomes such as
mechanical properties and biocompatibility. This approach led to the clinical
implementation of numerous materials for biomedical applications, such as joint
replacement, pacemakers, and orthodontics. The contemporary age of
biomaterials has advanced with a further focus on functionality, where materials
are now smarter and responsive to their environment; they incorporate bioactive
signals, and they have multifunctional design. These strategies are leading to
progress and improvements in fields ranging from medical devices, to drug
delivery, to regenerative medicine.
As one example, vascular stents have been widely used to open blocked
vessels and restore blood flow to ischemic tissues, and the design of these stents
has significantly evolved with time. With the development of Nitinol®, a metal alloy
of nickel and titanium with unique shape memory and superelastic properties, stent
design has improved to be implanted with simpler, minimally-invasive procedures
and to maintain function for longer periods of time. Next generation stents
2

transitioned from passive mechanical devices to those that actively regulate the
biological interface by integrating biodegradable polymer coatings that locally elute
drugs to limit restenosis and resulting stent failure. These advances enhanced both
the functionality and efficacy of stent technology for clinical use. Similarly, the
coating of traditional metal orthopaedic implants with bioactive ceramics improved
clinical outcomes by facilitating osseointegration with bony tissue, and after the
discovery of bone morphogenetic proteins and their recombinant production,
spinal fusion surgeries benefited from material delivery systems that enabled their
local presentation (e.g., INFUSE®). Collectively, these examples demonstrate how
material design can be used to present biological signals that result in new medical
devices and implants with superior clinical performance. In fact, a recent report
estimated the 2012 global biomaterial market at $44.0 billion and forecasted a 15%
compounded annual growth rate between 2012-2017, reaching $88.4 billion by
20172.
This perspective focuses primarily on recent developments in polymers and
soft materials, due to the large technological growth in these systems since the
1990s. This review is organized to highlight some of the major advances and
modern thinking in biomaterial design, such as the ability to manipulate and control
biomaterial properties at multiple length-scales, introduce dynamic behavior into
biomaterials, and capture biocomplexity and additive functionalities. We then
conclude with a forward-looking perspective about the current challenges and
future directions for designing the next generation of biomaterials.

3

1.2 From Molecular to Macroscopic
Biomaterials fabrication has evolved across all size scales—from molecular to
macroscopic—to impart biochemical and biophysical cues into cell culture
platforms for regenerative medicine, to achieve optimal outcomes in drug delivery
systems, and to improve in vivo success of medical implants. Our increased
understanding of native tissue architecture and cell-material interactions, as well
as the development of processing methods and chemical syntheses has driven the
design of new materials. This section will highlight advances that have been made
in the development of a toolbox of synthetic approaches and fabrication techniques
that impart defined structures over a range of biologically relevant length scales.

1.2.1 From Molecular Organization to Nanostructure
An increased understanding of biological structures, with a focus on their
biochemical composition and organization, has provided insight into the manner
by which molecular structure and chemistry impart properties into biological
systems. Covalent bonds endow stability (e.g., peptide bonds) while secondary
structures confer material resilience (e.g., resilin3, elastin4). Peptide coupling,
recombinant protein synthesis, and evolution via phage display have become
invaluable tools to recapitulate similar functionalities in synthetic biomaterial
analogues. Likewise, synthetic approaches (e.g., bio-orthogonal chemistry) have
evolved to enable the fabrication and functionalization of biomaterials (e.g.,
hydrogels) that capture aspects of native biological structures5. Collectively, these
techniques have allowed the production of biomaterials with unique capacity,
4

including post-modification of cell culture matrices and to crosslink implantable
materials.

Figure 1.1. The biomaterials toolbox. The toolbox of biomaterials processing techniques
that enable formation of highly controlled structures with biochemical and biomechanical
features that vary across many size scales, as well as levels of complexity. These include
nanoscale molecular self-assembly6, photolithography7,8, electrospinning9,10, geometric
self-assembly11,12, and 3D bioprinting13.

Covalent chemistries have dominated the biomaterials field since its
conception. However, the emergence of supramolecular chemistry has begun to
enhance our understanding of biology and capacity for creating precise,
physiologically structured materials. Nobel Laureate Jean-Marie Lehn insightfully
described supramolecular interactions as “chemistry beyond the molecule,”
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since they enable dynamic macromolecular interactions, as well as the selforganization necessary to form higher order structure in proteins and tissues15. In
5

the body, supramolecular presentation of bio-signals is exemplified by native
extracellular matrix (ECM) interactions, including receptor-ECM interactions and
heparin-binding

proteins.

As

such,

biomolecule

presentation

through

supramolecular interactions has emerged as a means of controllable delivery 16,
including through cyclodextrin-mediated sequestration of small molecules17 or
biomimetic electrostatic protein-matrix interactions18. Beyond the capacity for
single molecule-matrix interactions, the general ECM structure itself is largely the
result of self-assembly (e.g., fibrillar structure of collagen) and can be
recapitulated, in part, by well-designed synthetic analogues. These higher order
motifs are exemplified by self-assembling nanostructures from peptide
amphiphiles6 (Figure 1.1, top left), though many alternative means of biologically
inspired supramolecular materials have been explored and their implications
toward cell behavior recently reviewed19.

1.2.2 Building at the Mesoscale
While self-assembly processes based on molecular design have achieved vast
success in recapitulating certain aspects of the biological nanostructure, they face
notable challenges. Among these is relative homogeneity at larger scales
(resulting from thermodynamically controlled assembly) and physiologically low
mechanical properties (owing to the underlying weak intermolecular forces). In
order to address these aspects at the nano and mesoscale, more active
processing methods have been utilized to impart defined structure. Notably,
electrospinning (Figure 1.1, center) of naturally derived or synthetic materials has
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become a dominant technique to mimic the nanofibrous nature of ECM20. The
functional importance of such microstructural organization cannot be discounted,
as it enables mechanical anisotropy21 and therefore holds great promise for
formation of biomedical implants including vascular grafts22 and orthopedic
connective tissues23. Toward formation of porous architectures, other processes
such as phase separation, leaching, and directional freezing have also emerged
as versatile methods to process biomaterials that permit cell and tissue
infiltration24,25.
The aforementioned methods allow realization of bi-continuous structures at
the nano- and micro-scale, yet they often display limited capacity toward
generating complex topographical, mechanical, or biomolecular presentation. For
modulation of these aspects, post-processing of larger scaffolds, such as by lightmediated reactions (Figure 1.1, bottom left), has become instrumental toward
spatiotemporal control of biochemical signals on hydrogel surfaces26 or within 3D
hydrogels through either focused single photon7 or multiphoton27 irradiation
methods. Building on these advances, selective photopolymerization 28, addition
reactions29, and degradation mechanisms30,31 have enabled extension of
photopatterning methodologies toward 2D and 3D presentation of spatially or
temporally varying mechanical properties.

1.2.3 Macroscopic Materials and their Sub-Assemblies
Ultimately, material design for biomedical applications must achieve the
capacity for preparation at the tissue-scale with both structure and mechanical
7

properties suitable for in vivo implantation, preferably with necessary tissue
interfacing to achieve functionality. Methods reminiscent of industrial processes,
such as injection molding, have been employed to achieve macrostructure control
in biomaterials. These approaches have enabled recreation of complex structures
at the macroscale with utility toward application in craniofacial32 and meniscal33
implants. In some cases, the biological interaction with these materials has been
mediated by biomolecule presentation within the scaffold, such as sequestration
of heparin and, correspondingly, endogenous BMP-2 to enhance bone formation34.
Toward their utility in tissue engineering applications, material assemblies often
require advanced structural flexibility in order to recapitulate the inhomogeneity of
tissue structures (e.g., spatiotemporal presentation of cells and matrix). To achieve
this, appropriate molecular-, nano-, and meso-scale signals may be engineered
into macroscale structures through either modification of bulk hydrogels (topdown) or directed component assembly (bottom-up) approaches. A powerful
means of achieving controlled signal presentation within a homogenous scaffold is
photolithography (vide supra), which embodies the top-down methodology.
Alternatively, two primary means of bottom-up approaches have emerged to
create

tissue-scale

structures

with

non-homogenous

cell

and

material

compositions. First, pioneering work by the Whitesides group12 has demonstrated
means by which materials may be pre-cast into microgel components with the
desired composition and allowed to passively self-assemble (Figure 1.1, top right)
through hydrophobic or capillary forces35. Owing to the thermodynamic control of
assembly in these systems, repeatable geometric structures may be achieved over
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large length scales. Toward increasing the complexity of allowed structures, such
tools as field-driven input and direct serial manipulation have also been
employed11. As an alternative to this self-assembled approach, techniques like 3D
printing (Figure 1.1, bottom right)—the direct spatially controlled deposition of
materials, with or without included cells or signals — have emerged to introduce
material structure at the macro-scale. Within only the past few years, these
methods have been extended to include processes such as: sacrificial printing to
enable perfusion and viability within a secondarily cast hydrogel 36, layer-by-layer
printing of pluronics or other thermogels37, and methods to directly write complex
structures in 3D13. Looking forward, it is expected that further inclusion of smaller
scale sub-assemblies, such as nanostructured materials and microscale
patterning will aid in furthering success of these approaches.

1.3 From Static to Dynamic
Beyond control of material structure from the molecular to the macro-scale,
biomaterials are also evolving from a traditional, pre-engineered static design to
those that have dynamic properties. Historically, biomaterials were intended to
provide consistent functions, such as mechanical support (e.g., orthopaedic
implants) or optical properties (e.g., contact lenses). This approach has led to the
successful design of numerous clinically-used biomaterials; yet, advances in
material design and polymer chemistry have recently allowed us to incorporate
dynamic features into biomaterials. This approach ranges from the design of
9

materials that are degradable, to eliminate permanent implantation or a second
surgery for implant retrieval, to those that have stimuli-responsive properties,
where various chemical and biological signals can trigger changes in biomaterial
properties or release drugs on-demand.

Degradable
Dt
degrada on
Low Crosslink
Density

High Crosslink
Density

Stimuli-Responsive
DT,DpH

Shape-memory

Figure 1.2. Dynamic and responsive materials. Dynamic biomaterials based on
polymer degradation38, stimuli-responsive properties (e.g., local changes in temperature
or pH) for the release of therapeutics, or temperature induced shape-memory changes
(e.g., self-tying suture)39.

1.3.1 Incorporating Degradation into Biomaterials
Biodegradable materials are those that transition from an initial, stable structure
into soluble products that can be resorbed and processed by the body. Examples
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of such system have been around for numerous years, with biodegradable sutures
perhaps being the most common40. Original resorbable sutures consisted of
materials such as catgut that degraded via inherent biological mechanisms, but
these were later engineered from synthetic and hydrolytically degradable polymers
(e.g., poly(α-hydroxy esters)). Other examples of biodegradable materials used in
the clinic include biodegradable films that limit undesired adhesions after surgical
procedures and degradable fixation devices (e.g., screws and plates) in
orthopaedics41. Important considerations in the design of biodegradable materials
are the rate of degradation and ensuring that the degradation products are nontoxic when released.
Biodegradable materials have been applied widely to biomedical applications
to provide temporal control over material presentation, including towards the
engineering of tissues or the release of drugs and growth factors42. For tissue
engineering, the material may temporarily provide a 3D structure or ‘scaffold’ for
the growing tissue, whereas degradable materials for drug delivery are engineered
to protect and then release molecules at desired rates. Hydrogels are one such
class of biomaterials that have been designed with degradable linkers, for example
through the introduction of hydrolytically or enzymatically cleavable bonds into the
crosslinks. Degradable hydrogels have been synthesized from a range of
materials, including synthetic polymers (e.g., poly(ethylene glycol)43, poly(vinyl
alcohol)44, and poly(propylene fumarates)45) and biologically-derived polymers
(e.g., hyaluronic acid46) (Figure 1.2). Towards tissue engineering or wound healing
applications, it is important that the hydrogel remains intact long enough for
11

delivered or recruited cells to secrete their extracellular matrix, but not persist too
long so as to impede tissue formation. For example, hydrogels have been
optimized for cartilage tissue engineering by tuning the degradation rate to control
matrix production and distribution by encapsulated chondrocytes47. Likewise, for
delivery of entrapped biomolecules, hydrogel degradation is primarily used to alter
the diffusion and kinetics of molecule release, which subsequently controls their
spatiotemporal presentation to local cells and tissues48. Often times, these
biological signals are designed to act as morphogens and influence tissue
formation and healing49.
As a complement to hydrolysis, which often occurs at pre-engineered rates
throughout the bulk of a material, biomaterials have also been engineered to
degrade via proteases, more similar to how tissues are remodeled in the body. In
pioneering studies by Hubbell and colleagues, peptides were incorporated into
hydrogel crosslinks that cleave through cell-produced proteases50,51, such as
matrix metalloproteinases (MMPs), elastases, and plasmin52-54. With this proteasemediated degradation and the addition of cell-adhesive signals, these biomimetic
hydrogels were remodeled by cells55 and could be tuned for specific applications,
such as the regeneration of bone and vascular structures50,54,56,57. In some
examples, only growth factors were embedded into the matrices and their release
occurred in a “cell-demanded” fashion58. This approach can also be harnessed to
control the delivery of molecules to treat diseases where protease activity is
altered, such as rheumatoid arthritis59, cancer60, and after myocardial infarction61;
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here, the drug release rate and dose are controlled through a feedback mechanism
(i.e., elevated protease activity releases more drug more quickly).
Although these examples have focused on hydrogels, there are many other
instances where degradation is used to control the dynamic properties of
biomaterials. As one highlight, drug delivery reservoirs have been incorporated
into synthetic devices, where they are covered by a thin biomaterial film (e.g.,
poly(lactic-co-glycolic acid) (PLGA))62. Subsequent drug release is mediated
through degradation of the films, where the timing is dependent on the
biodegradable polymer design. Release profiles can be pulsatile, and efficacy has
been shown for the delivery of chemotherapeutics from device for targeting
tumors63. Furthermore, stents have been designed to incorporate various drugs
through biodegradable coatings and reservoirs (vide supra), where drugs (e.g.,
paclitaxel) are released through polymer degradation at concentrations and rates
that can locally influence tissue response (e.g., suppress unwanted scarring or
restenosis)64.

1.3.2 Stimuli-Responsive Biomaterials
Beyond degradation, biomaterials have been designed to respond to a range
of environmental stimuli that may involve signals such as changes in temperature,
ionic strength, light exposure, mechanical stress, magnetic fields, or pH65. These
stimuli may initiate from the local biomaterial environment (e.g., after implantation)
or be introduced as an external “trigger” (i.e., active systems) (Figure 1.2).
Biologically responsive mechanisms include enzyme catalysis66, competitive
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ligand-receptor binding67, and nanometer-scale protein motions68, where material
properties and therapeutic release are altered based on the biological
environment. Important examples in this area are the release of insulin in response
to glucose catalysis69 or biochemically-triggered growth factor release70, where the
disease stimuli controls drug delivery. Materials are also designed so that the
presence of specific proteins can disassemble nanoparticles, opening up diseasetriggered therapeutics and diagnostics71. Hydrogels with pH responsive swelling
changes provide advantages for the oral delivery of therapeutics, where
biomaterials are stable in the stomach and then release drugs in the intestines72.
As active systems, biomaterials are being designed with dynamic properties
that introduce temporal signals to cells, towards the engineering of tissues, the
expansion of stem cells, or to understand complex cellular processes. One
common dynamic hydrogel system includes those fabricated from poly(N-isopropyl
acrylamide), which transition from a swollen to a collapsed hydrogel when
processed through its lower critical solution temperature (LCST). Changes in
volume, mechanics, and optical transparency occur when the material transitions
through its LCST, and these changes have been exploited to release cells and cell
sheets for tissue engineering73. Another stimulus of particular interest is light, due
to the allowed spatiotemporal control. Anseth and colleagues introduced light as a
trigger for the cleavage of crosslinks (e.g., containing o-nitro benzyl groups) in
hydrogels30 for the release of tethered signals or to probe how dynamic mechanical
properties influence the phenotype of valvular interstitial cells74. Light has also
been used to stiffen materials, where light introduces new crosslinks that can alter
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material mechanics at a user-defined time75. Beyond light, dynamic properties may
be introduced in ionically crosslinked gels, by the addition of multivalent cations76
or in physically associated DNA-based gels through the introduction of
complementary DNA77. All of these systems have been used to probe cell behavior
in response to dynamic environments.
Actively controlling biomaterials once implanted in the body is more
challenging, particularly to introduce the stimuli to materials that are implanted
deep within tissues. Light penetration can be attenuated at many depths and
wavelengths; however, there are numerous examples where light has been used
to either form materials78 or alter their properties when implanted79. Ultrasound is
another trigger that can be introduced to disrupt polymer structure and release
therapeutics80,81. As described with the biodegradable reservoirs above, a similar
system has been developed with electrochemically activated microchips with
release through the dissolution of a gold membrane82. While this system is nonpolymeric, it constitutes an important example of stimuli-responsive properties for
controlled release in implanted materials.
As a sub-set of responsive biomaterials, shape-memory materials exhibit
changes in geometry based on triggers such as temperature or light83,84. In brief,
these materials are fixed into a temporary shape (usually under stress) and then
transition into a relaxed permanent shape following an external or environmental
trigger. (Figure 1.2) Such a dynamic process may lead to the next generation of
minimally-invasive implantable constructs, capable of altering their geometry once
implanted39. As mentioned above, shape memory alloys (e.g., Nitinol®) were
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developed many years ago and have found commercial application, but the last
few decades have led to an increase in the number of polymeric systems available
for biomedical applications, along with those that under multiple transitions that
allow for sequential geometric changes. These polymers can be processed from a
range of covalently and physically crosslinked polymers and copolymers, including
from biodegradable polymers83,84, and have the potential to be designed for
degradation, elution of drugs, or even signaling to local cells for improved wound
healing.

1.4 From Bioinert to Biocomplex
Building upon advances in dynamic and responsive biomaterials, another
recent direction in soft biomaterials is the design of systems that engage with,
respond to, and integrate into the biological landscape. Such systems extend
beyond passive biological function (bioinert), and researchers seek to engineer
materials that actively interface with biologically complex environments
(biocomplex). Discoveries in the biological sciences have revealed how
information is processed and exchanged in the body, exposing new routes toward
engineering material-tissue interactions. For example, the language of the genetic
code presents novel therapeutics; the critical role of the ECM informs tissue
engineering and regenerative medicine; the genetic basis of many diseases (e.g.,
cancer, Marfan syndrome) transforms the way patients are treated; the
communication networks of the immune system inform vaccinations and cancer
16

therapy; and the discovery of the microbiome restructures the way we think about
bacteria.
Toward fueling advances in medicine, these basic scientific discoveries are
essential in the design of future biomaterials. For example, biocomplex materials
have the potential to perceive malignant dysfunction and respond by releasing
therapeutics to restore homeostasis; alternative systems could mimic critical
aspects of the ECM to direct tissue morphogenesis ex vivo. Often, the biggest
challenge is reducing the biological complexity into essential elements (e.g., rate
limiting steps, critical signaling factors) that enable a synthetic material to perform
a desired task. In this manner, biomaterials scientists are leveraging biologic
understanding to design materials that are structurally simple, yet functionally
complex in order to communicate with, react to, and synergize with biology to
address clinical needs. This section articulates the concept of biocomplex
materials through the following examples.
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Figure 1.3. Biologically complex materials. Biocomplex biomaterials interact with and
direct cells both internally and externally. For example, advanced drug delivery vehicles
introduce exogenous nucleic acid content to up- or down-regulate protein expression by
transporting sensitive biomolecules through the circulation, actively targeting specific
cells, and releasing the therapeutics into the cytoplasm. In addition, biocomplex materials
are designed to present external signals to cells, either those that are delivered with the
matrix or those that are recruited exogenously. These biomaterial niches can be loaded
with multiple cues, presented in concert or sequentially, to communicate, recruit or signal
to cells locally. For example, immune activating materials cooperate with native biological
signaling to recruit naïve immune cells to a site in the body, activate them with target
antigens, and equip them to target specific cells or tissues, such as malignant tumor cells.

1.4.1 Materials to Deliver Therapeutics
Bioinert micro- and nanocarriers that achieve long circulation times in the blood
have transformed parenteral administration of small-molecule drugs

85,86.

Potent

macromolecular biotherapeutics (e.g., antibodies, recombinant proteins, and
nucleic acids) have been identified that treat a variety of diseases at the molecular
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scale; however, because of their nature, they present unique challenges for
delivery. For example, translation of these therapeutics requires carriers that not
only circulate for extended periods of time, but also shield the sensitive molecular
cargo from degradation in the bloodstream, target specific cells or tissues, and
release cargo at the appropriate site of action. Additionally, the design of
biocomplex nanocarriers that address these challenges must be balanced by the
need for structural simplicity that enables reproducible manufacturing.
Some of the most clinically relevant biotherapeutics, whose efficacy hinges on
the design of biocomplex delivery systems, are nucleic acids (NAs). NA-based
therapies, such as ribonucleic acid (RNA) interference (e.g., microRNA (miRNA)
or short interfering RNA (siRNA)) draw inspiration from native mechanisms and
regulation in the transcription and translation of genetic material into protein. RNA
interference is a native avenue for post-transcriptional silencing of gene
expression, whereby miRNA or siRNA selectively prevent protein synthesis87. In
addition, exogenous messenger RNA (mRNA) can induce the production of
specific proteins to upregulate protein expression

88.

Since NA-based therapies

alter intracellular machinery, their efficiency relies on cytoplasmic delivery.
Moreover, these biomolecules are particularly sensitive to in vivo conditions,
exhibiting very short half-lives before biochemical decomposition is observed.
Therefore, successful translation requires a delivery vehicle that offers protection
from clearance or nuclease degradation, site-specific targeting, passage across
the cellular membrane, and endosomal or lysosomal escape89,90.

19

Toward this end, biocomplex polymeric and lipid-based nanoparticle
formulations have been developed to deliver NAs intravenously, some of which
have progressed to clinical trials (Figure 1.3)91. Specific advances have focused
on stable nucleic-acid lipid particles (SNALPs) and ionizable lipids that package
NAs and increase transport across the cell membrane89,90. The majority of NA
nanocarriers unintentionally accumulate in the liver, and to overcome this issue,
lipid structures have been recently developed that allow for selective passive
targeting of heart, lung, and vascular endothelial tissues92. Targeting to tumor cells
has been achieved by functionalizing the surface of delivery vehicles with ligands
that bind specifically to proteins that are selectively expressed on the surface of
tumor cells 93. A major challenge that remains in the clinical use of NA therapeutics
is their escape from endosome or lysosomes into the cytoplasm. To address this
issue, Sahay et al. identified NPC1 as a critical protein in the trafficking of lipid
nanoparticles that can be exploited in the design of materials that better escape
the endosome94.

1.4.2 Materials to Present Matrix Cues
The fields of tissue engineering and regenerative medicine rely on the
proliferation and maintenance of human cells outside of the body. Seminal culture
scaffolds have been designed to permit cell survival and proliferation, but are
inherently passive. While these bioinert scaffolds provided a route to maintain and
culture cells, recent improvements in scaffold design integrate biofunctional
aspects of the native signaling landscape 95. In vivo, cells integrate a complex array
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of signals from the extracellular environment that synergize with the genetic code
to instruct cell function, such as proliferation, phenotype, and differentiation. As
discussed, ECM cues include both biophysical and biochemical signals that vary
on multiple length and time scales. Additional signals are introduced by
neighboring cells via cell-cell contacts or secreted cytokines and growth factors.
Biocomplex 3D culture matrices seek to recapitulate critical ECM cues and cellcell signaling events through spatiotemporal control over matrix mechanics and
ligand presentation

96.

Toward this goal, both static and temporally controlled

presentation of adhesive ligands has been exploited to bias chondrogenic
differentiation of hMSCs30,97. In addition, dynamic control over substrate modulus
has been leveraged to reveal new mechanism of ‘mechanical memory’, bias
differentiation of mesenchymal stem cells, and mature cardiomyocytes28,98-100.
In another approach to communicate with cells, researchers have developed
biocomplex materials that exploit the language of the immune system to treat and
detect disease (Figure 1.3). These strategies utilize an understanding of how the
immune systems senses a foreign substance, arms itself for attack, and carries
out the attack. Mooney and coworkers demonstrated implantable devices that
interact with the immune system to suppress tumor growth101; specifically,
chemotactic factors were released locally to recruit dendritic cells, that were then
activated by local presentation of tumor antigens, which then instructed the
immune system to target cancer cells. An alternative approach employs implanted
materials to cooperate with the immune system to prime a pre-metastatic niche for
the recruitment of metastatic cells, preventing distal metastases and enabling early
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detection of cancer. Further, a suite of synthetic vaccines have been developed
similarly that communicate with immune cells to increase immunogenicity and,
ultimately, vaccine efficacy102.

1.4.3 Materials for Tissue Integration
Beyond intracellular and extracellular signaling, biocomplex materials have
been designed to orchestrate multicellular events. For example, Miller et al. used
3D printing of sacrificial sugar networks embedded within hydrogels to fabricate
vascularized neo-tissues36. Culver et al. employed laser writing of adhesive
peptides to instruct multicellular organization for the fabrication of vascular
networks within hydrogels103. Further, gradient biomaterials that present
biochemical ligands in a spatially defined fashion have been used to recapitulate
osteochondral and osteotendinous interfaces104,105.
Despite these in vitro advances, a major hurdle in the clinical utility of
implantable biomaterials (including joint replacements, smart drug delivery
materials, and cell carriers) is non-specific protein adsorption and the
accompanying foreign body response (FBR)106. No implanted material is truly
bioinert; proteins rapidly adsorb to the surface of biomaterials in the body with
random orientations and configurations106,107. Early, this proteinaceous layer
facilitates neutrophil adhesion and activation106,107. With time, macrophages fuse
to form foreign body giant cells that attack the implant surface while recruiting
fibroblasts, which deposit ECM and form a dense, fibrotic capsule that isolates the
implant from the surrounding tissue108. As a more clear picture of implant rejection
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has developed, the community has begun to present an array of biocomplex
materials that mitigate the FBR and assist integration with resident tissue. For
example, Jiang and colleagues developed Zwitterionic hydrogels that demonstrate
ultra-low protein fouling109, and the surface chemistry and nanotopography of
implant surfaces has been designed to limit macrophage activation106. Ratner and
colleagues further showed that implant porosity can be exploited to tune the FBR
and tissue integration110. While these advances demonstrate that biocomplex
materials can assist in the organization of multiscale tissues, clinical translation
remains hindered by an incomplete understanding of which critical signals to
present and integrate within biocomplex scaffolds.

1.5 Moving into the Future
There are thousands of different types of medical devices, diagnostic kits, and
pharmaceutical formulations that exist today as a result of advances in biomaterial
science and engineering. The polymers and soft biomaterials employed are
diverse in their origin, classification, and properties, and many products integrate
multiple components that are carefully selected for their performance and function.
Yet, as we look towards the future, the design of soft biomaterials is unifying
around concepts that include: hierarchy, complexity, dynamics and adaptation, as
well as healing111, and to realize this potential, better experimental methods
and modeling tools are needed so that we can understand how to synthesize and
engineer advanced biomaterials systems. While modern chemistry allows the
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synthesis of polymers with controlled molecular weights, defined sequences, and
integrated biological functionality, biomaterial systems depend on how these
structural elements assemble and interact at complex biological interfaces, as
this hierarchy ultimately dictates performance and function.
The biomaterials that are native to our body (e.g., the ECM) are profound in
their ability to remodel, adapt, and store and retrieve information; this is critical
during processes such as development, growth, and wound healing. While
biomaterials do not need to mimic all aspects of the complexities of a living
organism112, understanding the fundamentals of these processes unlocks future
opportunities in rational design of biomaterials. Contemporary research topics
include the development of healable materials, drug delivery systems that interact
with and deliver their contents in response to signals from cells, active materials
that promote healing of tissues that could not otherwise occur, medical devices
that integrate seamlessly with tissues at the implant site, and stealth nanosystems
that serve as sentinels to monitor and treat disease. Many of these developments
occur and will continue to revolve around multidisciplinary institutes and
environments that eliminate barriers and bring together chemists, biologists,
engineers, and clinicians, that bridge the academic-industrial divide, and engage
researchers on a global scale.
Key to all of these advances will be synthetic tools that allow control of
biomaterials from the molecular to the macro, for patterning and dynamically
revealing biological functionalities, and for engineering biocomplex materials with
enhanced properties, desired stability, and loaded with the biological signals
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delivered in the right context, locality, and time. Importantly, all of this must be
achieved in a manner that allows manufacturing at large scales and that
overcomes any regulatory challenges with the translation of new materials.
Biological complexity demands better tools to characterize changes in material
properties in situ, from molecular level features of degradation to structural
changes and functional properties. The body is a dynamic environment, so
biomaterials constantly experience changes that alter performance, and this
highlights the profound need for methods to allow tracking of biomaterials in
physiologically complex niches and/or improved in vitro assays that allow better
prediction of in vivo performance. Finally, to facilitate the discovery process,
methods to screen and model the broad and diverse experimental space is critical.
Clearly, rational material design will remain an important and leading approach of
the community, but combinatorial and high-throughput strategies that are
complemented by biological assays will allow mining of huge data sets to evolve
new hypotheses for improved biomaterial design.
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CHAPTER 2

Specific Aims and Research Overview

2.1 Introduction and Specific Aims
The medical importance of soft biomaterials has motivated the development of
innumerable materials systems, many of which have been introduced in the
preceding introduction. Despite these advances, injectable hydrogels have been
confined largely to thermoresponsive and covalently crosslinked systems, placing
constraints upon the delivery methods allowed as well as the tunability of the
material properties relevant to both in vitro and in vivo applications.1-3 While
covalently crosslinked hydrogels have the potential to achieve greater moduli
(>250 kPa) than physically crosslinked materials, suitability toward percutaneous
delivery (i.e., syringe or catheter injection) for clinical translation remains
challenging, in part due to crosslinking kinetics. Rapid crosslinking results in
delivery failure, while slow crosslinking limits material retention at the injection
site.4,5
In contrast, physically crosslinked hydrogels have the potential for formation of
solid hydrogels (i.e., in a syringe) that can be subsequently injected through shearthinning of the hydrogel into a liquid state (within the needle) and then self-heal
(i.e, re-form a solid gel) for localization within the tissue.6-9 Despite the great
potential of shear-thinning hydrogel systems as injectable therapeutic systems,
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such materials typically exhibit low mechanical strength (moduli <1kPa), slow
healing, and stochastically controlled degradation on the order of hours to days.9,10
With these challenges in mind, the goal of this dissertation was the
development and characterization of a shear-thinning and self-healing hydrogel
system capable of injection. Hydrogels were designed to harness guest-host (GH)
interactions to form supramolecular assemblies through complexation of
hyaluronic acid (HA) separately modified by adamantane (Ad-HA, guest) and βcyclodextrin (CD-HA, host). Importantly, the system is synthetically tractable,
enabling scalable synthesis and tunability of material properties.
To bolster the therapeutic utility of these materials, the physical properties were
tuned through various modifications of the guest-host hydrogel system, including:
(i) introduction of protease-degradable peptides between the HA and guest
molecule, (ii) dual-crosslinking (DC) of methacrylated CD-HA (CD-MeHA) and
thiolated Ad-HA (Ad-HA-SH) by Michael addition subsequent to GH assembly, and
(iii) formation of double network (DN) hydrogels through assembly of GH hydrogels
in the presence of an interpenetrating covalent network (methacrylated HA,
MeHA). Application of these supramolecular guest-host (GH) and dualcrosslinking (DC) hydrogel systems was further investigated towards treatment of
myocardial infarction (MI), demonstrating their potential in an application where the
precise delivery of hydrogels with tunable properties is desired. To systematically
address the development, characterization, and employment of these materials
systems, the following aims were developed.
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Specific Aim 1: Develop and characterize guest-host (GH) hydrogels capable
of injection.
Hypothesis: Complementary macromers with physically associating chemical pairs
will enable formation of injectable supramolecular hydrogels with tunable
properties.
HA was separately modified by adamantane (Ad-HA, guest) and β-cyclodextrin
(CD-HA, host), enabling non-covalent GH hydrogel assembly by simple mixing of
the two polymer solutions in water. The tunability of GH hydrogel properties was
investigated by rheological, degradation, and biomolecule release studies.
Characterization of the GH hydrogel microstructure was further examined in the
hydrated state by fluorescence microscopy and micromechanical characterization,
elucidating the heterogeneity of supramolecular assembling materials that may
evolve temporally. Finally, bioactive degradation of GH hydrogels was achieved by
introducing an enzymatically-degradable peptide sequence to link Ad to HA, and
both in vitro and in vivo hydrogel erosion was monitored in comparison to nondegradable peptide controls. These investigations develop the GH hydrogel
system and a base understanding of its tunable biophysical properties.

Specific Aim 2: Develop dual-crosslinking (DC) hydrogels capable of both
guest-host assembly and secondary covalent crosslinking in situ on
clinically relevant timescales.
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Hypothesis: Properties of guest-host hydrogels can be modulated by tandem
covalent crosslinking in situ via Michael addition.
Dual-crosslinking (DC) hydrogels were developed to address the low moduli
and rapid erosion typical of supramolecularly assembled hydrogels. Here,
thiolation of Ad-HA and methacrylation of CD-HA allowed a secondary covalent
crosslinking tostiffen the hydrogel in situ. To allow for sufficient time for injection,
reactions kinetics were tuned through choice of the Michael acceptor and reaction
conditions. Properties of the DC hydrogels were evaluated, relative to GH
hydrogels, through mechanical characterization, degradation analysis, and in vitro
tissue injection. A rodent model of MI was used to establish the potential for
therapeutic use, which is expanded upon in Aim 3.

Specific Aim 3: Assess the therapeutic potential of guest-host and dualcrosslinking hydrogels to attenuate LV remodeling in an ovine infarct model.
Hypothesis: GH hydrogels will enable facile percutaneous delivery, and
subsequent dual-crosslinking will mitigate post-MI remodeling through mechanical
stabilization of the infarct.
The overall goal of this Aim was to develop a preventative therapy for heart
failure, through attenuation of adverse LV remodeling post-MI by targeting
abnormal stress distributions in the myocardium that are known to result in
myocardial thinning and infarct expansion. To accomplish this, direct epicardial
injection of the GH and DC systems was employed in an ovine model of
39

posterolateral

MI,

with

evaluation

relative

to

saline

injection

controls.

Computational modeling was performed to predict the ability of hydrogel injections
to alter myocardial stress, and the efficacy of the therapy toward attenuating LV
remodeling was assessed through longitudinal measurement of ventricular
geometry and function. The prevention of mitral regurgitation, a direct result of
ventricular dilation, was investigated by echocardiographic and MRI methods.
Additionally, percutaneous endocardial injection of the hydrogels was performed
with guidance by fluoroscopy and intracardiac echocardiography.

Specific

Aim

4:

Develop

injectable,

cytocompatible,

and

tough

supramolecular double network (DN) hydrogels through tandem guest-host
and covalent crosslinking reactions.
Hypothesis: Interpenetration of supramolecular and covalent networks will enable
formation of tough cytocompatible double networks.
To expand the attainable mechanical properties of DC hydrogels, the tandem
supramolecular-covalent crosslinking approach was explored in the context of
double networks. GH hydrogels were formed with an interpenetrating network of
methacrylated HA (MeHA) covalently crosslinked by dithiothreitol. Additionally,
partial methacrylation of the GH hydrogels was performed to explore tethering of
the two polymer networks. The bulk properties of the double network hydrogels
were examined by a combination of shear, compressive, and tensile mechanical
testing, including moduli, failure stress, toughness, and self-healing capacity.
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Methods for cytocompatible hydrogel crosslinking were developed, based upon a
highly efficient phosphine catalyst, and long-term viability of encapsulated
mesenchymal stem cells (MSCs) was assessed in vitro.

2.2. Research Overview
Chapter 1 has provided perspective on recent developments in polymeric and
soft materials that have occurred in recent decades, including modern thinking in
biomaterial design and therapeutic applications. Building upon this general
background, Chapter 3 provides an in depth review of supramolecular hydrogels
— specifically, those formed through guest-host macrocycle interactions.
Particular attention has been given to the hydrogel structure, formation, properties,
and applications relevant to recent progress and remaining challenges in the field.
Chapter 4 outlines the development and characterization of a synthetically
tractable and easily scalable supramolecular hydrogel, based on the guest-host
interaction of hyaluronic acid (HA) modified by coupling of 1-adamantane acetic
acid (Ad-HA, guest) or aminated β-cyclodextrin (CD-HA, host). This guest-host
(GH) hydrogel serves as the base material system that is explored throughout the
dissertation. Specifically, while Chapter 4 develops an understanding of selfassembly at the molecular scale, Chapter 5 furthers develops understanding of the
microscale heterogeneity of these GH hydrogels with dependence on time and
hydrogel composition. While GH hydrogels undergo passive stochastic erosion,
Chapter 6 introduces a responsive hydrogel degradation mechanism through
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inclusion of peptide linkers susceptible to proteolysis, relevant to applications in
drug delivery. Chapter 7 then further develops GH hydrogels where mechanical
stiffness and degradation behavior are easily modulated in vivo by addition of
secondary covalent crosslinking (i.e., dual-crosslinking, DC). Applications toward
treatment of MI are explored in a rodent model, establishing the utility of the GH
and DC hydrogel systems.
Application of GH and DC hydrogels as a preventative therapy for heart failure
following myocardial infarct is further explored in Chapters 8, with application to a
large animal MI model. Specifically, the percutaneous delivery of GH hydrogels via
catheter-based intramyocardial injection is demonstrated, and metrics of leftventricular (LV) remodeling, such as thinning and dilation associated and resultant
decline in myocardial function are assessed. Additionally, the work explores the
role of these hydrogels in prevention of ischemic mitral regurgitation (MR), which
is a devastating secondary consequence of LV remodeling.
Toward further harnessing of the unique crosslinking within this system, the
dual-crosslinking is further explored in Chapter 9 in the context of interpenetrating
networks. Characterization of hydrogel toughness, self-healing, injectability, and
cytocompatibility are performed. Finally, Chapter 10 provides a summary of the
work presented, illuminating the overall impact of the GH hydrogel system upon
the materials science and biomaterials fields. Limitations of these material systems
are discussed, and potential future directions are proposed that may further
expand the use of these supramolecular hydrogels, including toward clinical
translation.
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CHAPTER 3

Supramolecular Guest-Host Interactions for the Preparation of
Biomedical Materials

Adapted from: Rodell CB, Mealy JE, Burdick JA. Supramolecular guest-host
interactions for the preparation of biomedical materials. Bioconjugate Chemistry
26, 2279-2289 (2015).

3.1 Introduction
While chemists have traditionally focused on methods of assembling atoms and
molecules through the formation and rearrangement of covalent bonds, it has been
elegantly noted that this strategy pales in comparison to the array of possible
interactions utilized in nature to develop large, complex molecular structures
through non-covalent bonds.1 These interactions are encompassed within the field
of supramolecular chemistry, which includes electrostatics, hydrogen bonding, van
der Waals forces, п-п interactions, and hydrophobic or hydrophilic attraction for
molecular assembly.2 While such interactions have long been known, the field has
continued to rapidly expand since the 1987 Nobel Prize was awarded to
Pedersen,3 Cram,4 and Lehn5 for their pioneering work in formalizing synthetic
methods in this area.
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Lehn described the concept of supramolecular assembly as “chemistry beyond
the molecule.” 5 This is because the non-covalent nature of supramolecular bonds
renders them inherently weaker than covalent bonds and they may therefore
exhibit thermodynamic or forcefully induced rearrangement. As a result,
supramolecular bonds display a capacity for directed assembly at length scales far
exceeding that of single atoms or molecules, such as with the formation of higher
order structures in biological proteins and tissues. The capacity for spontaneous
and reversible binding between molecular species is likewise a driving force in the
development of structured,6-8 dynamic,9 and self-healing10 materials, as well as in
pharmaceutical applications11-13 and directed cell-material interactions which will
be discussed herein.
One particular subset of supramolecular chemistry, namely guest-host
interactions, is of particular interest toward the biomedical community. These
bonds are based on the transient association of a molecule containing a cavity (i.e.
a cavitand) with suitable molecular guests. The family of cavitands includes both
naturally-derived

(e.g.

cyclodextrin)

and

synthetic

(e.g.

cucurbit[n]urils,

calix[n]arenes, and pillar[n]arenes) macrocycles.12,14-16 The criteria for a guest-host
pair involves complementary size of the host cavity and guest molecule, as well as
their specific interactions (predominantly through hydrophobic attraction). 17,18
These broad criteria lend themselves to the pairing of macrocycles with numerous
potential guests, which may be inert or stimuli-responsive molecules,
pharmaceuticals, biomolecules (i.e. peptides, proteins), polymers, or other
chemical species. Owing to the array of guest and host molecules and their
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synthetic flexibility, incorporation of these groups into polymeric materials may be
easily achieved for a diverse range of biomedical applications. Despite recent
developments in polymeric guest-host materials, there remains a tremendous
capacity for growth in the biomaterial utilization of these unique chemistries.
Toward elucidating these future directions, this review will highlight recent
advances in both our understanding and application of materials and interactions
mediated by guest-host macrocycle assembly.

3.2 The Structure of Self-Assembly
3.2.1 Direct Molecular Recognition
Supramolecular assembly may be ambiguous, with non-specific interactions
between numerous groups. Examples of such interactions in material assembly
include the formation of hydrophobic crystalline domains or charge-based
assembly of polyelectrolyte or polyampholyte polymers. These interactions may
be preferable in some cases, such as to facilitate incorporation of hydrophobic 19,20
or charged drugs21,22. However, such assembly processes involve development of
long-range order over relatively long timescales, which may hamper rapid
formation and recovery. Moreover, the prevalence of competitive binding groups
(i.e. any non-charged molecule, salts) may disrupt bond formation and material
assembly. Thus, it is important to define supramolecular interactions that have
more specific associations to fabricate robust materials for biomedical interactions.
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Toward this, direct associating systems are based on specific molecular
recognition of a guest by its corresponding host molecule upon mixing (Figure 3.1).
Such direct interactions do not require long-range order and therefore occur
rapidly, with timescales governed by the association constant (ka), enabling rapid
initial material formation and self-healing upon rupture. Numerous molecular
structures have been identified and designed to form guest-host pairs. These
include the relatively weak association of crown ethers, cryptands, and related
molecules;23,24 though, such associations are generally more suited for ionic
sequestration and not molecular recognition. Alternatively, an array of transient
peptide and/or protein interactions have been devised, 25-29 which often display
greater affinity and specificity, but at the cost of increasing complexity and
laborious synthesis. Finally, the guest-host macrocycles combine rapid, high
affinity molecular recognition with ease and scalability of synthesis.
Of the guest macrocycles, cyclodextrin (CD) is the most prevalent due to its
relatively high water solubility, low toxicity, and extensive history of use. The first
reference to CD was that of Villiers, in 1891, who isolated a crystalline substance
following bacterial digestion of cellulose.30 While research continued on the
formation and characterization of these crystalline dextrans, nearly half a century
passed before their cyclic structure was proposed (D-glucose units arranged in a
toroidal fashion through α-1,4 glycosidic bonds) and isolation of homogenous
fractions of α, β, and γ cyclodextrin (which contain 6, 7, or 8 repeat units,
respectively) was accomplished.14 Importantly, improvements toward these
synthesis and purification processes have proceeded to industrial scale, as have
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many strategies for their synthetic modification, resulting in a relatively cheap and
abundant material source.14,31 Enabled by the scalability of synthesis, CD
molecules are used in a variety of industrial, commercial, and pharmaceutical
applications and have been categorized by the Food and Drug Administration as
“generally recognized as safe” (GRAS).32-34 Moreover, the cavity sizes of CDs
allow them to include a range of guest hydrophobic molecules in its interior. Of
these potential guest molecules, adamantane (Ad) is widely regarded as having
one of the greatest affinities (Keq ≈ 105 M-1) due to its complementary size for βCD
and high hydrophobicity.35 Alternatively, responsive guest-host interactions have
emerged as a means of regulating these intramolecular interactions. These include
azobenzene and ferrocene, which are known to interact with numerous species of
CD and are responsive to light36 and redox conditions,37,38 respectively. This
behavior renders them particularly useful toward the development of responsive
delivery vehicles,39 actuating materials,40,41 and dynamically assembling
systems.42-44
More recently, alternate cavitands have emerged and demonstrated relevance
toward biomedical applications. This second generation of cavitands includes
cucurbit[n]urils (CBs), pillar[n]arenes, and calix[n]arenes. While CBs were first
prepared in 1905,45 investigation of their structure was not performed until 1981,46
and numerous CBs (typically 5-10 repeat units) have since been explored. Recent
examination has revealed mild in vitro toxicity of these groups, though only at
doses far exceeding those typical in vivo, supporting their continued
pharmaceutical used.47 Binding affinities for CBs are often greater than that of
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other cavitands and can reach values as high as K eq ≈ 1015 M-1.48 This may be
attributed, in part, to the binding of guest molecules through a combination of
hydrophobic and cation-dipole interactions.48-50 Moreover, the unique geometry of
CB[8]s allows for multivalent binding of guest molecules (such as naphthalene and
methyl viologen), which enables reinforcement of binding affinity by cooperation
between п-п stacking or charge-transfer interactions for guest-host complex
formation.51 Recently, the use of the cup-shaped calix[n]arenes and pillar-shaped
pillar[n]arenes toward biomedical applications has begun.12 Their translation to this
field has been previously hampered both by lower guest-host affinity and water
solubility when compared to their CD and CB counterparts; though, recent work
has sought to improve the affinity and water solubility of these macrocycles such
as through repeated and efficient modification by solubilizing functional groups, 52
resulting in macrocycles with improved utility in aqueous environments.

Figure 3.1. Molecular guest-host assembly. (A) Generalized schematic of host (red)
interaction with its corresponding guest (blue) to form a guest-host complex (purple), with
bonding equilibrium governed by the association (ka) and dissociation (kd) constants. (B)
Schematic representation of cavitand host species, represented by pillar[5]arene,
calix[4]arene, cyclodextrin, and cucurbit[n]uril.
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3.2.2 Polymeric Assembly
Guest-host molecular recognition is particularly useful for the formation of
supramolecular structures (i.e. guest-host hydrogels). Toward hydrogel formation,
pioneering work by Harada demonstrated that poly(ethylene oxide) (PEO) could
be threaded within multiple αCD moieties, yielding a rotaxane structure.53 Pursuit
of such systems further illustrated the formation of pseudopolyrotaxanes and a solgel transition upon simple mixing of PEO and αCD through crystallization of CD
domains (Figure 3.2A).54 These and similarly formed pseudopolyrotaxanes, such
as through pendant polymer modification with PEO or similar polymers (Figure
3.2B), have since become a basis for supramolecular assembled hydrogels which
have been separately reviewed.55 Such systems may be limited in therapeutic use,
due to long recovery times after injection,56 which may hinder injection site
retention, and the inaccessibility of CD in the network to interact with surrounding
molecules.
Alternatively, modification of polymers with guest and host groups (either as
end-groups or pendant modification) has become the primary method for
fabrication of supramolecular networks from guest-host interactions. For example,
the end-modification of mono- and bifunctional polymers has been examined
(Figure 3.2C), where potential applications may include the self-sorting of linear
supramolecular polymers or assembly of block copolymers with utility toward such
materials as responsive micelle assembly.57-59 In extension of this methodology,
multiarm PEO has been modified with either βCD or cholesterol (the guest
molecule) and van de Manakker and colleagues demonstrated formation of
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supramolecular hydrogels by mixing these precursors with controllable rheological,
erosion, and cargo release profiles.

60,61

Similarly, Charlot et al. extensively

explored the rheological behavior of binary associating systems by conjugating
βCD and Ad to chitosan, hyaluronic acid (HA), and other polymers as pendant
groups (Figure 3.2D). While low modification resulted in weak supramolecular
networks (typical G’ < 100Pa), their results demonstrated the importance of
polymer concentration, charge, and competitive binding on network assembly. 62
Moreover, theoretical and experimental approaches have been combined to
illustrate the importance of multivalent and inter-polymer interaction to generate
high avidity and network stability.63,64 Toward harnessing this understanding, our
group has demonstrated that higher degrees of modification of HA with these same
guest-host groups enables formation of more robust supramolecular hydrogels (G’
= 10 kPa possible) through generation of larger net avidity between polymers
which may be enhanced by multifold polymer junctions.65
CB macrocycles have also been explored to produce robust supramolecular
hydrogels. This work has been pioneered by the Scherman group, where polymers
were modified with pendant methyl viologen or napthoxy derivatives that form
ternary complexes with soluble CB[8] with high affinity (Ka ≥ 1011 M-2, Figure 3.2E).
Such materials resulted in good network mechanical properties (typical G’ >
500Pa) even at low polymer modification (5-10% of repeats).66,67 For further
information regarding polymer architecture and molecular organization in guesthost hydrogels and their influence on bulk hydrogel properties, the reader is
referred to extensive reviews that cover these topics.2,68
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Figure 3.2. Schematic representation of guest-host polymeric assemblies. (A, B)
CD-PEO pseudopolyrotaxanes; (C) supramolecular polymers from heterobifunctional (i),
homobifunctional (ii), and monobifunctional (iii) gelators; (D) separate, pendant
modification by βCD and adamantane; and (E) separate, pendant modification of polymers
by methyl viologen or napthoxy derivatives with crosslinking by ternary complexes with
soluble CB[8].

Beyond the ability to assemble into networks, supramolecular guest-host
interactions may be used to introduce structure at the nano- and micro-scales.
Indeed, the organization of many natural structures is driven by supramolecular
interactions, such as native extracellular matrix (e.g., fibrillar structure of collagen)
and the DNA superstructure. Such aspects may be recapitulated by synthetic
analogues.69,70 Observations of such behavior have been noted in numerous selfassembling systems including peptide amphiphiles71, DNA-based hydrogels72,
dendritic materials8, and PEG-based supramolecular systems73. In recent years,
there have been numerous reports indicating that similar hierarchical structures
are possible in guest-host hydrogels, though most include only observation of dried
samples by electron microscopy. Recent reports have shown the formation of
nanoparticles with well controlled size through synthesis of diblock copolymers
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containing βCD.74 Moving this structure into two-dimensional assembly, semi-rigid
four-arm macromolecules have been modified by methyl viologen and 2,6dihydroxynaphthalene which assemble into two-dimensional films upon mixing
with CB[8] in water. Both TEM and AFM confirmed a nanofibrillar structure, and
SAXS estimated the spacing of these features to be well approximated by the
theoretical pore size.75 In an interesting example of three-dimensional structure,
aggregation of N-isopropylacrylamide (NIPAAM) thermogels has been controlled
by introducing CB[7] as polypseudorotaxane side chains. Such inclusion results in
semi-rigid polymer segments that induce transition from a globular to porous
morphology that could be observed by optical microscopy in a hydrated state. 76
Control of physical structure on these length scales holds great promise for the cell
biology and biomaterials fields, as dynamic self-assembly of these structures may
best recapitulate the natural processes that drive cell behavior. Though, systematic
studies including the effects of polymer architecture, bond affinity, and other
variables are still lacking.

3.3 Diverse Biomedical Applications
3.3.1 Injectable Hydrogels
Injectable materials have become important in the biomaterials community as
they can be introduced in a minimally invasive manner through direct injection into
a tissue or via catheters. Many methodologies exist for formation of injectable
materials, including in situ gelling via initiated or autonomous polymerization,
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addition crosslinking, or thermogelation; however, there are numerous limitations
to such systems based on gelation kinetics (i.e. too fast leads to clogging of
delivery device, too slow leads to material dispersion upon injection). Alternatively,
guest-host hydrogels may be formed prior to injection (Figure 3.3A, i) and extruded
via shear-induced flow. Such shear-thinning properties are of interest for numerous
supramolecular hydrogels,77 due to their dynamic bonds that can be broken and
then reformed. Many practical requirements should be considered when designing
guest-host hydrogels as deliverable materials, such as the injection process (i.e.,
ease of injection and capacity for retention), as well as the subsequent physical
properties after injection (i.e., suitable moduli and degradation times).

Figure 3.3. Guest-host hydrogel injection. (A) Hydrogels are pre-formed within the
syringe through guest-host bonds (i) which are broken by shear stress (τ) within the needle
(ii). Following extrusion, bonds rapidly re-form (iii) to enable retention within the tissue.
Subsequent disassembly of the hydrogel in vivo occurs through spontaneous dissociation
of the dynamic bonds and resultant surface erosion of the polymer (iv). (B) Representative
oscillatory time sweep demonstrating initial hydrogel mechanics (i), yielding to enable flow
under high strain (ii), and rapid recovery (iii) such as that proposed for injection. Adapted
from (Rodell et al, 2013) with necessary permissions.

For shear-thinning materials, the injection process is governed by the material
response to shear stress; ideally, the material is pre-formed and then exhibits a
decrease in viscosity (i.e., shear-thinning) during injection that permits flow.
54

Indeed, this is the case for the majority of supramolecular materials, as the physical
bonds that permit assembly are temporarily broken (Figure 3.3A, ii). The kinetics
of bond formation, though, are of key interest to the shear response of hydrogels.
Craig and coworkers extensively studied the relationship of bond kinetics and
polymer relaxation timescales, demonstrating that disadvantageous shearthickening behavior arises if polymer relaxation occurs more rapidly than
reconnection of broken crosslinks.78,79 As such, the decreased polymer relaxation
may be accomplished through formation of multifold junctions in highly modified
guest-host hydrogels to enforce shear-thinning behavior and ease of injection.80
The physical chemistry underlying the flow process, as well as other fundamental
behaviors of supramolecular networks have been recently reviewed. 9 Beyond
regulating flow properties, the binding kinetics are also essential toward material
formation following injection (Figure 3.3A, iii), as rapid bond reformation is
essential for material retention. In recent work, we demonstrated that rapidly selfhealing guest-host hydrogels are well retained (>98% of initial hydrogel volume)
upon injection into myocardial tissue, whereas slowly crosslinking covalent
controls were not retained as gelation was too slow.81 This high material retention
is essential, including toward successful implementation of injectable materials as
tissue supplements, drug reservoirs, or cell delivery vehicles as discussed in
subsequent sections.
Also critical to the success of injected biomaterials are the final properties in
vivo, following injection. In many cases, material degradation may be desired to
eliminate the need for implant removal or permanent implantation. Guest-host
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assembled materials are of great utility toward this, as they undergo natural
disassembly due to their dynamic bonds (Figure 3.3A, iv). Thus, their rate of
degradation can be controlled through features such as material concentration,
guest-host affinity, and number of guest-host bonds.61,80 Additionally, the
degradation rate of such materials may be altered by inclusion of conventional
degradation mechanisms, including hydrolysis or enzymatic degradation. Toward
such control of degradation, Tian et al utilized a hydrolytically degradable
poly(organophosphazine) backbone grafted with PEO of differing molecular
weights. In the presence of soluble αCD, hydrogels were formed which exhibited
controlled release of bovine serum albumin (BSA) over a period of 2-12 days, with
concurrent and prolonged hydrogel degradation.82 More recently, bioactive
degradation mechanisms have been demonstrated; in one embodiment, micelles
and hydrogels were formed through inclusion of glutathione in the micelle core to
enable bioreduction of the polymeric structures which effected release of
doxorubicin.83 Additionally, pendant Ad modification of HA has included a peptide
linker susceptible to cleavage by matrix metalloproteinases (MMPs) that are
naturally produced in remodeling of the extracellular matrix. When combined with
pendant modified βCD-HA, hydrogels were formed which exhibited enhanced
degradation in the presence of mammalian MMP-2.84 These means of degradation
are of interest to the biomedical community to ensure clearance of the eroded
materials (e.g. failed renal clearance of high molecular weight PEO may limit
applicability of αCD-PEO hydrogels without inclusion of such hydrolysis
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mechanisms) and because bioresponsive degradation perpetuates such
applications as on-demand drug release and tissue-material integration.
As an alternative to enhanced degradation, prolonged material presence may
be desirable. Many supramolecularly assembled materials degrade in the course
of days, which may be too rapid for numerous applications in cell delivery or tissue
repair. One approach to achieve improved degradation lifetimes is the use of
higher affinity interactions, such as CB[8] with an electron transfer pair, which has
enabled sustained release of biomolecules (BSA and lysozyme) for up to 160 days
in vitro.85 Interaction of CB[6] and polyamine modified HA has also been used, but
implantation was achieved not by shear-thinning injection but instead by sequential
subcutaneous injection of the two components, with supramolecular assembly in
vivo. Inclusion of fluorescently labeled CB[6] in the hydrogel demonstrated
presence as long as 11 days, whereas the free fluorophore was released within 24
hours as examined by in vivo fluorescence imaging.86 These approaches
demonstrate the capacity for high affinity guest-host pairs to provide prolonged
delivery of biomolecules by diffusion or through modular modification with the host
molecule, though such high affinity guest-host interactions may limit shear-thinning
properties, hindering their use as injectable materials.87
Alternatively, the use of secondary stabilization chemistries, subsequent to
supramolecular bonding, has been achieved to enhance mechanical stability
without affecting injectability. Such processes have been accomplished in proteinbased supramolecular assembly using photopolymerization or thermogelation as
secondary gelation mechanisms.28,88 To allow for in vivo crosslinking and long57

term mechanical stability, we have recently introduced secondary crosslinking in
vivo through autonomous Michael addition, enabling covalent crosslinking on
clinically relevant timescales. Application in a rodent model of myocardial infarct
(MI) demonstrated a capacity for mechanical stabilization of the injured tissue,
tending to improve geometrical and functional outcomes relative to untreated MI
or guest-host material controls without secondary crosslinking.81 Though, care
should be taken in these approaches, as rapid covalent crosslinking may result in
delivery failure.

3.3.2 Therapeutic Delivery
In addition to formation of injectable materials by guest-host mediated selfassembly, these unique interactions have significant applications in drug delivery
strategies. The most widely used materials in this field have been the CD
macrocycles, as they have been used in many pharmacological drug formulations
including Sporanox©, Yaz©, and Abilify© among others.89 CDs form inclusion
complexes with various drugs, which improves the drug bioavailability by
increasing drug solubility and protecting them from degradation, which has been
reviewed extensively elsewhere.13,89,90 Guest-host interactions have also been
used recently to develop materials as drug delivery systems, providing novel
biofunctionality through non-covalent conjugation of bioactive pendant groups, as
well as the development of bulk materials to provide the controlled release of
growth factors, genetic material, and small molecule therapeutics.
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While improving the physiochemical properties of drugs has prevailed in the
translational application of guest-host complexes, more advanced nanoparticle
systems are also being developed. These systems leverage the formation of
guest-host complexes as a conjugation strategy to provide stealth or targeting, or
to allow nanoparticles to carry hydrophobic payloads (Figure 3.4A). Work from the
Davis group provides an excellent example of exploiting guest-host complexes in
delivery systems that have translated to clinical trials.91 They developed CD
functionalized polymer backbones that form polyplexes with siRNA payloads, with
surfaces that may be decorated with Ad coupled macromolecules such as PEG or
transferrin.92-94 This type of conjugation allows for rapid and modular modification
of particle systems with a variety of ligands. Similar non-covalent conjugation
strategies have been employed using other guest-host pairs such as CB[6] with
polyamines to provide targeted delivery of nanocapsules. 95,96 In addition to
strategies for noncovalent surface modification, macrocycles have been
incorporated into nanoparticles to act as molecular “docking” sites that can
facilitate drug loading (Figure 3.4B). This carrier functionality has been exploited
using amphiphilic CD nanocapsules to entrap tamoxifen, ionic βCD nanoparticles
as doxorubicin carriers, and CB[6] particles to carry paclitaxel. 96-98 Furthermore,
macrocycle interactions have provided an avenue for direct, noncovalent
conjugation of biofunctional groups to drug molecules (Figure 3.4C). As examples,
βCD functionalized with lactoferrin and saccharide ligands has been used to
complex and target drugs to lactoferrin and mannose receptors, respectively. 99,100
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In addition to nanoparticle strategies, guest-host systems have been leveraged
in bulk hydrogels to provide controlled release of therapeutic payloads. Many
groups have employed guest-host assembly to drive the formation of hydrogels
that can provide sustained release of biomolecule payloads such as proteins and
growth factors (Figure 3.4D). These systems provide diffusive release kinetics that
may be tuned through network properties such as porosity, mesh size, and
degradation, which may in part be mediated by dynamic supramolecular
interactions. For example, Liu et al used polyrotaxane assembly between αCD and
tri-block copolymers to form gels that display tunable sustained release of dextran
molecules as a model for release.101 Furthermore, the Scherman group developed
systems based on CB[8] assembly that provide tunable release of bioactive
proteins over sustained periods in vitro, as previously discussed.85 Finally, work
from the Hennink group as well as our own have shown tunable protein release
from βCD-based hydrogels, where crosslink density was used to control release
for up to 60 days.65,102 These applications have recently been extended in vivo,
where the guest-host hydrogel was used as an injectable material for diffusive local
delivery of multiple biomolecules (interleukin-10 and anti-transforming growth
factor β) to treat chronic kidney injury.103 Similarly, hydrogels composed of αCD
pseudopolyrotaxanes with PEO terminated block copolymers have been used as
an injectable reservoir for delivery of erythropoietin (EPO) in a rodent model of MI.
The therapy resulted in a tendency toward increased vascular density as well as a
significant decline in apoptosis and increase in myocardial function (fractional
shortening) as compared to saline, hydrogel alone, and soluble EPO injection.
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These examples demonstrate the multifaceted use of such material systems as an
easily prepared injectable material to generate diffusively controlled drug delivery
reservoirs in vivo.
A last mechanism by which guest-host interactions can control release of
molecules is through inclusion effects of therapeutics with macrocycles anchored
to a polymer backbone (Figure 3.4E). Several groups have investigated covalently
crosslinked hydrogels containing CD pendant groups to provide sustained release
of small molecules.104-109 In one example, the von Recum group developed
polyurethane gels containing CD as device coatings for the controlled release of
numerous antibiotics.110 Work from our own group has also explored CD retentive
effects for controlled release of small molecules including doxorubicin,
doxycycline, and peptides containing tryptophan residues, from guest-host
assembled networks, leveraging these interactions to provide a material with
simultaneous injectable and sustained release properties.109 These systems
provide tunable small molecule release through the engineering of host content,
as well as the guest affinity for the host included in the network.
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Figure 3.4. Guest-host interactions in drug delivery systems. Guest-host chemistry
may be used for direct, non-covalent modification of drug molecules with targeting ligands
(A), to provide non-covalent modification of nanoparticle drug carriers with targeting or
stealth ligands (B), and to impart molecular carrier functionality to nanoparticles (C).
Furthermore, in hydrogel systems, guest-host chemistry may be used to tune crosslinks
in hydrogels for the diffusive release of biomacromolecular therapeutics (D) or to promote
retention of small molecule therapeutics within the hydrogel (E).

3.3.3 Cell-Material Interactions
While the above applications have targeted material implantation and
therapeutic delivery through guest-host mediated assembly, still others have
sought to develop methods for the direct modification of cell-material interactions
using guest-host chemistry. These approaches to modulate cell-material
interactions have primarily taken two forms: modification of material surfaces and
the pursuit of material-assisted cell delivery.
Surface modification strategies are useful to introduce various biophysical and
biochemical signals to cells, and guest-host interactions provide an opportunity to
introduce dynamic signals that can alter cell behavior. Stupp and colleagues
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utilized the guest-host complexation of guest-bound adhesive peptide sequences
to alginate-βCD surfaces to dynamically control biomolecule display.111
Specifically, they utilized the fibronectin derived cell-adhesion sequence RGD
bound to the guest molecule Ad or naphthalene, suspended in culture medium, to
impart cell adhesion and spreading on the material surface. Importantly, spreading
was observed to be dependent on the affinity of the guest for βCD and was
reversible when napthyl-RGD was removed by competitive binding with the higher
affinity non-cell adhesive sequence Ad-RGES. In concurrent work, the CooperWhite group used supramolecular interactions to display RGD in nanopatterned
topographies produced by the segregation of Ad terminated polystyrene-co-PEO
block copolymers (PS-PEO-Ad).112 Such topographies are known to influence cell
behaviors, including adhesion, spreading, and differentiation. 113-115 The ratio of
PS-PEO/PS-PEO-Ad used to control the concentration of βCD-RGD bound within
the nanodomains influenced cell adhesion and area. Interestingly, the facile
conjugation process enabled the concurrent addition of RGD and the laminin
derived sequence IKVAV in set molar ratios, demonstrating similar adhesion
across all ratios with spreading and stress fiber organization dependent on RGD
concentration alone.
These methods of dynamic surface modification have demonstrated promise
toward influencing cell adhesion and spreading; however, little work has been
performed to directly demonstrate influence over cell differentiation. There is a
growing interest in the field to understand the effects of substrate properties on
differentiation, as indicated by the recent use of covalently or ionically crosslinked
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hydrogels with tunable viscous behaviors (i.e., creep and viscoelasticity) to study
differentiation.116-118 Toward understanding differentiation in response to
mechanically dynamic substrates, αCD-PEO polyrotaxane coated surfaces have
recently been explored. Here, the mobility of αCD was modulated by
methacrylation—thus varying its affinity for PEO. Subsequent coating of this
polyrotaxane surface by fibronectin produced a cell-adhesive surface which
demonstrated enhanced osteogenic differentiation in response to molecular
mobility. Though, results are complicated by a lack of standardization in fibronectin
density between groups.119
Cell delivery for therapeutic applications is often problematic, as cells have
limited retention at injection sites; however, hydrogels can be used to enhance cell
retention, particularly with rapidly re-assembling hydrogels.88,120 Toward such a
delivery approach, Kimoon Kim and colleagues have developed an in situ forming
supramolecular hydrogel (Figure 3.5) based on the interaction of hyaluronic acid
modified by CB[6] and alkylammonium ions 1,6-diaminohexane (DAH) or spermine
(SPM). Initial studies demonstrated the rapid formation of a hydrogel upon mixing
of CB[6]-HA with either DAH-HA or SPM-HA, though SPM-HA hydrogels exhibited
significant toxicity toward fibroblasts in culture. In contrast, DAH-HA hydrogels
exhibited good cytocompatibility and fibroblast proliferation was observed when
hydrogels included the cell adhesive RGD sequence which was modularly included
by guest-host interaction through preparation and addition of c(RGDyK)-CB[6].86
Building upon this work, they utilized the materials as a platform for the delivery of
engineered mesenchymal stem cells (eMSCs) for suppression of tumor growth. 121
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The authors engineered MSCs to produce interleukin-12 (IL-12) through
adenoviral transfection and demonstrated increased IL-12 production by hydrogel
inclusion of retinoic acid (RA, hydrolytically bound to HA) and CB[6] conjugated
dexamethasone (Dexa-CB[6], guest-host bound). Assessment of enhanced green
fluorescent protein (EGFP) expression in a subcutaneous injection model
demonstrated cell retention and continued protein expression beyond 60 days,
greater than three-fold longer than control hydrogels. Delivery of IL-12 producing
eMSCs in a subcutaneous murine melanoma model was successful in retarding
tumor growth and enhancing survival outcomes. Importantly, this effect was
enriched by inclusion of Dexa-CB[6] and RA, demonstrating the utility of
supramolecular drug inclusion.

Figure 3.5. In situ hydrogel formation. Schematic representation of in situ
supramolecular hydrogel formation including cell encapsulation (A), through mixing of
cucurbit[6]uril-conjugated hyaluronic acid (CB[6]-HA) and polyamine-conjugated HA (PAHA) and subsequent modular modification with various CB[6] bound tags. The chemical
structures (B) of CB[6] and PAs of diaminohexane (DAH) and spermine (SPM). Adapted
from (86) with necessary permissions.

While these studies by the Kim group have utilized sequential injection of the
hydrogel precursors and in situ hydrogel formation, such approaches may be
enhanced by a priori hydrogel formation in the presence of cells and subsequent
shear-thinning delivery. Indeed, numerous shear-thinning hydrogel systems have
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increased delivery efficiency both by increasing cell viability and retention at the
target site. Toward these efforts, the use of shear-thinning hydrogels based on CDHA and Ad-HA, previously discussed, have been used to encapsulate and deliver
endothelial progenitor cells (EPCs) to myocardial infarct tissue in rodents. Results
demonstrated enhanced engraftment of the EPCs with hydrogel delivery (via
constitutive GFP expression) at 1 week post-injection when compared to injection
of suspended EPC controls. The cell-hydrogel therapy likewise resulted in
enhanced vasculogenesis and contractile function when compared to controls of
saline, EPC suspension, and hydrogel alone injections.122 While results from such
studies are promising, there is still much work to be done to optimize injection
conditions of guest-host systems to make certain that viable cells are being
delivered. However, it is known that guest-host type hydrogels exhibit
characteristic shear-thinning and shear-banding, similar to other supramolecular
hydrogels where such studies have been performed. For example, in alternative
supramolecular systems such as in β-hairpin peptide hydrogels, shear-thinning
behavior resulted in plug-flow through cylindrical channels (mimicking injection
through a needle or catheter), which reduced exposure of encapsulated cells to
shear stresses and increased viability.123 Continuation of this work in loosely
crosslinked alginate hydrogels has highlighted the importance of extensional flow,
such as near entrance to the syringe needle, as a primary cause of acute cell
death.124 Extension of these studies toward direct assembling guest-host
hydrogels is essential toward understanding cell viability with respect to clinical
applications of cell delivery.
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3.4 Conclusions and Future Directions
Supramolecular guest-host chemistry has made great strides over the past
decades since formalization of synthetic methods for their production and
subsequent polymer modifications. Particularly in the field of bioengineering, these
unique chemistries have shown great potential toward numerous applications.
Arguably, the most advanced of these is therapeutic delivery, where the use of
cavitands (cyclodextrin in particular) to enhance solubility and bioavailability of
pharmaceutical drugs has become common practice. However, the capacity to
harness these interactions for drug delivery systems (i.e. nanotherapeutics, drugeluting coatings, and bioresponsive materials) currently remains primarily limited
to basic research. Similar to alternative methods of now conventional delivery,
such as liposomal formulation of chemotherapeutics, these methods hold promise
as a means to revolutionize the pharmaceutical industry; though, their
development to industrial scale and market approval remains a challenge.
At a more basic level, the use of guest-host materials as injectable therapeutics
is of great interest to the medical community. Such material systems perpetuate
numerous applications, including the local delivery of biomolecular therapeutics
via diffusion and the supramolecularly controlled delivery of small molecules or
suitably modified biomolecules. The use of such materials may also be of interest
in tissue bulking applications (e.g., dermal fillers, regenerative scaffolds) and
therapeutic cell delivery. However, the investigation of these important material
systems and applications is mainly limited to in vitro investigation, with exceedingly
few examples demonstrating in vivo efficacy. Further investigation of the in vivo
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material properties is needed to develop an understanding of material degradation,
mechanics, and therapeutic elution. Similarly, the biological response to guesthost materials, including macrophage recruitment and long-term fibrotic
encapsulation remains almost wholly unexamined. Further understanding of these
systems in a functional, biological setting is a needed priority in the field.
Finally, with respect to basic biological understanding—guest-host assembly
offers a unique platform for investigation of cell behavior in response to substrates
that mimic aspects of the dynamic ECM. This is embodied in the capacity to
dynamically alter cell culture substrates, including to mimic features such as
adhesion ligand mobility and substrate viscoelasticity in an attempt to represent
more biomimetic cellular environments. Toward the applications discussed herein,
understanding of the underlying chemical processes and polymer physics are of
utmost importance, as they ultimately control the bulk material properties to enable
dynamic, tunable, and responsive materials and bioconjugated systems.
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CHAPTER 4

Rational Design of Network Properties in Guest-Host Assembled
and Shear-Thinning Hyaluronic Acid Hydrogels

Adapted from: Rodell CB, Kaminski AL, Burdick JA. Rational Design of Network
Properties in Guest-Host Assembled and Shear-Thinning Hyaluronic Acid
Hydrogels. Biomacromolecules 14, 4125-4134 (2013).

4.1 Introduction
Injectable hydrogels continue to gain interest as scaffolds for biomolecule
delivery and tissue engineering due to their potential for minimally invasive delivery
and tunability in properties.1-3 Many injectable systems have been designed which
undergo chemical crosslinking in situ, ranging from transdermally photoinitiated
systems to autonomous redox reactions or Michael-addition crosslinking.
However, in situ polymerizing systems may be limited by initial diffusion of the
polymer from the injection site4 and the potential for premature gelation and
resulting delivery failure.5 Additionally, many of these systems are based on radical
initiation and potential issues such as cytocompatibility6,7 and protein bioactivity810

must be considered.
In contrast to hydrogels that form in situ with covalent crosslinking, hydrogels

based on physical crosslinking mechanisms (e.g., ionic and hydrophobic
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interactions, chain entanglement) have also been developed. While physical
crosslinking naturally leads to less mechanically robust hydrogels, this may be
beneficial as the physical associations are also the basis for advantageous shearthinning and self-healing behavior.11,12 In these systems, the application of shear
force breaks the physical crosslinks and creates fluid-like flow, allowing easy
injection of the material through a syringe or catheter, including with cells and
therapeutics as cargo. Upon cessation of shear, the hydrogel is able to
autonomously reassemble at the target site through these same crosslinking
mechanisms.
Numerous systems exhibiting shear-thinning properties have been reported.11
Typically, these systems rely on weak interactions to drive assembly of a global
architecture, including formation of entangled β-sheets or microcrystalline
domains.13-16 As a result of the required macrostructural assembly, these
hydrogels often exhibit recovery times on the order of minutes to hours when shear
is removed.11,17,18 These long times may limit their application as injectable
hydrogels, since the material components or therapeutic cargo may diffuse from
the injection site prior to reassembly. In contrast, systems based on the direct
interaction of complementary binding motifs have shown improved recovery times
and even near-immediate recovery of initial mechanics in some cases.19-22 One
example of complementary binding is embodied by guest-host chemical
interactions, which are composed of two or more chemical species which interact
through non-covalent bonds to drive molecular complexation in a defined structural
arrangement. Specifically, host macrocycles such as cyclodextrins have
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hydrophobic interior cavities which have high affinity for specific hydrophobic guest
moieties.23 Several systems employing guest macrocycles for supramolecular
assembly have been reported and reviewed.12,23-27 To date, such systems focused
largely on the development of nano and microparticulate drug carriers,
viscosupplements, triggerable interactions (e.g., light or heat), or the development
of applicable network theory to describe rheological behaviors. While there are
some examples on the development of supramolecular hydrogels, these structures
have been relatively weak mechanically, exhibited rapid erosion and biomolecule
release, or have not exhibited tunable network properties.
For many applications of injectable hydrogels, matching the physical properties
of the hydrogel and implant site is desirable. Recent studies have highlighted this,
as soft injectable materials resulted in reduced mechanical damage as compared
to analogous tougher hydrogels when injected for intrarenal drug delivery.28
Beyond the delivery mechanism, the final hydrogel properties are also important
as diffusive properties and hydrogel erosion control biomolecule release 20,29 and
the physical properties may influence encapsulated cell behavior with respect to
cellular migration,30,31 proliferation,32-35 and differentiation.36-39 Thus, it is important
to design systems where biophysical properties may be tailored for specific
applications and optimal outcomes.
Here, we report the synthesis and characterization of self-assembling
hyaluronic acid (HA) hydrogels based on the guest-host interactions of
adamantane-modified HA (guest macromer; Ad-HA) and β-cyclodextrin-modified
HA (host macromer; CD-HA). HA was chosen as the backbone polymer since it is
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found abundantly in tissues and has already been used extensively in biomedical
applications.40 The HA derivatives are therefore expected to provide a highly
biocompatible material as adamantane derivatives are widely used in the
pharmaceutical industry41 and cyclodextrins have attained FDA GRAS approval
and are readily included in pharmaceutical, cosmetic, and food products. 42,43
Moreover, the specific guest-host pair was chosen because it has been widely
investigated and is known to have a relatively high association constant on the
order of 1x105 M-1.23 As a result of this high affinity, mixing of the two macromer
components in aqueous solution resulted in hydrogels composed of non-covalent
bonds. The goal of this study was to investigate the tunability in network properties
and structure, as well as features such as molecule release and erosion.

4.2 Methods
4.2.1 General Materials.
Sodium hyaluronic acid (HA, 74kDa) was purchased from Lifecore (Chaska,
MN). All other chemicals were purchased from Sigma-Aldrich unless otherwise
indicated.

4.2.2 HA-TBA Preparation.
The sodium salt of HA was dissolved in DI water at 2 wt%, exchanged against
Dowex-100 resin, neutralized by tetrabutylammonium hydroxide, and then frozen
and lyophilized.44
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4.2.3 Ad-HA Synthesis.
Various functionalizations of Ad-HA were prepared by coupling 1-adamantane
acetic acid (Acros Organics) to HA-TBA via esterification. A round bottom flask
was charged with HA-TBA (3.0 g, 4.20 mmol repeat units, 1 eq), 1-adamantane
acetic acid (2.45 g, 12.59 mmol, 3 eq), and 4-dimethylaminopyridine (0.38 g, 3.15
mmol, 0.75 eq). The vessel was purged by nitrogen, and anhydrous DMSO added
via cannulation to afford an approximately 2wt% solution. Once fully dissolved, ditert-butyl dicarbonate (BOC2O) was added via syringe (quantity adjusted to afford
the desired final adamantane functionalization: 20%: 0.41 eq, 30%: 0.54 eq, 40%:
0.81 eq, 50%: 1.15 eq) and the reaction carried out at 45○C for 24 hours.
Purification was performed by dialysis for 3 days against DI water, precipitation in
acetone, and further dialysis. The solutions were frozen and lyophilized to afford
the final products. Adamantane functionalization of the macromers was quantified
by 1H-NMR (Bruker 360MHz) and determined from integration of the ethyl multiplet
of adamantane (δ=1.50-1.85, 12 H) relative to the HA backbone (δ=3.20-4.20, 10
H). The percent of HA repeat units modified were varied from 20%-50% as denoted
by the component subscript.

4.2.4 β-CD-HDA Synthesis.
Synthesis of 6-(6-aminohexyl)amino-6-deoxy-β-cyclodextrin (β-CD-HDA) was
performed by adaptation of similar reported syntheses. 45-47 β-cyclodextrin (20 g,
17.62 mmol, 1 eq) was suspended in water (125 mL) and cooled to 0°C. ptoluenesulfonyl chloride (TosCl; 4.2 g, 22 mmol, 1.25 eq) was dissolved in minimal
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acetonitrile (~10 mL) and added dropwise. The reaction was stirred at room
temperature for 2 hours. Sodium hydroxide (2.18 g, 53.6 mmol, 3.1 eq) was
dissolved in water and added dropwise. The reaction was stirred at room
temperature for 30 minutes before the pH was adjusted to 8.5 by addition of solid
ammonium chloride. The solution was cooled on ice and the precipitate collected.
The crude product was re-precipitated from cold water (3x200mL), washed by
acetone (3x50mL) and dried under vacuum to afford the intermediate 6-omonotosyl-6-deoxy-β-cyclodextrin (5.12 g, 23%) as a white powder. 1H-NMR
(DMSO-d6) δ = 2.42 (s, 3 H), 3.12-3.80 (m, overlaps with HOD), 4.12-4.40 (m, 6
H), 4.77 (s, 2 H), 4.83 (s, 5 H), 5.60-6.05 (br s, 14 H), 7.43 (d, 2 H), 7.75 (d, 2 H).
A round bottom flask was charged with 6-o-monotosyl-6-deoxy-β-cyclodextrin (5
g, 3.88 mmol, 1 eq), 1,6-hexanediamine (HDA; 20 g, 172.24 mmol, 45 eq), and
DMF (25 mL). The reaction was carried out under nitrogen at 80 ○C for 18 hours.
The product was precipitated from cold acetone (5x500mL), washed by cold diethyl
ether (2x100mL) and dried under vacuum to afford the final product (3.26 g, 68%)
as a white powder. 1H-NMR (DMSO-d6) δ = 1.14-1.61 (m, 12 H), 3.12-3.45 (m,
overlaps with HOD), 3.48-3.78 (m, 28 H), 4.28-4.56 (br s, 6 H), 4.83 (s, 7 H), 5.595.88 (br s, 14 H).

4.2.5 CD-HA Synthesis.
CD-HA was prepared by coupling β-CD-HDA to HA-TBA via amidation.39 A
round bottom flask was charged with HA-TBA (2.5 g, 3.43 mmol repeat units, 1 eq)
and β-CD-HDA (2.96 g, 4.86 mmol, 0.5 eq). The vessel was purged by nitrogen
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and anhydrous DMSO added via cannulation to afford an approximately 2wt%
solution.

Once

fully

dissolved,

(benzotriazol-1-

yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP; 1.06 g,4.86
mmol, 0.5 eq) was dissolved in minimal DMSO and added via syringe. The reaction
was carried out at room temperature for 2 hours. Purification was performed by
extensive dialysis against DI water and filtration to remove insoluble byproducts
from the reaction. The solution was frozen and lyophilized to afford the final
product. Functionalization was determined from integration of the hexane linker
(δ=1.35-1.85, 12 H) relative to the methyl singlet of HA (δ=2.1, 3 H).The percent
of HA repeat units modified was ~20% as denoted by the component subscript.

4.2.6 Determination of Apparent Binding Affinity.
To achieve the required solubility, 1-adamantane acetic acid was converted to
the sodium salt by neutralization with sodium hydroxide. Either the resulting 1adamantane acetate sodium salt or Ad20-HA was dissolved at approximately
2.5mM in DI water and titrated by either β-cyclodextrin or CD-HA. Samples were
frozen, lyophilized, and reconstituted in D2O for 1H-NMR spectroscopy. The ethyl
chemical shift of adamantane (CH2, 6H, δ0=1.61) was used to monitor guest-host
complex formation. The apparent binding affinity (Ka) was determined by fitting the
change in this shift (Δδ) and total β-cyclodextrin concentration [H]0 to the BenesiHildebrand equation
1
𝛥𝛿

1

=𝐾

1

𝑎 𝛥𝛿𝑚𝑎𝑥 [𝐻]0
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1

𝑚𝑎𝑥
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eq. (4.1)

where Δδmax is the maximum possible change in this NMR shift occurring with a
large excess of β-cyclodextrin, extrapolated from the curve fit. Linear models for
each case were fit in R and compared by ANOVA.

4.2.6 Hydrogel Formation.
For all characterization studies, hydrogels were prepared from stock solutions
of the individual macromers in PBS at the desired concentration. For hydrogel
formation by the guest-host assembly mechanism, the two component solutions
were combined and mixed by manually stirring to ensure a homogenous hydrogel
which was then briefly centrifuged to remove entrapped air. Unless otherwise
stated, adamantane and β-cyclodextrin were present in stoichiometric balance,
and the concentration refers to the overall weight percent of combined macromers.

4.2.7 Rheological Characterization.
All characterization was performed using an AR2000 stress-controlled
rheometer (TA Instruments) fitted with a 20 mm diameter cone and plate geometry,
59 min 42 s (0.995º) cone angle, and 27 μm gap. Rheological properties were
examined at 25ºC by oscillatory frequency sweeps (0.01-100 Hz; 1% strain),
oscillatory time sweeps at various frequencies (0.01, 1.0, 10, or 100 Hz; 1% strain),
oscillatory strain sweeps (0.01-500% strain 10Hz), and continuous flow
experiments with the shear rate linearly ramped from 0-0.5 s-1 or 0-5.0 s-1 and
returned. For shear recovery experiments, shear-thinning was performed at 250%
strain with recovery at 0.5% strain, each at 10 Hz. Frequency and time sweeps
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were performed on a minimum of 3 different samples and comparisons of moduli,
loss tangent, and bulk relaxation times between groups were performed by an
unpaired Student’s t-test. Comparison within groups at varying frequency was
performed by a paired Student’s t-test.

4.2.8 Fluorescent Labeling.
For erosion studies, Adx-HA products were fluorescently labeled to allow direct
quantification of polymer concentrations in solution. Following adamantane
modification,

products

were

again

converted

to

their

corresponding

tetrabutylammonium salts. Alexa Fluor 350 hydrazide was then coupled by BOP
mediated coupling in DMSO and purification was performed by extensive dialysis.

4.2.9 Hydrogel Erosion and BSA Release.
Custom fabricated molds of cast acrylic plastic (McMaster-Carr) were used to
contain the hydrogels within a 5 mm diameter 6 mm high depression exposed
directly to an overlying reservoir of buffer. The hydrogels were either fluorescently
labeled for erosion or loaded with 0.1 wt% fluorescein isothiocyanate conjugated
bovine serum albumin (FITC-BSA) as a model biomolecule to monitor release
behavior. Hydrogels were prepared as above, loaded into a 0.5cc syringe, and 20
μL of the desired hydrogel was injected into the depression. The mold was briefly
centrifuged to level the hydrogel surface. Hydrogels were covered with 1 mL PBS
and allowed to erode for up to 60 days statically at 25°C. At specified time points,
the buffer was removed from the well and replaced with fresh buffer. Macromer
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and BSA release were quantified calorimetrically relative to standard curves, and
data points represent the mean and standard deviation of three gels for each
composition.

4.3 Results and Discussion
4.3.1 Chemical Modification of HA.
The controlled esterification of HA with carboxylic acid containing groups has
been previously demonstrated to be a powerful means of reproducibly controlling
HA functionalization.48 Similar methodology was utilized here (Figure 4.1A,B) to
couple adamantane to HA, where 1-adamantane acetic acid was present in excess
and the final HA functionalization was controlled simply by altering the molar ratio
of BOC2O to HA repeat units. The chemical structure of Ad-HA was confirmed by
1H-NMR

spectra (Figure 4.1C), and functionalizations of 21.0, 29.1, 39.2, and

49.8% were produced as confirmed by integration of the ethyl multiplet of
adamantane (δ=1.50-1.85, 12 H) relative to the HA polymer backbone (δ=3.204.20, 10 H).
Various methods of producing CD grafted HA have been previously reported,
including the use of the Mitsunobu reaction and coupling through reductive
amination.49,50 Here, we utilized the amine coupling of β-CD-HDA to HA (Figure
4.1A), as the methodology allows for homogenous reaction conditions, controlled
final functionalizations, formation of a stable amide linkage, and requires a
monofunctionalized derivative of β-cyclodextrin which is easily prepared (Figure
4.1B). The chemical structure of CD-HA was confirmed by 1H NMR (Figure 4.1D)
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and a functionalization of 20.6% was determined by integration of the hexane linker
(δ=1.35-1.85, 12 H) relative to the methyl singlet of HA (δ=2.1, 3 H).

Figure 4.1. Synthesis of guest (Adx-HA) and host (CD20-HA) macromers. (A). (i) 3.0
equiv Ad-COOH, DMAP/BOC2O, DMSO, 45ºC, 24 h. (ii) 0.5 equiv β-CD-HAD, 0.5 equiv
BOP, DMSO, room temp, 2 h. (B). (i) 1.25 equiv TosCl, NaOH, H2O, room temp, 30 min.
(ii) 45 equiv HDA, DMF, 80ºC, 18 h. (C) 1H NMR of Ad20-HA. (D) 1H NMR of CD20-HA.
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4.3.2 Inclusion Ability of Guest and Host Macromers.
The hydrogel crosslinking scheme used here is based on the specific and direct
interaction of two complementary binding motifs, namely the guest-host
complexation of adamantane and β-cyclodextrin. As discussed in a recent review,
others have reported inhibition of the CD complex formation with guest compounds
having a low molecular weight or molar volume when the guest is attached to a
polymer chain.43 It is therefore essential to the molecular design that the binding
of the guest and host motifs is not impeded, such as by steric hindrance of the
proximal bulky HA polymer backbone.
The apparent binding affinity of the native guest-host complex and the
synthesized macromers was examined, as depicted in Figure 4.2. For each case,
the guest component was dissolved and titrated by the corresponding host
component. As a result of the hydrophobic interaction within the guest-host
complex, a pronounced down-field shift and broadening of the ethyl peak was
observed in the 1H-NMR spectra of adamantane (Figure 4.2B). This shift was
monitored throughout the titration and utilized to construct mole ratio plots of the
chemical shifts due to this interaction. All groups show a strong linear correlation
between the chemical shift and mole fraction (R2>0.98, Figure 4.2C), indicative of
the known one-to-one association of adamantane with β-cyclodextrin.
The apparent binding affinity was determined for each system by fit to the
Benesi-Hildebrand equation. While large error estimates in the maximum shift
make it difficult to directly compare the association constants reliably, 51 no
significant increase in slope for the linear models (i.e. decrease in binding affinity)
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was observed for the grafted guest and host molecules relative to the native
complex (p>0.054). The association constants are similar for all cases examined,
ranging from 503 to 536 M-1 and on the order of those determined by similar
spectrographic methods.52 The results confirm that the chosen macromer design
follows the expected one-to-one guest-host complexation and that tethering of
either the guest or host molecule to HA does not impede the binding of these
components with their complement.

Figure 4.2. Binding affinity determination. Confirmation of guest-host complexation for
modified macromers by titration of the guest (adamantane, Ad) by the host (β-cyclodextrin,
CD). (A) Schematic of Ad and CD interactions examined, either alone or when either Ad
or CD are coupled to HA (illustrated as black line). (B) Corresponding 1H NMR spectra of
Ad monitored throughout the titrations. (C) Mole ratio plots showing the ethyl chemical
shift of Ad with various molar ratios of CD/Ad investigated.
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4.3.3 Hydrogel Formation.
When HA macromers modified with either adamantane or cyclodextrin were
mixed in solution, near-immediate formation of a pseudoplastic hydrogel occurred
through the complexation of reversible guest-host moieties on complementary
macromers (Figure 4.3A). Specifically, while the individual macromer solutions
were flowable liquids, the formed hydrogel was stable to a qualitative inversion test
(Figure 4.3B). Oscillatory rheology confirmed that individual macromers were both
viscous solutions and that an increase in moduli of several orders of magnitude
occurred following mixing (Figure 4.3C).

Figure 4.3. Overview of hydrogel formation. (A) Schematic of dynamic crosslink
formation utilizing guest-host complexation. (B) Qualitative inversion test; Ad20HA 5wt%
(blue, left), CD20HA 5wt% (red, middle), CD20HA + Ad20HA 5wt% (purple, right). (C)
Oscillatory time sweeps of individual macromers and hydrogel formed at 5wt%; storage
modulus (G’, filled symbols) and loss modulus (G’’, empty symbols) at 10 Hz, 1.0% strain.
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The utility of spectroscopic methods previously discussed are limited to
solutions, as hydrogel formation results in freezing of the NMR signal. Thus, the
interaction of the Ad-HA and CD-HA in a one-to-one fashion was confirmed by
oscillatory rheology of hydrogels (7.5 wt%) consisting of either excess Ad 20-HA or
CD20-HA. Representative frequency sweeps (Figure 4.4A) demonstrate a
decrease in relaxation times and moduli for hydrogels containing excess Ad 20-HA.
Further quantification (Figure 4.4B) of the storage and loss moduli at various
stoichiometries shows a clear convergence on maximal properties when the guest
and host are present in a one-to-one ratio, confirming that balanced stoichiometry
affords the most robust hydrogel. As highlighted in Table 4.1, this condition also
coincides with the maximum theoretical crosslink density as may be expected for
such self-assembling systems.

Figure 4.4. Moduli dependence on guest-host mole fraction. Rheological confirmation
of optimal guest-host mole fraction. (A) Representative oscillatory frequency sweeps
showing storage modulus (G’, filled symbols) and loss modulus (G’’, open symbols) of
hydrogels containing excess adamantane in the given ratio with cyclodextrin. (B)
Quantification of moduli from time-sweeps performed at 10Hz, 1% strain and values
represent the mean of a single 5 minute time sweep for each formulation.
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Table 4.1. Hydrogel compositions examined. Parameters investigated and hydrogel
formulations used for each case are provided. Crosslink density reflects the maximum
theoretical density of guest-host pairs.

4.3.4 Control of Network Properties.
The crosslink density and architecture may be varied by the concentration of
the individual macromers and the extent of functionalization of the macromers with
either the guest or host molecules, as well as the ratio of guest to host components.
It has been previously proposed that two primary junction points exist within binary
associating systems similar to those developed here, as depicted in Figure 4.5A.
These include both weak network junctions composed of few guest-host
complexes and multifold junctions where multiple polymer chains entangle and are
joined by several guest-host complexes.53 Multifold junctions contribute largely to
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the properties of the hydrogels, as the sum of many guest-host interactions results
in an avidity greater than the affinity of a single guest-host bond. While both of
these junction point architectures may contribute to the moduli, the multifold
junctions dominate the slow dynamic properties of the hydrogel as stress
relaxation at these junctions requires the simultaneous slipping of multiple guesthost bonds. For any binary associating system, these two types of junction points
must exist in a thermodynamic equilibrium which governs the time-dependent
properties of the network.27

Figure 4.5. Representative frequency dependence. Example frequency dependence of
material behavior. Schematic representation of a weak network junction (top) and a
multifold junction (bottom) that are proposed to constitute the network junction points (A).
Representative oscillatory frequency sweeps showing storage modulus (G’, filled
symbols) and loss modulus (G’’, open symbols) of hydrogels composed of different
macromer concentrations (B) or Adx-HA modifications (C) as indicated.

In order to control the properties of assembled hydrogels, we altered the
crosslink density and junction point architecture through both the macromer
concentration and the guest macromer modification. First, an increase in the
macromer concentration (2.5 to 10 wt%) was utilized to increase the theoretical
crosslink density from 4.87 to 21.13 mM. At concentrations of 2.5 wt% and below,
hydrogels were observed to assemble and exclude excess solvent, which
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prevented consistent rheological measurement; at concentrations greater than 10
wt%, solutions were highly viscous and homogenous mixing was difficult.
Separately, the guest macromer modification was increased from 20 to 50% while
maintaining a macromer concentration of 7.5 wt%. Although this resulted in a
minimal change in the theoretical crosslink density (15.42 to 19.97 mM), the
proportion of effective multifold junctions is expected to increase as formation of
guest-host complexes requires the coordination of multiple polymer chains. The
frequency response of the materials illustrates the changes in network structure
for these separate conditions. Specifically, while an increase in the macromer
concentration resulted in an increase in moduli as well as a moderate reduction in
crossover frequency (Figure 4.5B), an increase in the guest macromer modification
resulted in drastic changes in the crossover frequency with little change in the
moduli across groups (Figure 4.5C).
Quantification of these observations across the frequency range demonstrated
the hypothesized phenomena. Notably, the storage modulus increased with both
macromer concentration and frequency according to a power law (Figure 4.6A,
4.7A). Similar relationships were observed for the loss moduli (Figure 4.7A),
though a more rigid solid was formed with increasing macromer concentration as
indicated by the decrease in the loss tangent (tan(δ), Figure 4.6C, 4.8A). However,
the moduli of hydrogels composed of varying guest macromer modifications did
not scale similarly with frequency. Rather, a moderate increase in moduli was
observed across groups, which was significant only at low frequencies (Figure
4.6B, 4.7B). A great reduction in the loss tangent (Figure 4.6D, 4.8B) at high
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modifications and low frequencies suggests the change in properties is a result of
the network junction architecture. In particular, a disproportionate increase in the
proportion of multifold junctions must limit network relaxation and thereby increase
moduli at low frequency.

Figure 4.6. Frequency dependence of material properties. Storage modulus (G’) of
hydrogels composed of different macromer concentrations (A) or Adx-HA modifications
(B). Loss tangent (tan(δ)) of hydrogels composed of different macromer concentrations
(C) or Adx-HA modifications (D). Values represent the mean measurement of 3 different
hydrogels. Please note the directional change in frequency magnitude between the
storage modulus and loss tangent plots. For two-dimensional representation, including
loss moduli and statistical analysis, please refer to Figure 4.7 and 4.8.
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Figure 4.7. Statistical comparisons of frequency dependence. Storage modulus (G’,
blue) and loss modulus (G’’, red) of hydrogels composed of different macromer
concentrations (A) or Adx-HA modifications (B). Values represent the mean ± standard
deviation of 3 different hydrogels. For (A) and (B), all differences across frequency are
significant. Within each frequency, insignificant differences are indicated (*) and pertain to
differences between groups for both G’ and G’’.

Figure 4.8. Statistical comparison of loss tangent. Loss tangent. Loss tangent of
hydrogels composed of different macromer concentrations (A) or Adx-HA modifications
(B). Values represent the mean ± standard deviation of 3 different hydrogels. For (A) and
(B), all differences across frequency are significant. Within each frequency, insignificant
differences are indicated (*).
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To corroborate these observations, the bulk relaxation time was examined. The
relaxation time is the characteristic timescale over which an applied stress is
dissipated by viscous behavior of the pseudoplastic hydrogel (i.e. bond reorganization to eliminate internal shear stress) and is directly determined from the
loss tangent as a function of frequency (tan(δ)=1; Figure 4.9). Guest macromer
modification was found to exhibit a greater influence over the bulk relaxation time
than macromer concentration (Figure 4.10A,B). For instance, an increase in
polymer concentration from 7.5 to 10 wt% resulted in a four-fold increase in the
bulk relaxation time; whereas, a similar increase in the theoretical crosslink density
by increasing macromer modification from 20 to 50% resulted in a nearly ninetyfold increase in the bulk relaxation time. These results support the notion that an
increase in the proportion of multi-fold junctions is produced by a mismatch of the
guest and host macromer modifications, and the effects on hydrogel behavior are
visually demonstrated in long-term flow experiments (Figure 4.10C). It was
observed that hydrogels having relatively short bulk relaxation times flow to allow
relaxation of internal shear stresses. However, hydrogels consisting of guest
macromers with high modifications exhibited negligible flow over the course of one
week. Taken together, the results demonstrate a methodology to independently
control the moduli and relaxation behavior of binary associating systems.
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Figure 4.9. Representative loss tangent and determination of relaxation time.
Representative oscillatory frequency sweeps showing loss tangent of hydrogels
composed of different macromer concentrations (A) or Adx-HA modifications (B). The
point at which the loss tangent is equal to one represents the crossover frequency where
the storage modulus (G’) is equal to loss modulus (G’’). The inverse of the crossover
frequency affords the bulk relaxation time.

Figure 4.10. Bulk relaxation behavior of hydrogels. Relaxation times with varied
macromer concentration (A) or Adx-HA modification (B). Values were quantified from the
frequency sweeps of three independent hydrogels and represent the mean ± standard
deviation of a minimum of 3 samples. All groups are significantly different with the
exception of 40 to 50% Adx-HA modification. (C) Images of hydrogels of varied
composition that were formed in the bottom of glass vials and the vials were placed on
their sides for up to one week.
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4.3.5 Shear-thinning and Recovery.
Since the guest-host assembly mechanism is based on reversible dynamic
bonds, formed hydrogels exhibited flow and recovery characteristics. To
demonstrate the desired shear-thinning ability required for injectable delivery
systems, hydrogels were subject to continuous flow experiments. Here, the shear
rate was linearly ramped from 0-0.5s-1 to investigate the effect of flow rate on
viscosity and resultant shear stress. In this regime of simulated slow flow
conditions, hydrogels that were formed from various macromer concentrations
(Figure 4.11A) or extent of guest macromer modification (Figure 4.11B) show the
desired shear-thinning behavior where viscosity decreases with shear rate.
Consequently, the shear stress approached a maximum. The terminal viscosity
and shear stress magnitudes were observed to increase with both macromer
concentration and modification of the guest macromer, while the profiles of shear
stress and viscosity changes with increased shear rate were similar across all
systems investigated.
While this behavior demonstrates the shear-thinning ability of this hydrogel
system, the shear rate experienced within a syringe may be far greater than those
explored here.54 Upon exploring higher shear-rates (up to 5s-1), trends in shearthinning behavior were not observed to change for increases in macromer
concentration; however, an increase in the guest macromer modification resulted
in a pronounced decline in shear-stress at high shear-rates (Figure 4.12). Similar
trends have been examined in various supramolecular networks, and shown to be
a consequence of network rearrangement during shear-induced flow.12,27,55,56
Specifically, if the chain relaxation time is slower than the reconnection of
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unassociated crosslinks, then a regime of drastic shear-thinning may be induced
above a critical shear rate. From these observations and previously discussed bulk
relaxation behavior, it is reasonable to conclude that the increased local stability
of multifold junctions decreases the chain relaxation time, resulting in pronounced
shear-thinning behavior when the extent of guest macromer modification is
increased. For biomedical applications, such drastic shear-thinning behavior may
be advantageous as it increases the materials ability to flow through a catheter or
narrow gauge syringe, which reduces the necessary force for injection.
To examine the timescale of material recovery, such as following injection,
hydrogels were subjected to cycles of large amplitude oscillatory stain followed by
low amplitude oscillatory strain. First, a strain sweep (Figure 4.11C) was used to
determine the yield stress for the hydrogel examined (~60% strain at yield), from
which a low (0.5%) and high (250%) strain were determined for recovery
experiments. Under cyclic deformation, materials demonstrated a clear decline in
moduli and concurrent gel-sol transition at the onset of high strain conditions
(Figure 4.11D). At the transition from high to low strain conditions, rapid recovery
to initial mechanics was observed. Even at a sampling rate of 0.75Hz, the transition
could not be observed as greater than 80% of the initial moduli were recovered in
this time and complete recovery was observed within 30 s. Similar recovery
characteristics were observed regardless of the number of cycles performed or the
composition of the hydrogel. These results indicate that the materials are capable
of near-immediate recovery following shear-thinning delivery, allowing optimal
retention of both material components and potential therapeutic cargo at the target
site.
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Figure 4.11. Guest-host hydrogel flow and recovery characteristics. Continuous flow
experiments showing the shear stress (closed symbols) and viscosity (open symbols) of
hydrogels composed of different macromer concentrations (A) or Adx-HA modifications
(B) as indicated by adjacent labels. Storage modulus (G’, red dotted line), loss modulus
(G’’, blue dashed line), and loss tangent (tan (δ), black solid line) of a hydrogel undergoing
a strain sweep at (C) or cyclic deformation (D) of 0.5% (low, unshaded areas) and 250%
(high, shaded areas) strain at 10Hz.
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Figure 4.12. Continuous flow at increased shear rate. Continuous flow experiments
at increased shear rate showing the shear stress (closed symbols) and viscosity (open
symbols) of hydrogels composed of different macromer concentrations (A, labels on
outside of plot) or Adx-HA modifications (B).

4.3.6 Hydrogel Erosion and Biomolecule Release.
Hydrogel erosion and the sustained delivery of therapeutic biomolecules are
required for many applications and the desired degradation and release kinetics
are dependent on the specific application. Although this study is not targeted
towards a single application, we investigated the tunability of hydrogel erosion and
concurrent biomolecule release through changes in crosslink density and network
architecture. Hydrogels investigated were contained within the depression of
custom fabricated erosion cells and exposed directly to buffer. For controls
comprised of individual macromer components, near immediate dissolution into
the buffer was observed. For all hydrogels investigated, initial high erosion rates
were followed by a slower phase of nearly linear erosion (Figure 4.13A,B). The
initial release of macromer is likely related to macromers that are not well
incorporated to the bulk system and can be released rapidly as the dynamic guesthost interactions become limited. Increasing the crosslink density through the
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macromer concentration resulted in a clear trend of decreased erosion rates
(Figure 4.13A). This is expected as the disassembly of gels is related to the number
of guest-host interactions in the network. Interestingly, increases in the guest
macromer modification were found to increase the rate of erosion, particularly in
the later near linear phase (Figure 4.13B). These results are counterintuitive
considering the erosion of dynamically bonded hydrogels are known to be
dependent on valency of the associating groups, as erosion of a macromer
requires the simultaneous dissociation of all binding groups.20 In this case, erosion
likely proceeds by surface erosion of small clusters of the macromers which are
no longer linked to the bulk hydrogel, suggesting network homogeneity plays an
important role in long-term stability.
As cyclodextrins are known to interact strongly with a great variety of small
organic molecules, primarily through hydrophobic interactions, they have been
extensively employed in the pharmaceutical industry. Particularly, cyclodextrins
have been investigated for their ability to complex with and control the release of
small organic molecules,24,26 and their interaction with proteins has also been
investigated for pharmaceutical applications as discussed in recent reviews.43
While such small molecule interactions have proven efficacy, the utilization of
supramolecular network structure to control biomolecule release has rarely been
examined.57 In order to perform a generalizable examination of this behavior, we
utilize bovine serum albumin (BSA) as it is a moderately sized biomolecule (66.5
kDa) with globular structure. Some proteins may contain phenylalanine or tyrosine
residues on the surface, enabling binding of cyclodextrins to the protein and
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resulting in interference with release. It is known that no such significant interaction
exists between β-cyclodextrin and BSA58 and the utilization of FITC-BSA has
previously been scrutinized in release from β-cyclodextrin based materials and no
interaction with fluorescein was observed.59
In this general study, we observed sustained release that was dependent on
both the macromer concentration and guest macromer modification. For all
hydrogels examined, release beyond 60 days was observed, which extends the
release capabilities beyond what has been achieved in hydrogels based on similar
supramolecular crosslinking. Importantly, release rates were readily tailorable
according to the macromer concentration (Figure 4.13C). Specifically, the time until
90% cumulative release was increased from approximately 21 to 53 days between
2.5 and 10 wt% hydrogels. While trends in protein release followed those of the
erosion profiles, protein release occurred faster than erosion, indicating that a
combination of diffusion and surface erosion likely contributes to release. This is
in contrast to similar reported systems employing high polymer concentrations
(>20 wt%) that showed zero-order release consistent with primarily surface
erosion.59 The effect of surface erosion is apparent in the release from hydrogels
of various guest macromer modifications. Here, a tendency towards increased
release rates with guest macromer modifications was observed, despite a
moderate increase in crosslink density (Figure 4.13D). These observations are
consistent with the previously described increase in erosion for these hydrogels.
The influence of this erosion based release mechanism minimally affected release,
with the time to 90% cumulative release occurring between 39 and 46 days for all
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hydrogels within this group. The observations herein provide a strong basis of
understanding the design parameters controlling hydrogel erosion and
biomolecule release for the guest-host hydrogels developed, perpetuating their
use in future applications.

Figure 4.13. Erosion and molecule release characteristics. Cumulative guest-host
hydrogel erosion profiles for various macromer concentrations (A) or Adx-HA modifications
(B). Model biomolecule (FITC-BSA) release from hydrogels composed of different
macromer concentrations (C) or Adx-HA modifications (D). Values represent the mean ±
standard deviation of 3 different hydrogels, each initially loaded with 0.1wt% FITC-BSA.
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4.4 Conclusion
Self-assembling HA hydrogels based on a guest-host assembly mechanism
were developed. The reactions chosen for modification of HA with the host
cyclodextrin and guest adamantane were simple, direct, and resulted in the desired
products with controlled functionalization and potential for scalable synthesis. The
resulting guest and host macromers were found to have a binding capacity which
was unhindered by the molecular structure. Formation of a hydrogel by simple
mixing of the two macromer components in aqueous solutions was demonstrated,
and the properties of the resulting hydrogel was dependent on crosslink density
and network architecture which were separately controlled by macromer
concentration and guest macromer modification. Importantly, all hydrogel
formulations examined were capable of shear-thinning behavior to enable ease of
injection as well as rapid recovery to localize the hydrogel and its potential
therapeutic cargo at the site of injection. Erosion and model biomolecule release
demonstrated a remarkable stability and tunability based on hydrogel design. In
short, the hydrogel system developed shows great potential as a minimallyinvasive injectable material platform due to its demonstrated tunable mechanical
properties, near-ideal flow and recovery characteristics, and remarkable stability
towards erosion which affords controlled long-term biomolecule release.
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CHAPTER 5

Evolution of Hierarchical Porous Structures in Supramolecular
Guest-Host Hydrogels

Adapted from: C.B. Rodell, C.B. Highley, M.H. Chen, N.N. Dusaj, C. Wang, L.
Han, J.A. Burdick. Evolution of Hierarchical Porous Structures in Supramolecular
Hydrogels. (In Preparation).

5.1 Introduction
Material heterogeneity arises naturally from supramolecular self-assembly
processes, leading to complex structures that are adaptive and temporally
evolving.1 Indeed, natural materials such as the extracellular matrix are formed via
supramolecular self-assembly (e.g., the fibrillar structure of collagen). The
formation of such structures has been mimicked with synthetic analogues,
including with peptide-based assemblies2-6 that recapitulate many aspects of the
native extracellular matrix such as its fibrillar structure.7-9 Similar principles have
been exploited to form highly ordered and even porous materials through block
copolymer assembly,10,11 hydrogen bonding,12,13 and with DNA-based materials.14
Though, the utility of such methods is limited largely to the fabrication of structures
at the nanoscale.15
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Alternatively,

bulk

physical

hydrogels

have

been

formed

through

supramolecular assembly of modified polymers.16-18 Prominent among these
physical hydrogels is the utilization of cyclodextrins, cucurbit[n]urils, and other host
macrocycles that form dynamic physical associations with an array of
corresponding guest molecules. Through polymer conjugation, these macrocycles
have bridged the gap between simple supramolecular bonding and complex
macromolecular self-assembly processed, enabling formation of precise nanoand micro-particulates, as well as bulk hydrogels.18,19 Within these bulk hydrogel
systems, the polymer structure has been generally regarded as highly disordered
and homogenous. However, theoretical exploration has predicted well-ordered
states, such as polymer alignment, are thermodynamically preferred. 20 Such states
are proposed to arise from the dynamic rearrangement of supramolecular bonds,
which enables the polymers to self-sort into their lowest energy state — the
configuration in which the number of guest-host complexations is maximized.
Monte Carlo simulations of polyelectrolytes have demonstrated such phenomena,
including polyelectrolyte collapse into dense heterogeneous structures through
introduction of divalent counterions.21 Experimentally, recent reports have
indicated the potential of bulk physical hydrogels, including those formed through
macrocyclic assembly, to form heterogeneous structures.22-26 Despite the depth of
theoretical works, there remains a lack of experimental observation bridging the
gap between directed polymeric self-assembly and supramolecular microstructure.
Towards the development of these physical hydrogels, a better understanding
of the underlying phenomena is needed, in conjunction with experimental
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examination of the hydrogel microstructure and ways to control its features.
Hydrogels from supramolecular assemblies are finding widespread use in
biomedical applications, including as injectable hydrogels for the delivery of
therapeutics and cells.27-31 In this case, heterogeneity may influence outcomes
such as drug release profiles and cellular interactions, where the scale at which
biochemical and biophysical signals are presented to cells may be important. 32,33
The control of microstructural evolution in supramolecular assemblies may add to
techniques such as particle leaching, gas foaming, freeze-drying, and
electrospinning34 which are currently used to introduce structural heterogeneity.
Herein, we investigated the evolution of heterogeneity in supramolecular
hydrogels formed through guest-host association of β-cyclodextrin (CD) and
adamantane (Ad) when separately conjugated to hyaluronic acid (HA).
Investigation was performed via confocal microscopy in the hydrated state to
elucidate hierarchical assembly via guest-host induced polymer condensation. The
temporal evolution and influence of hydrogel composition on porosity were
explored via quantitative image analysis. Further, multiple modalities of
micromechanical analysis were used to explore the extent of polymer segregation.
The work represents a systematic study of hierarchical microporous assembly in
supramolecular hydrogels, offering insights into mechanisms of formation and
control of the hydrogel structure.
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5.2 Experimental Methods and Materials
5.2.1 Materials Synthesis.
Reagents were purchased from Sigma-Aldrich, unless otherwise indicated.
Hyaluronic acid (HA, 90kDa; Lifecore Biomedical) was methacrylated (MeHA) via
esterification with methacrylic anhydride (pH 8.25-8.5, 3 hrs, 30% modification)35
and subsequently converted to the tetrabutylammonium salt (MeHA-TBA) by ion
exchange against Dowex 50Wx8 hydrogen form and neutralization by aqueous
tetrabutylammonium hydroxide (0.4M, Fisher Scientific).36 MeHA-TBA was
modified by 1-adamantane acetic acid (Acros Organics) to form Ad-MeHA or 6-Omonotosyl-6-deoxy-β-cyclodextrin to form CD-MeHA by anhydrous reaction in
DMSO according to our previously published methods.37 Briefly, coupling of
cyclodextrin (0.6 eq) and HA (1.0 eq disaccharides) was accomplished by reaction
in

the

presence

of

(benzotriazol-1-yloxy)tris(dimethylamino)phosphonium

hexafluorophosphate (BOP, 0.6 eq), yielding 25% of disaccharides modified.
Esterification of adamantane (3.0 eq) and HA (1.0 eq disaccharides) proceeded by
reaction with di-tertbutyl dicarbonate (BOC2O) and 4-dimethylaminopyridine
(DMAP, 1.5 eq) where the amount of BOC2O was varied to alter HA modification:
25% (0.47 eq) and 50% (1.13 eq). For all HA derivatives, purification was
performed by exhaustive dialysis, filtration to remove insoluble byproducts where
necessary, and lyophilization. 1H NMR spectra were acquired in deuterated water
(360 MHz, Bruker) and determination of HA modifications performed as previously
described.37,38
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In order to fluorescently label the hydrogels, the peptide GCKKG was prepared
by solid phase peptide synthesis (PS3, Protein Technologies) from FMOC
protected amino acids and glycinol 2-chlorotrityl resin (Novabiochem) and
terminated with either 5(6)-carboxyfluorescein (GCKKG-Fluor) or rhodamine B
(GCKKG-Rho). Molecular weight was confirmed by MALDI-tof mass spectrometry
(Applied Biosystems Voyager 6030; GCKKG-Fluor: m/z = 893.3, expected 893.5
Da and GCKKG-Rho: m/z = 959.5, expected 959.5 Da).
Ad-MeHA and CD-MeHA were labeled by the fluorescent peptides to form AdMeHA-Fluor and CD-MeHA-Rho, respectively. The desired peptides were
dissolved in deionized water (0.015 eq) and added dropwise to a solution of the
methacrylated polymer (220 mmol disaccharides, 1.0 eq) dissolved in
triethanolamine buffer (0.2 M TEOA in PBS, 10 mL, pH 10). Following reaction at
room temperature for two hours, purification was performed by exhaustive dialysis
and products recovered by lyophilization.

5.2.2 Hydrogel Formation.
Adamantane and β-cyclodextrin were maintained in a one-to-one ratio, and AdMeHA of 25% modification was used for all samples, except where indicated. The
concentration (1.25-10.0 wt%) denotes the combined weight percent of both guest
and host polymers. Hydrogels were prepared from separate solutions of the guest
and

host

polymers

in

PBS

containing

5.0

mM

lithium

phenyl-2,4,6-

trimethylbenxoylphosphonate (LAP, photoinitiator). The two component solutions
were combined, manually mixed, and centrifuged to remove entrapped air.
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5.2.3 Microscopic Characterization.
For analysis of polymer co-localization, separately labeled guest (Ad-MeHA-Fluor)
and host (CD-MeHA-Rho) polymers were utilized. Hydrogels were formed as
described, cast in cylindrical molds (8 mm diameter, 75 µL hydrogel), covered in
PBS, and incubated for the prescribed period. Prior to confocal imaging (Leica TCS
SP5, 20 µm z-spacing, 20x immersion lens), buffer was changed to PBS
supplemented with 5.0 mM LAP (2 hr incubation) and photocrosslinked (EXFO
OmniCure Series 1000, 320-390 nm filter, 10 mW/cm2, 3 min) to stabilize the
structures.
Examination of hydrogel porosity was similarly performed, with hydrogels
consisting of Ad-MeHA and CD-MeHA. For imaging and quantification, GCKKGFluor was included (5.0 mM) in the buffer at the time hydrogels were dissolved as
well as during LAP incubation prior to photocrosslinking. Samples were repeatedly
washed by PBS prior to image acquisition, which was performed as described. For
quantification (ImageJ) of hydrogel void fraction, images were thresholded and
converted to binary (n = 4 hydrogels/group, 10 slices/hydrogel). The pore diameter
(n = 4 hydrogels/group, > 3pores/hydrogel) was determined as the maximum
diameter for the observed pore. Data is reported as mean ± standard deviation.

5.2.4 Atomic Force Microscopy.
Hydrogels were formed as described and cast into ~ 200 µm thick layers between
two glass slides. To aid in sample recovery, one slide was hydrophobically treated
(Rain-X). Following incubation for 3 days, samples were incubated with 5.0 mM
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LAP (2 hrs) and photocrosslinked (10 mW/cm 2, 3 min). The top surface was
exposed by removal of the treated slide and then subject to atomic force
microscopy (AFM)-based nanoindentation. Nanoindentation was performed on the
top surface and pore center (n ≥ 2 locations/sample, 3 repeats/location) at 10 µm/s
indentation depth rate using a borosilicate microspherical tip (R = 12.5 µm, nominal
spring constant k= 0.03 N/m) and a Dimension Icon AFM (BrukerNano). The
effective indentation modulus, Eind, was calculated by fitting the loading portion of
each indentation force-depth (F-D) curve to the elastic Hertz model:
𝐹=

3
1
4∗𝐸𝑖𝑛𝑑 ∗𝑅 ⁄2 ∗𝐷 ⁄2

[3(1−𝑣 2 )]

eq. (5.1)

where R is the tip radius and ν is Poisson’s ratio (0.49 for highly swollen
hydrogels).39 Data are reported as mean ± standard error and comparison was
performed by a two-tailed Student’s t-test with significance determined at P < 0.05.

5.2.5 Diffusive Microparticle Tracking.
Hydrogels were cast in thin layers, as described for AFM characterization, with
hydrogels containing 0.2 µm fluorescent carboxylate-modified polystyrene beads
(Fisher, 6.7x10-3 wt%). Following swelling at 37○C for 7 days, a concentrated
solution of microbeads (< 5 µL, 0.04 wt%) was introduced into the aqueous phase
via a microinjector and beads were allowed to passively diffuse throughout the
construct. Controls included suspension of microbeads (6.7x10-3 wt%) in PBS
containing soluble unmodified HA (0, 2.5, 5.0, and 10.0 wt%) as well as beads
adhered to a glass surface (fixed, non-diffusive control). Fluorescent beads were
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imaged for 30 seconds at 62.5 fps (Basler acA640-90uc) at 40x magnification
(Olympus BX51).
For analysis, images were corrected via background subtraction and
sharpening (ImageJ). Corrected images were analyzed (Trackpy) to determine the
trajectory and mean squared displacement (MSD) of individual particles; drift
correction was used as necessary to account for non-diffusive motion. Data was
analyzed (MATLAB) by assessment of MSD during the first second of recorded
motion, where data for each particle was approximated by a power law:
𝑀𝑆𝐷 = 𝐷𝜏 𝛼

eq. (5.2)

where D represents the diffusion coefficient and the power, α, describes the
diffusivity law of the sample (i.e., superdiffusive, diffusive, or subdiffusive). Data
for MSD (n = 3 sample/group, >25 particles/sample) and fit parameters are
reported as mean ± standard error. Fit parameters were determined by leastsquares regression in MATLAB (Mathworks) and comparisons performed by
ANOVA with post hoc Tukey’s HSD; significance was determined at P < 0.05.

5.3 Results and Discussion
5.3.1 Material Preparation and Polymer Co-Localization.
Macrocyclic guest-host assembly has been used to form hydrogels with diverse
polymeric structures and guest-host pairs.18 Here, we utilized hyaluronic acid (HA)
modified (Figure 5.1A) by 1-adamantane acetic acid (Ad-HA) and aminated βcyclodextrin (CD-HA) as previously described.37 Upon aqueous dissolution and
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combination of Ad-HA and CD-HA polymers, hierarchical assembly (Figure 5.1B)
is initiated at the molecular scale through guest-host (GH) complexation. At the
macromolecular level, it has been proposed that binary associations between
polymers

with

such

structure

(i.e.,

linear

and

pendantly

modified)

thermodynamically favor the formation of specifically structured polymer pairs,
including lateral assembly in a “railway” type complex to minimize free energy, 20
resulting in GH polymer condensation. Extrapolating this conception to a dense
combination of guest and host polymers, we hypothesized that the initially
homogenous mixture would not represent the thermodynamically favored state.
Rather, stochastic rearrangement of bonding pairs was expected to result in
polymer condensation at the microscale.

Figure 5.1. Polymer structure and self-assembly. (A) Chemical structure of the
component polymers, including hyaluronic acid (HA, black) modified by 1-adamantane
acetic acid (Ad, green) or β-cyclodextrin (CD, red). (B) Schematic of guest-host (GH)
hydrogel hierarchical organization at the molecular, polymeric, and microscales.

Indeed, macromolecular self-assembly has resulted in ordered structures,
including in porous network assembly by crown ethers26 as well as in thin film and
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bulk hydrogel assemblies by cucurbit[8]uril.24,25 Though, such observations have
primarily been made by scanning electron microscopy (SEM) of dried samples,
where freeze-drying may induce porosity via ice crystal formation as an artifact of
the methodology. Such artifacts have been observed in cucurbit[8]uril hydrogels
by examination via small-angle neutron scattering (SANS) which revealed no
change in nanostructure with increased crosslink density, despite observation of
porous structure by SEM.40
Given these prior observations, direct visualization of hydrogels in the hydrated
state was deemed essential. To enable microscale imaging in aqueous conditions,
guest and host polymers were methacrylated to allow fluorescent labeling via
Michael addition reactions—where Ad-MeHA and CD-MeHA were labeled by
thiolated fluorescein (Fluor) and rhodamine (Rho) to yield Ad-MeHA-Fluor and CDMeHA-Rho, respectively. Additionally, methacrylate functionalization was utilized
to stabilize the supramolecular hydrogels via photopolymerization 41 in the
presence of lithium phenyl-2,4,6-trimethylbenxoylphosphonate (LAP) to prevent
disruption of the structures, which may occur due to physical agitation or thermally
induced GH complex dissociation.
Solutions of Ad-MeHA-Fluor (0.95 wt%), CD-MeHA-Rho (1.55 wt%), and their
corresponding GH hydrogel (2.5 wt%: 0.95 wt% Ad-MeHA-Fluor + 1.55 wt% CDMeHA-Rho) were incubated for three days prior to photopolymerization and
examination. Photopolymerized Ad-MeHA-Fluor and CD-MeHA-Rho controls
remained translucent at the macroscale (Figure 5.2A); whereas, GH hydrogels
were translucent upon formation but then turbid by day 3, indicative of light
diffraction by microstructural inhomogeneity. When identical samples were
examined with confocal microscopy and quantified with intensity profiles (Figure
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5.2B), the CD-MeHA-Rho or Ad-MeHA-Fluor hydrogels were homogeneous,
whereas the GH hydrogel assumed a heterogeneous and highly porous
architecture. This microscale polymeric condensation has been previously
unobserved for GH hydrogels in the hydrated state. Controls did not develop
structural

arrangement,

including

after

identical

incubation

and

photopolymerization. The observed GH hydrogel structure is therefore the direct
result of hierarchical assembly and not an artifact of hydrophobic polymer
association or polymerization-induced aggregation.

Figure 5.2. Binary associations and heterogeneity in guest-host hydrogels. (A)
Micrograph of CD-MeHA-Rho (left, 1.55 wt%), Ad-MeHA-Fluor (middle, 0.95 wt%), and
corresponding GH hydrogel (2.5 wt%: 0.95 wt% Ad-MeHA-Fluor + 1.55 wt% CD-MeHARho) polymerized at day 3 following incubation. Scale bar: 5.0 mm. (B) Fluorescent
confocal images (top) and normalized intensity profiles (bottom, path indicated by yellow
dotted line) of separate guest-host hydrogel components and the corresponding GH
hydrogel. Scale bar: 50 µm.
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In order to probe the initial state and evolution of porous structure, GH hydrogels were formed
(2.5 wt%) and imaged over time to evaluate temporal changes in structure (Figure 5.3). Initially
(day 0), the guest and host polymers were uniformly distributed, as confirmed by their
corresponding intensity profiles. Over time, porous structures developed throughout the hydrogels
(day 1 and day 3). Intensity profiles further demonstrated a high degree of spatial co-localization
between the fluorescein and rhodamine signals, indicating co-localization of the modified polymers.
Likewise, examination of three-dimensional (3D) reconstructions (Figure 5.4) demonstrated colocalization of the separate polymers throughout space with relative heterogeneity of pore size
throughout the depth (400 µm) examined. Such co-localization is requisite for the hierarchical
assembly mechanism proposed, as both guest and host polymers are required to achieve GH
polymer condensation.

Figure 5.3. Temporal evolution of hydrogel porosity and component co-localization.
(A) Representative fluorescent confocal microscopy images of GH hydrogels (2.5 wt%) at
day 0 (top), day 1 (middle) and day 3 (bottom), where components were separately labeled
for imaging: Ad-MeHA-Fluor (green) and CD-MeHA-Rho (red). Scale bar: 100µm. (B)
Corresponding normalized intensity profiles along the path indicated (yellow dotted line),
illustrating spatiotemporal co-localization of guest and host polymers.
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Figure 5.4. Three-dimensional representation of structure. Orthogonal view of threedimensional (3D) reconstructions (A) and maximum projection (B) of the guest-host
hydrogels (Day 0-3; 2.5 wt%). Stacks are merged channels from confocal Z-stacks at day
0 (left), day 1 (middle) and day 3 (right). Scale bar: 100 µm.

5.3.2 Control of Heterogeneity.
In various self-assembled systems, the resulting superstructure is dependent upon
the material composition, including component topology and concentration. 2,12,13,42
These factors govern the configurations in which macromolecules may assemble
and the influence of secondary interactions (i.e., entanglement, additional
hydrogen bonding, and electrostatic repulsion), respectively. Additionally, the
formation of supramolecular structure is temporally dependent, as macromolecular
re-arrangement is required.12 Accordingly, both temporal dependence and
hydrogel composition were systematically investigated by microscopy methods,
where hydrogels were allowed to evolve to the determined time point prior to
photocrosslinking in the presence of thiolated fluorescein (5 mM). Inclusion of the
fluorophore during the crosslinking process enabled improved contrast for
quantification of pore features, including void fraction and pore diameter.
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Heterogeneity rapidly developed in these systems, with void fractions of
67.8±4.2% observed within 6 hours that slowly increased to 93.3±2.4% by day 7.
Results were indicative of relatively rapid GH polymer condensation to achieve
thermodynamic equilibrium. During this timeframe, the pore size steadily increased
from 58.3±3.5 µm at 6 hr to 1025.4±209.4 µm at day 7. The drastic growth in pore
size despite reduced relative changes in void fraction imply that pore growth may
have resulted from microscopic restructuring, such as the merger of adjacent pores
due to wall thinning (Figure 5.5A, indicated).
To evaluate how hydrogel composition influenced porosity, samples were
evaluated at day 3. Both void fraction (90.9±2.6% to 44.1±6.8%) and pore diameter
(418.8±1.5 µm to 31.5±9.8 µm) were inversely proportional to polymer
concentration (1.25-10 wt%). Increased modification of the guest polymer (50%
modified Ad-HA) and varied polymer concentration demonstrated that pore size
was controlled independent of polymer concentration. Void fractions (86.6±1.7%
to 8.5±0.9%) were similar to those of 25% modified Ad-HA with drastic reductions
in pore size (122.4±19.4 µm to 2.1 ± 0.5 µm). Taken together, these results indicate
that polymer concentration alone is a governing factor in controlling the void
fraction. Secondary polymeric interactions, including polymer solvation and
electrostatic repulsion of HA are therefore implicated in suppression of void
formation as they prevent polymer condensation. Independent of these
mechanisms, increased Ad modification (i.e., increased multivalence) is known to
drastically reduce dynamic rearrangement of guest-host hydrogels as a result of
increased polymer avidity and formation of multifold junctions, as examined
through prior characterization of bulk relaxation behaviors.37,43 Here, reduction in
macromolecular dynamics due to increased avidity translated to reduced
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microstructural rearrangement and hence reduced pore size. Due to the influence
of macromolecular dynamics on the observed porosity, it is notable that the feature
size and evolution timescale may also be drastically altered through selection of
the supramolecular binding pairs, as the timescale for the transient associations is
related to the equilibrium association constant (Keq) which varies by orders of
magnitude.18,44

Figure 5.5. Control over hydrogel porosity. (A) Representative confocal images (left)
and corresponding quantification (right) of hydrogel void fraction and pore diameter over
time (Day 0-7; 2.5 wt%; 25% modified Ad-HA). Wall thinning and pore merger, proposed
to contribute to restructuring, is indicated (▼). Pore features were dependent on polymer
concentration (B; Day 3; 1.25-10.0 wt%; 25% modified Ad-HA), including with change in
Ad-HA modification (C; Day 3; 1.25-10 wt%; 50% modified Ad-HA).

5.3.3 Micromechanical Characterization.
Imaging in the hydrated state allowed discrete quantification of hydrogel
heterogeneity. However, the composition of the solid and solute phases within the
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hydrogel cannot be determined by optical methods, due to light diffraction which
produces a non-zero intensity throughout the sample. In order to confirm phase
segregation, both atomic force microscopy (AFM) and diffusive microparticle
tracking analysis were performed.
To probe heterogeneous structures via AFM, hydrogels (2.5 wt%) were cast in
thin layers (~200 µm thick) and allowed to evolve for three days prior to
photocrosslinking. The top surface was exposed and subject to indentation testing
(Figure 5.6) at the hydrogel surface (i), where an indentation modulus of 0.41±0.07
kPa was observed. The probe was re-located to the pore center (ii) at height
identical to (i), where indentation yielded no measurable modulus. Assisted by the
z-step motor of AFM (resolution = 0.1 µm), the indenter tip was lowered for ≈ 50
µm until the pore surface (iii) was located. Throughout this process,
nanoindentation measurements were repeated (approximately every 10 µm). At
location (iii), nanoindentation yielded a modulus of 0.47±0.13 kPa. The inability of
nanoindentation in step (ii) indicates that the pore phase indeed contained no
crosslinked solid phase material, as no resistance to indentation was observed
throughout the pore region. Moreover, the moduli of the gel phase were similar (p
= 0.77) at both the top surface (i) and bottom of the pore region (iii), indicating
homogeneity throughout the gel phase. It should be noted that these moduli are
representative of the GH hydrogel only after the introduction of covalent crosslinks
with photocrosslinking.
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Figure 5.6. Examination of guest-host hydrogel heterogeneity via atomic force
microscopy (AFM). (A) Schematic illustration of testing (side view), where moduli of the
hydrogel (Day 3; 2.5 wt%) were determined at the top surface (i), in the pore center (ii,
same z position as (i)) and at increments of approximately 10 µm until the bottom surface
of the pore region (iii) was located. (B) Bright field image, approximate location of testing
indicated. Scale bar: 100 µm. (C) Indentation moduli at the locations tested. (mean ± SE;
n ≥ 6; p = 0.77).

While AFM nanoindentation is useful to illustrate varied hydrogel moduli in
space, it is unable to account for changes in viscoelastic behavior of the material
or solute viscosity which may occur due to un-crosslinked polymer in solution.
Toward investigation of viscosity and viscoelasticity, microparticle tracking has
become a standard methodology, including in its active (i.e., traction force
microscopy and driven microbead rheology) and passive (i.e., diffusive microbead
rheology) forms. Moreover, these techniques have recently enabled investigation
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of micro-heterogeneous environments, including in the intracellular and pericellular
space.45,46 Thus, diffusive microbead rheology was explored herein, as it enables
facile investigation and precision suit able to discern changes in viscosity resulting
from small changes in HA concentrations.47,48

Figure 5.7. Microrheological examination of guest-host hydrogels. (A)
Representative epifluorescent image of microbeads (0.2 µm diameter) entrapped within
the hydrogel (I, Day 7; 2.5 wt%) or diffusing throughout the pores (ii). Scale bar: 50µm.
(B) Trajectories of particle motion within the x-y plane over a 30 second period for a
microbead engrafted within the hydrogel (Gel, orange) or diffusing throughout a pore
(Pore, blue). (C-D) Mean squared distance (MSD) traces of particle motion as a function
of time for representative subpopulations (n=20 particles/group shown) within the hydrogel
(C) and for solutions consisting of PBS or soluble hyaluronic acid (2.5, 5.0, 10.0 wt% HA
in PBS) and fixed (non-diffusive) controls (D). (E) Diffusion coefficients, determined by fit
to eq. (5.2) (mean ± SE; n > 25; *p < 0.05).

To assess properties via microrheology, samples were prepared in thin layers
with inclusion of 0.2 µm fluorescent beads without photocrosslinking. As included
microbeads are entrapped within the polymer mesh during structural evolution,
diffusive beads were not initially observed within the pores and were thus
introduced by microinjection of concentrated suspensions and allowed to diffuse
throughout the constructs prior to image acquisition. Particle motion and
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trajectories within the hydrogels (Figure 5.7A,B) indicated two discrete
populations—a population of diffusive particles grossly similar to those in buffer
(PBS) and a separate population with constrained trajectories. Examination of
mean-squared distance (MSD, Figure 5.7C,D) and fitting of diffusion parameters
(eq. 5.2) confirmed diffusive, unconstrained motion (α = 1.04 ± 0.013) and
subdiffusive motion (α = 0.76 ± 0.049) of particles within the pore and gel phases,
respectively. Between the two populations, diffusion coefficients differed (Figure
5.7E, Tukey p < 0.0001). Significant differences were also noted relative to
measurement in buffer alone (PBS) and particles fixed to a glass surface,
indicating some viscosity of the pore phase and some motion in the gel phase.
To further validate sensitivity of the method toward viscosity changes, particle
motion was examined in HA solutions of varying concentration (Figure 5.7D).
Drastic changes in gross particle motion and diffusion coefficients (Tukey p <
0.001) were observed with varied concentration. Exponential fits were performed
to diffusion coefficients (D) as a function of HA concentration ([HA] mg/ml), (𝐷 =
2.70𝑒 −0.54[𝐻𝐴] ; 𝑅 2 > 0.98), from which the HA concentration within pores was
approximated to be 0.16 wt%. Low concentrations of unbound polymer within the
pore were likely a result of stochastic dissociation of guest or host polymers from
the gel surface.49
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5.4 Conclusions
Supramolecular interactions were utilized to produce physical hydrogels that
evolved through hierarchical assembly to produce highly porous microstructures
over time. Assembly resulted from macromolecular condensation, driven by
dynamic molecular guest-host complexation. Micromechanical analysis indicated
that the pores were indeed devoid of solid hydrogel—containing only low
concentrations of dissociated polymer from stochastic erosion. Furthermore, the
porosity evolved temporally to increase both void fraction and pore diameter.
Owing to polymer solvation and electrostatic repulsion, component concentration
was primarily responsible for suppression of the void fraction. Reduction in network
dynamics (i.e., increased polymer modification) influenced the timescale of
macromolecular

rearrangement,

altering

pore

diameter.

Through

these

mechanisms, pore diameters spanning three orders of magnitude were achieved
and void fractions as great as 93.3±2.4% were observed. These studies begin to
close the gap in knowledge which exists between directed polymeric assembly and
microstructure within supramolecular hydrogels.
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CHAPTER 6

Selective Proteolytic Degradation of Guest-Host Assembled,
Injectable Hyaluronic Acid Hydrogels

Adapted from: Rodell CB, Wade RW, Purcell BP, Dusaj NN, Burdick JA. Selective
Proteolytic Degradation of Guest-Host Assembled, Injectable Hyaluronic Acid
Hydrogels. ACS Biomaterials Science & Engineering 1, 227-237 (2015).

6.1 Introduction
Hydrogels are well suited for a range of biomedical applications, particularly
due to their biophysical and biochemical properties. While synthetic hydrogels are
not typically bioactive, they may be regarded as a blank slate, where desirable
signals (e.g., topography, adhesion, mode of degradation) can be introduced. The
incorporation of these signals has been widely used to engineer synthetic
extracellular matrix (ECM) analogues for use as therapeutic scaffolds for tissue
engineering or drug delivery applications. Such an engineering approach allows
for reproducibility and more accurate control over physiochemical properties, when
compared to naturally derived materials that exhibit many of the same features. 1,2
The incorporation of degradation into hydrogels is necessary for many
applications, such as to control therapeutic delivery or to enable autonomous,
noninvasive clearance of implanted or injected materials. Although numerous
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degradation mechanisms exist (e.g. hydrolysis,2-5 and stochastic surface erosion68),

recent studies have focused on incorporating enzymatically degradable peptide

crosslinkers9 to engineer cell-material interactions,10-14 drug delivery systems,1,1517

tissue engineering scaffolds,18-21 and biosensors.22-24 Such enzymatic

degradation may be accomplished through polymeric or oligopeptide based
crosslinkers with sensitivity to various enzymes, as discussed in numerous
reviews.2,4,25,26 Of these enzymatically responsive systems, degradation by matrix
metalloproteinases (MMPs)14,27,28 is particularly powerful, owing to the array of
known MMPs, their specific expression patterns by cells and in response to
injury,29 and the tailorable enzyme-substrate activity.30,31 These features lend
themselves to therapeutic use, such as the generation of specific degradation in
response to cell invasion or tissue damage.
For employment of such systems in vivo, an implantable solid hydrogel may be
formed by crosslinking ex vivo. This approach has been quite useful, including in
drug delivery applications where cell-mediated degradation results in controlled
biomolecule release.28,32 Alternatively, these systems may be injectable, such as
through Michael-addition crosslinking where MMP-mediated delivery of multiple
growth factors covalently bound to hydrogels is possible.16 Hydrogel formation
through Schiff-base addition reactions has also enabled in situ hydrogel formation,
with degradation used to modulate release of an MMP inhibitor, constituting a
feedback system for modulation of tissue remodeling processes.17 While such
covalent chemistries may enable injection, they pose the potential clinical
challenge of premature crosslinking and delivery failure. These concerns are
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particularly evident in the case of percutaneous delivery, where materials may be
necessarily held within the injection device (i.e., syringe or catheter tubing) for a
prolonged period (>1 hr) prior to injection.
To address such challenges, self-assembling hydrogels may be of great utility.
These systems may be exemplified by supramolecular self-assembling hydrogels,
formed through the specific interaction of pendant or end group functionalities. In
the majority of cases, these noncovalent interactions are readily reversible,
enabling shear-induced flow for injection and rapid recovery at the target site for
high retention.33,34 Systems based on various guest-host chemistries8,35 or
engineered peptide and protein complexation7,36,37 demonstrate these desirable
injectable properties. Numerous other noncovalently crosslinked networks have
been formed that exhibit proteolytic degradation, including those based on
thermogellation14,27 and ionic crosslinking.19 Self-assembling peptide systems
have also been reported,15,38-43 including where degradation behavior influences
molecule release15 and encapsulated cell behavior.39,43 While such systems show
promise, their utility may be hampered by the limited scale of production and
mechanical robustness, as well as difficulties associated with the synthesis and
characterization of peptide units modified to incorporate degradable domains. 40
Herein, we sought to harness the advantages of both shear-thinning injectable
materials and protease degradation. To accomplish this, we employed the guesthost hydrogel system (Figure 6.1A), in which hydrogels undergo noncovalent
hydrogel formation through the supramolecular interaction of adamantane (guest,
Ad) and β-cyclodextrin (host, CD), which were separately coupled to hyaluronic
143

acid (HA). Such modification enabled formation of shear-thinning hydrogels with
stochastically governed surface erosion. To permit proteolytic degradation,
adamantane was bound via a peptide tether, which included the MMP degradable
sequence VPMS-MRGG (Figure 6.1B, left) or the modified sequence VDMSMAGG (Figure 6.1B, right).

Figure 6.1. Overview of material design. (A) Schematic of supramolecular assembly,
with dynamic crosslink formation generated via guest-host complexation of β-cyclodextrin
(host, CD) and adamantane (guest, Ad). (B) Design of the positively charged peptide linker
(PAd – to allow MMP degradation) and negatively charged peptide linker (NAd – to limit
specific MMP degradation), including Ad end-modification (i), cysteine residue for Michaeladdition coupling (ii), MMP cleavage site (iii), and local variation of charge near the
cleavage site as underlined in amino acid sequence (iv).

6.2 Materials and Methods

6.2.1 General Materials and Methods.
Sodium hyaluronic acid (HA, 90 kDa) was purchased from Lifecore Biomedical,
Type II Collagenase from Worthington Biomedical, and recombinant human MMP2 (carrier-free) from R&D Systems. Other reagents were purchased from SigmaAldrich and used as received unless otherwise indicated. 1H NMR spectra were
144

acquired at 360 MHz (Bruker) and chemical shifts are reported relative to the
residual solvent peak.

6.2.2 Peptide Synthesis.
In order to permit guest-host assembly and MMP degradation, adamantane
terminated

peptides

Ad-GGNSVPMSMRGGSNCG

(PAd)

and

Ad-

GGNSVDMSMAGGSNCG (NAd) were prepared by standard solid phase peptide
synthesis (PS3 automated peptide synthesizer, Protein Technologies) with glycinol
2-chlorotrityl resin and FMOC protected amino acids (Novabiochem). The amine
terminus was reacted with the free acid of 1-adamantane acetic acid by
substitution of the guest compound in place of the terminal amino acid. The peptide
was cleaved from the resin by hydrolysis in trifluoroacetic acid, triisopropyl silane,
and water (95/2.5/2.5) and recovered by repeated precipitation from cold ethyl
ether and lyophilization from water. To enable in vivo imaging, the near-IR
fluorescent peptide Cy7.5-GKKCG (CyP) was likewise prepared by substitution of
the free carboxylic acid of cyanine 7.5 in place of the terminal amino acid. Expected
mass was confirmed by MALDI-tof mass spectrometry (Applied Biosystems
Voyager 6030; PAd: m/z=1729.64, expected 1730.01 Da, NAd: m/z=1684.81,
expected 1662.88 Da (measured mass corresponds to expected peptide
complexed with a sodium ion), CyP: m/z=1165.66, expected 1166.48 Da (without
chloride ion)).
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6.2.3 Peptide Degradation.
In order to compare relative rates of proteolytic peptide degradation,
fluorometric analysis of peptide cleavage was performed, based on modification of
a previously reported protocol.44 Stock solutions of PAd and NAd peptides were
prepared at 250 µM in PBS and supplemented with 1.0 mM CaCl2. The solutions
were diluted by MMP-2 or Type II Collagenase to yield 125 μM peptide in either 1
U/mL collagenase or 1.0 nM MMP-2, and samples were incubated at 37°C.
Substrate cleavage was periodically monitored by sampling 75 µL of the
substrate/enzyme solution, reacting with 20 μL fluorescamine (50 mM in acetone),
and immediately detecting fluorescence (Tecan infinite M200 spectrophotometer;
λabs/em = 380/480 nm). For determination of reaction kinetics, the fluorescence was
converted to amine concentration relative to cystamine standards and plotted as a
function of time. At early times, the concentration of substrate is much greater than
the enzyme concentration, allowing approximation of zero-order kinetics and initial
reaction rates were thus determined by linear fit.

6.2.4 Peptide Modification of Hyaluronic Acid.
Maleimide modified HA (MaHA) was prepared similar to previous reports12,32
by coupling aminated maleimide to HA-TBA via amidation. Briefly, HA-TBA (1.6 g,
2.23 mmol repeat units, 1.0 eq) and N-(2-aminoethyl)maleimide trifluoroacetate
salt (0.37 g, 1.49 mmol, 0.67 eq) were dissolved at 2.0 wt% in DMSO under
anhydrous

conditions

and

the

coupling

agent

(benzotriazol-1-

yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP; 0.66 g, 1.49
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mmol, 0.67 eq) was added by dissolution in DMSO and subsequent cannulation.
Purification was performed by extensive dialysis against DI water at 4ºC, to prevent
maleimide hydrolysis, and filtration to remove insoluble byproducts from the
reaction. The solution was frozen and lyophilized to obtain the final product.
Functionalization was determined from integration of the vinyl group (δ=6.96, 2 H)
relative to the methyl singlet of HA (δ=2.1, 3 H). The percent of HA repeat units
modified was determined to be approximately 25%.
For peptide coupling to the polymer, MaHA was dissolved in DI water at 1.0
wt%. The desired peptide (1.1 eq PAd or NAd to maleimide) was dissolved in DI
water and added dropwise. The reaction was slowly titrated to pH 6.5-7.0 with 0.1N
NaOH and allowed to stir >2 hours at room temperature prior to purification by
extensive dialysis and lyophilization to obtain the final product. For fluorescent
derivatives, the peptide CyP (0.01 eq to HA repeats) was combined with the MaHA
solution and stirred for 10 minutes prior to addition of PAd or NAd peptides.

6.2.5 CD-HA Synthesis.
β-Cyclodextrin modified hyaluronic acid (CD-HA) was prepared as previously
described.8 Briefly, amine functionalized cyclodextrin was synthesized in the form
of

6-(6-aminohexyl)amino-6-deoxy-β-cyclodextrin

(β-CD-HDA)

by

methods

analogous to our previous reports. Amidation of HA-TBA (2.0 g, 1.76 mmol repeat
units, 1.0 eq) with β-CD-HDA (1.76 g, 0.5 eq) was performed in the presence of
BOP (0.63 g, 0.5 eq) as described above for MaHA. Functionalization was
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determined to be approximately 25% by integration of the hexane linker (δ=1.221.77, 12 H) relative to the methyl singlet of HA (δ=2.1, 3 H).

6.2.6 Hydrogel Formation.
Hydrogels were formulated such that adamantane and β-cyclodextrin were
present in stoichiometric balance and the concentration refers to the overall weight
percent of combined polymers, which was maintained at 7.5 wt% unless otherwise
noted. Hydrogels were prepared from stock solutions of the desired polymers in
PBS. The two component solutions were combined, mixed by manually stirring,
and then briefly centrifuged to remove entrapped air.

6.2.7 Rheological Characterization.
Characterization was performed using an AR2000 stress-controlled rheometer
(TA Instruments) fitted with a 20 mm diameter cone and plate geometry, 59 min
42 s cone angle, and 27 μm gap. Rheological properties were examined at 37ºC
by oscillatory frequency sweeps (0.01-100 Hz; 0.5% strain), oscillatory time
sweeps at various frequencies (0.01, 1.0 or 10.0 Hz; 0.5% strain), and continuous
flow experiments with the shear rate linearly ramped from 0-0.5 s-1 and returned.
For shear recovery experiments, shear-thinning was performed at 250% strain with
recovery at 0.5% strain, each at 10 Hz.
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6.2.8 In Vitro Hydrogel Erosion.
Acrylamide molds were used to contain the hydrogels within a depression
having 5 mm diameter and 6 mm height. Hydrogels were prepared as described
and 30 μL of the desired hydrogel was loaded into the depression. Hydrogels were
submerged with the desired buffer and allowed to degrade at 37°C. For
collagenase degradation, the buffer was constituted of PBS supplemented with 1.0
mM CaCl2 and collagenase at 0, 10, or 100 U/mL. For MMP-2 degradation, the
buffer was similarly constituted of PBS supplemented with 1.0 mM CaCl2 and
containing 5.0 nM MMP-2 and 0.1 wt% BSA (R&D, DY995) to prevent MMP-2
adsorption to the acrylamide surface. The buffer was sampled periodically, with
replacement of buffer or protease solution (to maintain protease activity in the
hydrogel). At the study terminus, 1.0 mg/mL hyaluronidase was used to degrade
any remaining hydrogel to allow determination of remaining HA content and
release was quantified by uronic acid assay.45

6.2.9 In Vivo Hydrogel Erosion.
To allow for degradation to be longitudinally assessed in vivo, polymer
components were labeled by the near-IR dye Cy7.5 as described above. All
experiments conformed to the NIH Guide for the Care and Use of Laboratory
Animals, and the procedures were approved by the Institutional Animal Use and
Care Committee of the University of Pennsylvania. After injection of 25 µL of
hydrogel subcutaneously in the upper right flank of BALB/c mice, degradation was
assessed biweekly over 6 weeks (Pearl Impulse, LI-COR). For all animals, the
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fluorescence signal (λex/λem=785/820 nm) was integrated over identically sized
regions of interest centered over the injection site. Values were baseline corrected
to the intensity of images of mice prior to injection, and normalized to the peak
intensity (reached at one week post injection) for the material group.

6.2.10 Statistical Analysis.
All data is reported as mean ± standard deviation (SD). For peptide degradation
studies, fit parameters were determined by linear regression in R and compared
directly by ANOVA; error in fit parameters was determined from the regression
analysis with propagation of error where necessary for calculation of dependent
parameters (kcat). For degradation studies, comparison between groups was
performed by Students t-test with two-tailed criteria and significance determined at
α < 0.05.

6.3 Results and Discussion
6.3.1 Modulation of Peptide Proteolysis.
Numerous MMP sensitive sequences have been investigated in the context of
biomaterials; many have utilized the α1(I) collagen derived sequence
GPQG↓IAGQ

or

its

derivative

with

enhanced

degradation

rate,

GPQG↓IWGQ.23,28,43,46 The α1(IV) collagen sequence GDQG-IAGF has been
utilized as a non-degradable control,28,43,46 where a lack of proteolysis may be
attributed to amino acids adjacent to the cleavage site. Indeed, it has been shown
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that MMP activity and selectivity towards specific substrates may be controlled, at
least in part, as a response to the position-sensitive selection of neighboring amino
acids.30 Of particular interest are the P3 and P2’ sites which differ between the
non-degradable α1(IV) and degradable α1(I) collagen sequences. Basic or
hydrophobic amino acids are generally preferred for the P2’ site, and the P3 site
selects strongly for proline across all MMPs examined.30 Building on this work, we
hypothesized that similar amino acid substitution could be used to alter peptide
susceptibility to degradation via specific proteases. We therefore examined the
degradation potential of two peptides. The first is optimized for activity in MMP-1,
but shows high activity toward MMP-2 and other mammalian MMPs
(VPMS↓MRGG),12,31 designated PAd due to the positive charge and adamantane
terminus. The second sequence (VDMS-MAGG) incorporates the substitutions
described and is designated NAd due to its negative charge and adamantane
terminus.
To examine the general peptide susceptibility to proteolytic activity, kinetic
analysis of both PAd and NAd was first performed in Type II Collagenase (1 U/mL).
Proteolysis was monitored by formation of the free amine terminus by reaction with
fluorescamine, following modification of reported protocols.44 In response to
collagenase, both PAd and NAd peptides were observed to undergo proteolysis
and exhibited temporal profiles indicative of Michaelis-Menten kinetics (Figure
6.2A). Linear fits to early timepoints yielded initial velocities for proteolytic
cleavage, which did not differ between PAd (162.57±9.33 µM/hr) and NAd
(155.41±36.94 µM/hr) peptides (p=0.78). The similar response toward degradation
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in collagenase may be expected, as bacterially derived collagenases are known to
exhibit broad activity, including toward nearly all collagenase types. The observed
products are therefore a consensus of fragments generated by multiple MMPs,
caseinase, clostripain, and other enzymes prevalent in bacterial collagenases. 47
To further examine specific activity toward mammalian MMPs, a similar
analysis was performed in the presence of MMP-2 (1.0 nM). As the peptides are
readily accessible in solution and the enzyme-substrate pair exhibits high affinity
(Km ≈ 2 mM),31 saturation of the enzyme and observation of zero-order degradation
may be expected, where the velocity is determined as
𝑣 = 𝑣𝑚𝑎𝑥 = 𝑘𝑐𝑎𝑡 [𝐸].

eq. (6.1)

Indeed, degradation of PAd (Figure 6.2B) was observed to be linear (R2>0.98) in
agreement with these predictions and prior observations. 28 A velocity of 18.98
±1.77 uM/hr was determined and an estimation of kcat obtained, based on the
observed zero-order behavior and known MMP-2 concentration. The determined
value of 5.27±0.49 s-1 is in good agreement with the reported literature value. 31
Examination of NAd showed no proteolysis in the presence of MMP-2, as there
was no significant difference between the amine concentration at baseline and 6
hours post incubation with MMP-2 (p=0.53). Correspondingly, analysis of fit
parameters by ANOVA revealed that the initial velocity for degradation of NAd did
not significantly different from 0 (p=0.41). These results demonstrate that both
peptides undergo proteolytic cleavage in the presence of Type II collagenase,
indicating that it is suitable for analysis of degradation behavior in vitro. Moreover,
specific substitution of select amino acid residues was successful in modulating
152

substrate activity for a specific mammalian MMP, indicating that the sequence is
suitable to investigate modular degradation behavior and that the chosen
substitutions may be a generalizable methodology to achieve this end.

Figure 6.2. Proteolytic degradation characterization. (A) Cleavage of PAd (green, solid
lines) and NAd (blue, dashed lines) peptides in either (A) collagenase (Type II, 1.0 U/mL)
or (B) MMP-2 (1.0 nM). Values represent mean ± SD; n=4.

6.3.2 Chemical Modification of Hyaluronic Acid.
After establishing the specific proteolytic potential of the peptides, they were
used to modify HA for hydrogel formation. Due to the high efficiency and selectivity
of the maleimide-thiol Michael-addition reaction,12 the maleimide modification of
HA is a potent means of intermediate pendant HA modification. Such modification
has previously enabled processes such as selective addition-crosslinking in the
presence of methacrylates to enable secondary photopolymerization.13 Here, this
methodology was extended to allow for efficient modification of HA by complete
reaction of the maleimide with excess peptide (Figure 6.3A). 1H NMR confirmed
the desired maleimide modification of HA (25%) and quantitative addition of
peptide (PAd) both by complete consumption of the maleimide peak and
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quantification of the adamantane ethyl peak (Figure 6.3B). Results demonstrate
that maleimide modification is a facile means of biopolymer modification by
oligopeptides containing a cysteine residue or other similarly thiolated molecules.
Moreover, maleimide modification allows for modular modifications of HA by
multiple peptides in a one-pot process. Previously, networks containing vinyl
functional groups were formed with addition of cysteine-containing cell-adhesion
peptides and then crosslinking via a bifunctional thiol. 12,20,28,31,32,46 Similar to such
procedures, MaHA was reacted with the fluorescent peptide CyP as the limiting
reagent with subsequent addition of excess PAd or NAd peptides. We previously
showed that similarly prepared fluorescent peptides retain native fluorescence and
are useful for longitudinal analysis of degradation in vivo.48 Further, such reaction
allows for an estimated 1.05% modification of repeat groups by the fluorophore.
The extent of modification is in agreement with previous reports for fluorophore
modifications of HA as an optical imaging agent, not exhibiting interchain
quenching.49 Subsequent consumption of maleimides by PAd or NAd enabled
facile preparation of such fluorescent material derivatives, necessary for later in
vivo imaging. Therefore, this synthetic modification scheme allows for modular
one-pot modification by two, or potentially more pendant groups, which may be
useful to impart additional crosslinking or cell-directive functionalities.
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Figure 6.3. Synthesis of peptide-modified HA. (A) The tetrabutyl ammonium salt of HA
(HA-TBA) underwent amidation with N-(2-aminoethyl)maleimide (i) to form maleimide
modified HA (MaHA) and successive coupling to the desired peptide (PAd) via Michaeladdition (ii) to form PAd modified HA (PAd-HA). (B) 1H NMR confirmed the maleimide
modification (MaHA, 25% disaccharide repeats), as well as the complete conversion to
peptide modification (PAd-HA). The same approach was taken for synthesis of NAd
modified HA.

6.3.3 Hydrogel Formation and Mechanical Properties.
Following modification by guest and host pendant groups, we characterized
hydrogel formation and properties to ensure maintenance of the guest-host
assembly mechanism, as well as the shear-thinning and self-healing properties
necessary for injectable delivery. As in previous reports,8,48 the individual modified
HA components were solutions, exhibiting moderate viscosity due to polymer
entanglement. Upon mixing of the two solutions, a hydrogel was rapidly formed
through desired guest-host complexation of β-cyclodextrin and adamantane.
Correspondingly, an increase in moduli was observed by oscillatory rheology
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(Figure 6.4A). As expected, the moduli were dependent upon crosslink density as
may be controlled through polymer concentration (Figure 6.4A,B).
Due to the dynamic character of the guest-host crosslinks, hydrogels exhibited
frequency dependence (Figure 6.4B). In contrast to previous reports,8,50,51 bulk
relaxation was not observed over the frequency range examined. This may be the
result of bridging between multifold junctions by the elongated peptide linker, which
would result in bonding of adjacent multifold junctions and a concurrent decrease
in network dynamics.51 We therefore concluded that guest-host assembly is
retained in the presence of the peptide crosslinker PAd, and that the dynamic
nature of crosslinks is evident despite a reduction in fluid-like stress relaxation.

Figure 6.4. Rheological characterization of guest-host assembled hydrogels. (A)
Oscillatory time sweeps of individual guest (5.0 wt% PAd-HA, blue) and host (5.0 wt% CDHA, red) macromers and hydrogel (purple) formed at various polymer concentrations as
indicated; storage modulus (G’, filled symbols) and loss modulus (G’’, empty symbols) at
0.1 Hz, 0.5% strain. (B) Representative oscillatory frequency sweeps showing storage
modulus (G’, filled symbols) and loss modulus (G’’, open symbols) of PAd-HA hydrogels
formed at different polymer concentrations as indicated (0.5% strain).

For comparison of degradation behavior between hydrogels containing PAd
and NAd tethers, it is desirable to attain similar mechanical properties between the
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two groups. In direct comparison of the two systems, mechanical features of the
hydrogels were consistent. Hydrogels formed from PAd-HA and NAd-HA exhibited
similar moduli across the frequency domain (Figure 6.5A). Moreover, the
incorporation of peptide linkers did not hinder the guest-host hydrogels known
capacity for shear-induced flow recovery. For both hydrogels, strain sweeps
(Figure 6.5B) displayed characteristic shear-yielding behavior, with applied strains
in the range of 50-80% inducing network yielding and a reduction in mechanical
properties. As a direct consequence of dynamic crosslink yielding, materials
exhibited shear-thinning behavior (Figure 6.5C,D) following accumulation of
internal shear-stresses capable of inducing yield and subsequent flow. To
demonstrate self-healing following the cessation of flow, hydrogels were subjected
to repeated cycles of high (250%) and low (0.5%) strain. In accordance with
previous observations, high strain induced a drastic change in shear moduli (>50%
G’) with complete recovery (>95% G’) within 3 seconds following reduction in shear
(Figure 6.5E,F).
It may be expected that changes in crosslinker length, charge, or conformation
may affect the mechanical properties. However, we show here that the hydrogel
mechanical properties with PAd and NAd tethers remain similar. These
observations may be due to the minimal and selective modification of the nondegradable peptide sequence, allowing it to retain its functional conformation.
Moreover, we demonstrate that the guest-host hydrogel system retains dynamic
properties similar to that of other binary associating systems. These dynamic
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properties are important toward percutaneous delivery, as they enable shearthinning for injectable delivery and rapid recovery at the injection site.

Figure 6.5. Rheological characterization of hydrogel mechanics and flow. (A)
Representative oscillatory frequency sweeps of 7.5 wt% PAd-HA (green) and NAd-HA
(blue) hydrogels; storage modulus (G’, filled symbols) and loss modulus (G’’, open
symbols) at 0.5% strain. (B) Oscillatory strain sweeps of 7.5 w% PAd-HA and NAd-HA
hydrogels; storage modulus (G’, filled symbols) and loss modulus (G’’, empty symbols) at
10 Hz. (C,D) Continuous flow examination of 7.5 wt% PAd-HA (C) and NAd-HA (D)
hydrogels under linearly ramped shear rate; shear stress (closed symbols) and viscosity
(open symbols). (E,F) Recovery characterization of 7.5 wt% PAd-HA (E) and NAd-HA (F)
hydrogels; storage (G’, red dotted line), loss modulus (G’’, blue dashed line), and loss
tangent (tan (δ), black solid line) throughout cyclic deformation of 0.5% (low, unshaded
areas) and 250% (high, shaded areas) strain at 10 Hz.

6.3.4 Control of Proteolytic Hydrogel Degradation.
Proteolytic degradation of hydrogels has emerged as a key hydrogel feature
for in vitro studies of cell behavior and in vivo applications toward drug and cell
delivery. We sought to transfer such features to guest-host hydrogels as well as to
verify the synthesis of peptides with selectively modified relative degradation.
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Importantly, the hydrogel degradation is mediated by the interplay of two distinct
mechanisms, as depicted in Figure 6.6A.
First, it is recognized that dissociation of any polymer chain from the network
requires the simultaneous dissociation of all guest-host crosslinks, which
dynamically oscillate between a bound (i) and unbound (ii) state. The probability a
polymer chain having n modified groups with k groups unbound is described by
the probability mass function
𝑛

𝑃(𝑋 = 𝑘) = ∑ 𝑋𝑘

eq. (6.2)

𝑘=1

where n is the number of guest or host molecules per polymer chain and Xk is the
probability of dissociation for a single complex. Because states are binary (bound
or unbound) and assuming the probabilities for each guest-host dissociation are
identical (Xk = p) and independent, the function simplifies to the binomial
distribution, allowing approximation of the number of dissociated chains by the
binomial distribution, which simplifies to (3) for complete dissociation.
𝑃 = 𝑝𝑛

eq. (6.3)

In the absence of proteolytic degradation, PAd and NAd hydrogels were observed
to undergo degradation due to spontaneous, stochastically governed erosion at
identical rates, as all timepoints are statistically undifferentiated between groups
(p > 0.31). Results indicate that hydrogels are similarly formed and undergo
identical degradation behavior in the absence of proteolytic degradation, despite
modification of the peptide tether.
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In the presence of proteolysis (Figure 6.6A, (iii)), dynamic crosslinks are
permanently removed from the system. By extension of eq. (6.3), the probability
function for polymer dissociation is:
𝑃 = 𝑝(𝑛−𝛿(𝑡))

eq. (6.4)

where δ(t) is the number of degraded crosslinks at any time, t. The probability for
dissociation thus increaes with degradation. Accordingly, both PAd and NAd
peptides underwent proteolysis and exhibit increasing degradation rates in a dose
dependant manner in the presence of collagenase (Figure 6.6B,D). Moreover, as
the peptides undergo proteolysis at near identical rates in collagenase, it is
expected that δ(t) is similar between groups. Degradation kinetics in 25 U/mL
collagenase were observed to be similar between groups, with no statistical
differences before the terminal point at day 5. Cumulative degradation was likewise
similar between groups in the presence of 100 U/mL collagenase.
Finally, we examined the degradation kinetics of the two hydrogels in response
to MMP-2. For the MMP-2 degradable sequence, PAd, increased erosion was
observed in response to MMP-2 (Figure 6.6C). Beyond day 6, statistical
differences between groups were noted and degradation followed a linear trend
(R2 > 0.98) in agreement with results for peptide degradation in solution and other
literature observations.17,28 In contrast, the proteolysis of NAd by MMP-2 is
negligible, and thus dynamic crosslinks are not proteolytically removed from the
network (Figure 6.6A, (iv)). Correspondingly, the probability of polymer
dissociation is unaltered from eq. (6.3) and erosion proceeded without observation
of a degradation response (Figure 6.6E).
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Figure 6.6. Hydrogel erosion and degradation characteristics in vitro. (A) Schematic
of mass loss due to combined erosion and degradation processes. Guest-host crosslinks
(i) undergo continuous dissociation (ii) and re-association processes, which contribute to
erosion. Proteolysis of peptide crosslinks (iii) contributes to degradation, which may be
hindered by selective peptide modification (iv). (B-E) Cumulative hydrogel erosion profiles
of 7.5 wt% PAd-HA (B,C) and NAd-HA (D,E) hydrogels in in either collagenase (B,D) or
MMP-2 (C,E) at concentrations noted. Values represent mean±SD; n=4.

These results provide proof of principle for the design of injectable, degradable
hydrogels based on direct binary associations, as well as a context for describing
their combined erosion and degradation behaviors. Hydrogels formed containing
either oligopeptide tether exhibited similar and complete degradation in
collagenase, indicating a propensity for proteolytic degradation. Though, only the
PAd sequence displayed enhanced degradation in response to MMP-2, indicative
of the desired sequence modification. Moreover, statistical conceptualization of the
erosion behaviors provides an initial context to understand the erosion behaviors,
though such methodology may benefit from more rigorous mathematical
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treatment51 to aid in modeling approaches capable of describing these behaviors
more completely.1
While numerous material systems with tunable degradation behavior have
been developed, not all such systems translate to similarly distinguishable
differences in vivo,52,53 including those with designed enzymatic degradation. 23,54
Therefore, the material system was investigated in a subcutaneous injection
model, where degradation was monitored to demonstrate their capacity toward
injectable delivery, target site retention, and modulation of the in vivo degradation
response. Hydrogels were injected subcutaneously into the flank of mice, forming
a visible and palpable mass directly at the injection site. Degradation behavior was
continuously monitored by non-invasive imaging and quantification of the bound
near-IR fluorophore (Figure 6.7). Both hydrogel systems approached nearcomplete clearance by 6 weeks post-injection. However, the clearance of
hydrogels containing the NAd tether proceeded at a reduced rate, with significantly
reduced clearance observed prior to day 35. The observed degradation behavior
is in qualitative agreement with in vitro proteolysis and degradation studies, which
demonstrated enhanced proteolysis and degradation of PAd hydrogels. However,
there is a notable quantitative discrepancy between the in vivo and in vitro
degradation rates. In vitro, degradation is likely accelerated by supraphysiological
MMP concentrations as well as the unconfined conditions (i.e., exposed directly to
buffer without confinement). In vivo, degradation and erosion is also affected by
mechanical confinement to prevent erosion as well as the presence of tissue
inhibitors of MMPs (TIMPs), native to the tissue.
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Figure 6.7. Hydrogel erosion and degradation characteristics in vivo. Time course
images of near-IR fluorescence imaging of 7.5 wt% PAd-HA (A, green) and NAd-HA (B,
blue) hydrogels after injection subcutaneously in the right flank of mice. Both hydrogels
included covalent conjugation of the near-IR dye Cy7.5. (C) Quantification of normalized
signal intensities. Values represent mean±SD; n=3.

Herein, we have directly examined the clearance of polymer from the injection
site and the capacity for this degradation to be influenced by proteolytic
degradation. Such release kinetics may also reflect those experienced by
therapeutics which are covalently bound to the polymer network.46,55 However, the
degradation response may also be of interest to direct the release of therapeutitc
proteins which are diffusively released from a physically crosslinked network at the
site of action.56 Toward the controlled release of such factors, their sequestration
by interaction with the polymer network may be of interest. Such methods may
include the exploitation of native protein-matrix afffinity.17,32,57 Due to the inclusion
of cyclodextrin in the material formulation, utilization of guest-host interractions in
sequestration of therapeutic agents is also of key interest. Indeed, numerous small
molecule pharmacologics are known to interect strongly with β-cyclodextrin.58,59
Moreover, their interaction with specific amino acid resudues both in peptides and
proteins has been investigated and is a promosing approach toward engineered
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affinity for peptide-based pharmaceutical agents.60,61 Further exploration into the
role of proteolytic degradation’s influence on such modes of molecule release is of
great interest toward the development of therapeutic biomaterials.

6.4 Conclusion
In sum, we have developed a materials system for the formation of selfassembling, injectable, and enzymatically degradable hydrogels. Rational peptide
design was used to alter MMP-mediated hydrogel degradation kinetics. As a result
of minimal changes in two amino acids, both mechanical and stochastic erosion
properties of hydrogels were conserved. Importantly, the utilization of direct binary
association between the guest and host functional groups enabled injection with
high target site retention and prolonged degradation in vivo, which was influenced
by proteolytically degradation. There has been a recent and concurrent drive
toward the development of injectable and biodegradable materials, owing to their
potential for clinical translation and versatility. The materials system developed
herein may serve as a vital bridge between these two important fields, facilitating
such applications as drug and cell delivery in regenerative medicine.
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CHAPTER 7

Shear-Thinning Supramolecular Hydrogels with Secondary
Autonomous Covalent Crosslinking to Modulate Viscoelastic
Properties In Vivo

Adapted from: Rodell CB, MacArthur JW, Dorsey SM, Wade RJ, Woo YJ, Burdick
JA. Shear-Thinning Supramolecular Hydrogels with Secondary Autonomous
Covalent Crosslinking to Modulate Viscoelastic Properties In Vivo. Advanced
Functional Materials 25, 636-644 (2015).

7.1 Introduction
Hydrogels are water-swollen polymeric networks that are used widely in
biomedical applications as scaffolds for tissue reconstruction and regeneration or
as delivery vehicles for cells, pharmaceuticals, or other cargo. Injectable hydrogels
hold particular value in translational medicine as they may be implanted with
minimally invasive methods.1-5 To accomplish this, in vivo self-assembly either
through physical or covalent mechanisms is often employed. Unfortunately, neither
of these mechanisms is without issue for widespread use in biomedical
applications.
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Hydrogels assembled by physical mechanisms may be formed from numerous
materials and interactions. These include biologically derived materials such as
alginate, fibrin, gelatin, Matrigel or decellularized extracellular matrix; 2-4,6,7
however, these systems are limited in application, due to a high degree of batchto-batch variability and minimal control over important material properties (e.g.,
mechanics and degradation). Thermoresponsive hydrogels, such poly(N-isopropyl
acrylamide), block copolymers, and polymer blends8,9 often display rapid sol-gel
transition on injection to aid in localized retention.10 However, these systems may
not be suitable for percutaneous delivery (e.g., catheters) where materials are
subject to necessary prolonged exposure at 37°C within the catheter, prior to
injection. Under these conditions, the sol-gel transition may occur within the device
and prevent desired delivery. Synthetic hydrogels including self-assembling
peptides

and

α-cyclodextrin/PEG

pseudopolyrotaxanes

have

also

been

extensively investigated, as discussed in a recent review.1-3,7 These systems are
synthetically well defined and are stable toward external stimuli, such as
temperature. However, they require potentially slow formation of higher order
assemblies such as entanglements or microcrystalline domains in order to recover
mechanical strength, compromising material retention at the target site. Moreover,
extension of these systems to include end capped polyrotaxanes has shown the
capacity to afford highly elastic and even thermoresponsive systems. 11 Yet,
extension of these systems to include in vivo formation has yet to be demonstrated.
As an alternative to these systems, supramolecular self-assembly based on the
direct association of molecular components has recently emerged as a means of
172

preparing hydrogels through specific, non-covalent crosslinks. Such assembly
produce inherently dynamic networks that enable shear-thinning and self-healing
properties, and thus injectability.12 Both binary and ternary associating systems,
such as those based on heterodimeric peptide/protein 13,14 or host macrocycle
interactions,15,16 have demonstrated shear-thinning abilities in conjunction with
rapid network recovery. Similarly, the utilization of cationically terminated linear or
dendritic binders in conjunction with clay nanosheets has demonstrated utility in
formation of shear-thinning and self-healing nanocomposites through ionic
interactions.17,18 Such recovery characteristics may aid in retention at the injection
site,9,19-21 particularly for tissues that are under mechanical stress (e.g., nucleus
pulpous) or those that undergo continual dynamic motion (e.g., cardiac tissue).
Unfortunately, these materials are inherently limited in that they typically exhibit
low mechanical strength1,12 and may exhibit rapid erosion dependent on the
valence of crosslinking groups and their affinity.1,14,22
For more physically demanding applications, covalently crosslinked systems
may be more appropriate. In addition to increased relative mechanical strength,
hydrogels formed through covalent means display great versatility with the allowed
inclusion of controlled network degradation and the introduction of biological cues
such as cell adhesion and bioactive factor delivery. Indeed, numerous chemical
mechanisms have been employed for in vivo crosslinking including redoxinitiated23 and externally triggered24,25 radical polymerizations, as well as various
addition

reactions

including

Schiff-base,

Michael-addition,

and

Huisgen

cycloaddition chemistries.3 Michael-addition reactions remain prominent in the
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field, due in part to mild reaction conditions, bioorthogonal mechanisms, and
readily tailorable reaction kinetics.26 These properties are highly beneficial toward
injectable applications where the hydrogel must form in vivo without crossreactivity (e.g., with protein amine residues) or other biological consequence (e.g.,
exothermic necrosis). The ability to control crosslinking kinetics is also of utmost
importance, as clinical procedures may require the hydrogel to remain in an
injectable state for an hour or more, making rapid crosslinking reactions unsuitable.
For ease of clinical application, the hydrogel must therefore undergo crosslinking
with slow reaction kinetics to prevent premature crosslinking and delivery failure.
While such slow reaction kinetics may allow delivery, it is realized that slow
crosslinking results in undesirable loss of material from the injection site.19,27 Thus,
there is basic design flaw with currently developed hydrogels for applications as
an injectable material.
To address these inherent limitations of current injectable hydrogel systems, a
generally applicable dual-crosslinking mechanism is developed herein. The
hydrogels first undergo physical assembly ex vivo through supramolecular selfassembly mediated by guest (adamantine, Ad) and host (β-cyclodextrin, CD)
pendant groups. This mechanism enables shear-thinning delivery with high
retention at the target site. Following injection, a secondary covalent crosslinking
occurs in situ via Michael-addition to stabilize the network. Crosslinking kinetics of
this secondary network are clinically appropriate and controlled through both the
Michael-acceptor reactivity and catalytic conditions. The novel combination of
autonomous physical and covalent crosslinking demonstrated is a generally
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applicable method for retention and subsequent reinforcement of injectable
materials amenable to clinical application and may serve as a platform for
numerous ventures in bioengineering and regenerative medicine. To demonstrate
this, the materials developed are utilized in a mechanical stabilization approach for
treatment of myocardial infarctions.

7.2. Materials and Methods
7.2.1 General Materials and Methods.
Sodium hyaluronic acid (HA, 90kDa) was purchased from Lifecore (Chaska,
MN). All other chemicals were purchased from Sigma-Aldrich unless otherwise
indicated. 1H NMR spectra were acquired at 360MHz (Bruker) and chemical shifts
reported relative to the residual solvent peak.

7.2.2 HA-TBA Preparation.
To prepare the organic soluble tetrabutylammonium salt of HA (HA-TBA), the
sodium salt of HA was dissolved in DI water at 2.0 wt%, exchanged against Dowex100 resin, neutralized by tetrabutylammonium hydroxide, and then frozen and
lyophilized.28

7.2.3 Ad-HA Synthesis.
Ad-HA was prepared by coupling 1-adamantane acetic acid to HA-TBA via
esterification (Figure 7.1).15 A round bottom flask was charged with HA-TBA (3.0
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g, 4.18 mmol repeat units, 1 eq), 1-adamantane acetic acid (2.44 g, 12.52 mmol,
3 eq), and 4-dimethylaminopyridine (DMAP; 0.76 g, 6.26 mmol, 0.5 eq). The vessel
was purged by nitrogen, and anhydrous DMSO added via cannulation to afford an
approximately 2wt% solution. Once fully dissolved, di-tert-butyl dicarbonate
(BOC2O) was added via syringe (0.32 mL, 1.40 mmol,0.33 eq) and the reaction
carried out at 45°C for 24 hours. Purification was performed by dialysis for 3 days
against DI water, precipitation in acetone, and further dialysis. The solutions were
frozen and lyophilized to obtain the final products. Adamantane functionalization
was quantified by 1H-NMR and determined to be 21.4% from integration of the
ethyl multiplet of adamantane (δ=1.42-1.70, 12 H) relative to the HA backbone
(δ=3.10-4.10, 10 H).

Figure 7.1. Synthesis of Ad-HA. (A) Synthesis scheme. (B) Corresponding 1H NMR
spectra.
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7.2.4 β-CD-HDA Synthesis.
Synthesis of 6-(6-aminohexyl)amino-6-deoxy-β-cyclodextrin (β-CD-HDA) was
performed by adaptation of similar reported syntheses.15,29-31 β-cyclodextrin (45 g,
39.65 mmol, 1 eq) was suspended in water (300 mL) and cooled to 0°C. ptoluenesulfonyl chloride (TosCl; 8.35 g, 43.61 mmol, 1.1 eq) was dissolved in
minimal acetonitrile (25 mL) and added dropwise. The reaction was stirred at room
temperature for 2 hours. The reaction was cooled on ice prior to the dropwise
addition of NaOH (4.75 g, 118.94 mmol, 3.0 eq) dissolved in water (20 mL). The
reaction was stirred further at room temperature for 30 minutes before the pH was
adjusted to 8.5 by addition of solid ammonium chloride (~40 g). The solution was
then cooled on ice and the precipitate collected. The crude product was reprecipitated from cold water (3x400mL), washed by acetone (3 x 200 mL) and dried
under vacuum to afford the intermediate 6-o-monotosyl-6-deoxy-β-cyclodextrin
(8.80 g, 22%) as a white powder. 1H-NMR (DMSO-d6) δ = 2.42 (s, 3 H), 3.12-3.80
(m, overlaps with HOD), 4.12-4.40 (m, 6 H), 4.77 (s, 2 H), 4.83 (s, 5 H), 5.60-6.05
(br s, 14 H), 7.43 (d, 2 H), 7.75 (d, 2 H). A round bottom flask was charged with 6o-monotosyl-6-deoxy-β-cyclodextrin (8.8 g, 6.83 mmol, 1 eq), 1,6-hexanediamine
(HDA; 35 g, 300.17 mmol, 44.2 eq), and DMF (50 mL). The reaction was carried
out under nitrogen at 80°C for 18 hours. The product was repeatedly precipitated
from cold acetone, washed by cold diethyl ether and dried under vacuum to afford
the final product (6.75 g, 80%) as a white powder. 1H-NMR (DMSO-d6) δ = 1.141.61 (m, 12 H), 3.12-3.45 (m, overlaps with HOD), 3.48-3.78 (m, 28 H), 4.28-4.56
(br s, 6 H), 4.83 (s, 7 H), 5.59-5.88 (br s, 14 H).
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7.2.5 CD-HA Synthesis.
CD-HA was prepared by coupling β-CD-HDA to HA-TBA via amidation (Figure
7.2).15,32 A round bottom flask was charged with HA-TBA (1 g, 1.41 mmol repeat
units, 1 eq) and β-CD-HDA (0.70 g, 5.65mmol, 0.4 eq). The vessel was purged by
nitrogen and anhydrous DMSO added via cannulation to afford an approximately
2wt%

solution.

Once

fully

dissolved,

(benzotriazol-1-

yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP; 0.25 g, 0.565
mmol, 0.4 eq) was dissolved in minimal DMSO and transferred to the reaction
vessel via cannulation. The reaction was carried out at room temperature for 2
hours. Purification was performed by extensive dialysis against DI water and
filtration to remove insoluble byproducts from the reaction. The solution was frozen
and lyophilized to obtain the final product. Functionalization was determined to be
20% by integration of the hexane linker (δ=1.22-1.77, 12 H) relative to the methyl
singlet of HA (δ=2.1, 3 H).

Figure 7.2. Synthesis of CD-HA. (A) Synthesis scheme. (B) Corresponding 1H NMR
spectra.
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7.2.6 HA-SH Synthesis.
HA-SH was prepared by coupling 3,3’-dithiopropionic acid (DTPA) to HA-TBA
via esterification, followed by reduction with DTT to obtain the free thiol (Figure
7.3). Esterification was performed as above, with reactants: HA-TBA (0.75 g, 1.14
mmol repeat units, 1 eq), DPTA (1.20 g, 5.71 mmol, 5.0 eq), DMAP (0.35 g, 2.85
mmol, 2.50 eq), and Boc2O (0.20 mL, 0.88 mmol, 0.4 eq) to afford the intermediate
DTP-HA. Functionalization of the macromer was quantified by 1H-NMR and
determined from integration of the ethyl multiplet (δ=2.61-2.72, 2 H) relative to the
methyl singlet of HA (δ=2.1, 3 H). Subsequently, the disulfide was reduced with
DTT to obtain the free thiol. DTP-HA (0.5g, 1.27 mmol, 1.0 eq) was dissolved in DI
water (50mL), and DTT (0.5g, 32.41 mmol, 25.5 eq) and NaCl (0.5g) added in solid
form. The pH was increased to 8.5 with 0.1N NaOH and the reaction stirred at
room temperature for 3 hours, at which time the NaCl concentration was increased
to 5.0%w/v and the pH adjusted to 3.5 by 0.1N HCl. The product was recovered
by precipitation in cold EtOH (450mL) followed by repeated washing by 100%
EtOH. EtOH was removed under vacuum prior to re-dissolving in DI water and
lyophilization to obtain the final thiolated HA (HA-SH). Functionalization of the
macromer was quantified by 1H-NMR and determined from integration of the ethyl
singlet (δ=2.80-3.0, 4 H) relative to the methyl singlet of HA (δ=2.1, 3 H). Both the
intermediate, DTP-HA, and HA-SH modification of the HA by the desired functional
group was determined to be approximately 20%.
As attempts to thiolate HA via amidation showed a high degree of disulfide
crosslinking and because acidic conditions utilized in product isolation may be
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hydrolytic toward the polymer backbone, products were examined by gel
permeation chromatography (GPC) with 90kDa sodium hyaluronate (HA) as a
control reference. Elution traces showed partial crosslinking as a result of HA
modification with the bifunctional carboxylic acid DTPA. However, following
reduction by DTT and isolation as described above, HA-SH elution traces showed
recovery of product without disulfide formation or degradation of the macromer.

Figure 7.3. Synthesis of HA-SH. (A) Synthesis scheme. (B,C) Corresponding 1H NMR
spectra of the intermediate prior to DTT reduction (B) and following reduction (C).
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7.2.7 MeHA Synthesis.
Methacrylated HA (MeHA) was prepared through the conventional methacrylic
anhydride route (Figure 7.4).33 Briefly, HA (3g, 7.61mmol, 1.0 eq) was dissolved in
DI water (300mL) and cooled on ice. The pH was adjusted to 8.5, and methacrylic
anhydride (2.25 mL, 15.1 mmol, 2 eq) added. With vigorous stirring, the pH was
maintained at pH 7.5-8.5 by addition of 5N NaOH for 8 hours. Additional
modification was similarly performed the following day by addition of 1.125mL
methacrylic anhydride and maintenance of the pH at 7.5-8.5 for an additional 4
hours. Functionalization of the macromer was quantified by

1H-NMR

and

determined to be 30% from integration of the vinyl group (δ=5.82, 1 H and δ=6.25,
1 H) relative to the HA backbone (δ=3.20-4.20, 10 H).

Figure 7.4. Synthesis of MeHA. (A) Synthesis scheme. (B) Corresponding 1H NMR
spectra.
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7.2.8 AHA Synthesis.
Acrylated HA (AHA) was prepared by esterification of acrylic acid to HA-TBA
as previously described (Figure 7.5).34 Synthesis was performed analogous to that
of Ad-HA, with reactants: HA-TBA (0.5 g, 0.715 mmol repeat units, 1 eq), acrylic
acid (0.122 mL, 1.79 mmol, 2.5 eq), DMAP (6.5 mg, 53.5 μmol, 0.075 eq), and
BOC2O (0.144 mL, 0.625 mmol, 0.875 eq). Acrylate functionalization was
quantified by

1H-NMR

and determined from integration of the vinyl peaks

(δ=5.6.55, 6.30, 6.09 1 H ea.) relative to the methyl peak of HA (δ=2.10, 3 H). The
percent of HA repeat units modified was determined to be 17.5%.

Figure 7.5. Synthesis of AHA. (A) Synthesis scheme. (B) Corresponding 1H NMR
spectra.
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7.2.9 VS-HA Synthesis.
Vinyl sulfone HA (VS-HA) was prepared by reaction of HA-SH with
divinylsulfone (Figure 7.6). HA-SH was prepared as described above. Following
precipitation in EtOH, HA-SH (0.1g, 0.359mmol, 1.0eq) was dissolved in DI water
at approximately 2wt% and added dropwise to excess divinylsulfone (0.7mL,
7.19mmol, 20eq) dissolved in 5mL DI water. The solution was titrated to pH 7.0 by
0.1N NaOH and stirred on ice for 2 hours. Purification was performed by extensive
dialysis against DI water. The solution was frozen and lyophilized to obtain the final
products. Vinyl functionalization of the macromers was quantified by 1H-NMR and
determined from integration of the vinyl peak multiplets (δ=6.50, 2 H and δ=6.95,
1 H) relative to the HA backbone (δ=3.20-4.20, 10 H). The percent of HA repeat
units modified was determined to be approximately 20%.

Figure 7.6. Synthesis of VS-HA. (A) Synthesis scheme. (B) Corresponding 1H NMR
spectra.
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7.2.10 MaHA Synthesis.
MaHA was prepared by coupling N-(2-Aminoethyl)maleimide trifluoroacetate
salt to HA-TBA via amidation (Figure 7.7). Reaction was carried out as described
above, with reactants: HA-TBA (1.6 g, 2.26 mmol repeat units, 1.0 eq), N-(2Aminoethyl)maleimide (0.215 g, 0.848 mmol, 0.375 eq), and BOP (0.375 g,0.848
mmol, 0.375 eq). Purification was performed by extensive dialysis against DI water
at 4ºC, to prevent maleimide hydrolysis, and filtration to remove insoluble
byproducts from the reaction. The solution was frozen and lyophilized to obtain the
final product. Functionalization was determined from integration of the vinyl group
(δ=6.96, 2 H) relative to the methyl singlet of HA (δ=2.1, 3 H). The percent of HA
repeat units modified was determined to be approximately 19%.

Figure 7.7. Synthesis of MaHA. (A) Synthesis scheme. (B) Corresponding 1H NMR
spectra.
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7.2.11 Ad-HA-SH Synthesis.

Figure 7.8. Synthesis of Ad-HA-SH. (A) Synthesis scheme. (B) Corresponding 1H NMR
spectra.

Ad-HA-SH was prepared by sequential modification of HA by adamantane then
the mercapto group as described above (Figure 7.8). A portion of Ad-HA prepared
(1.1g) was dissolved in 50mL DI water and exchanged against 3.3g Dowex-100
resin, neutralized by tetrabutylammonium hydroxide, and then frozen and
lyophilized to obtain the intermediate Ad-HA-TBA. A round bottom flask was
charged with Ad-HA-TBA (1.44 g, 2.19 mmol repeat units, 1 eq), 3,3’dithiopropionic acid (2.30 g, 10.95 mmol, 5.0 eq), and 4-dimethylaminopyridine
(0.70 g, 5.48 mmol, 2.50 eq). The vessel was purged by nitrogen, and anhydrous
DMSO added via cannulation to afford an approximately 2wt% solution. Once fully
dissolved, di-tert-butyl dicarbonate (BOC2O) was added via syringe (0.20 mL, 0.88
mmol, 0.4 eq) and the reaction carried out at 45°C for 24 hours. Purification was
performed by dialysis for 3 days against DI water, precipitation in acetone, and
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further dialysis. The solutions were frozen and lyophilized to obtain the
intermediate Ad-HA-DTP. Functionalization of the macromer was quantified by 1HNMR and determined from integration of the ethyl multiplet (δ=2.61-2.72, 2 H)
relative to the backbone of HA. Subsequently, the disulfide was reduced by DTT
to afford the free thiol, as described above for HA-SH. Thiol modification of the
macromer was quantified by 1H-NMR and determined from integration of the ethyl
singlet (δ=2.60-2.82, 4 H) relative to the HA backbone.

7.2.12 CD-MeHA Synthesis.
CD-MeHA was prepared by sequential modification of HA by methacrylates
then CD-HDA by reactions as described above (Figure 7.9). A portion of MeHA
(1.5g) was converted to the TBA salt as previously described to afford the
intermediate MeHA-TBA. A round bottom flask was charged with MeHA-TBA (1 g,
1.41 mmol repeat units, 1 eq) and cyclodextrin modification carried out identically
to that for preparation of CD-HA. Because both the HA backbone and methyl peak
are obscured by cyclodextrin and the methacrylate, respectively, methacrylate
modification was assumed to remain unchanged and functionalization by CD-HDA
was determined to be 20% by integration of the hexane linker (δ=1.35-1.85, 12 H).
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Figure 7.9. Synthesis of CD-MeHA. (A) Synthesis scheme. (B) Corresponding 1H NMR
spectra.

7.2.13 CD-MeHA-CyP Synthesis.
In order to label guest-host (GH) and dual-crosslinking (DC) hydrogels for
monitoring in vivo degradation, the fluorescent peptide GCKKG-Cy7.5 (Figure
7.10A) was prepared by standard solid phase peptide synthesis (PS3 automated
peptide synthesizer, Protein Technologies) with glycinol 2-chlorotrityl resin and
FMOC protected amino acids. The amine terminus was reacted with the free acid
of Cy7.5 (Lumiprobe; 3x molar excess to resin loading) by substitution of the
fluorophore in place of the terminal amino acid. The peptide was cleaved from the
resin by reaction with trifluoroacetic acid, triisopropyl silane, and water (95/2.5/2.5)
and recovered by repeated precipitation from cold diethyl ether. Expected mass
(1165 Da) was confirmed by MALDI-tof mass spectrometry (Applied Biosystemd
Voyager 6030; Figure 7.10C). Absorbance and emission spectra were obtained
(Tecan infinite M200 spectrophotometer (Figure 7.10D) in dilute aqueous solution.
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The peptide displayed a characteristic absorbance in the 560-850 nm range (λmax
abs=800

nm) and strong fluorescence in the near-IR range (λmax em=808 nm).

For peptide coupling (Figure 7.10B) to the polymer for imaging, CD-MeHA (100
mg, 0.15 mmol, 1.0 eq) was dissolved in 20mL of triethanolamine buffer, pH 10.
The fluorescent peptide (6.5 mg, 5.56µmol, 0.036eq) was dissolved in minimal DI
water and added dropwise. The reactions were allowed to proceed at 4 oC for 4
hours prior to extensive dialysis and lyophilization which afforded the final product.

Figure 7.10. Synthesis of CD-MeHA-CyP. (A) Design of Cy7.5-terminated fluorescent
peptide (CyP). (B) Scheme for coupling of CyP with CD-MeHA. (C) MALDI-MS conforming
molecular weight of CyP. (D) Absorbance and emission spectra of CyP. .
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7.2.14 Hydrogel Formation.
For all studies, hydrogels were prepared from stock solutions of the individual
macromers in PBS at the desired concentration. For hydrogel formation by guesthost assembly, the two component solutions were combined and mixed by
manually stirring to ensure a homogenous hydrogel then centrifuged to remove
entrapped air. Hydrogels were formulated such that adamantane and βcyclodextrin were present in stoichiometric balance, and the concentration refers
to the overall weight percent of combined macromers. Formation of hydrogels via
the Michael-addition and dual-crosslinking mechanisms was similarly performed,
with the pH of dissolution buffers adjusted to obtain the desired pH.

7.2.15 Mechanical Characterization.
Rheological characterization was performed using an AR2000 stresscontrolled rheometer (TA Instruments) fitted with a 20 mm diameter cone and plate
geometry, 59 min 42 s cone angle, and 27 μm gap. Rheological properties were
examined at 37 ºC by oscillatory frequency sweeps (0.01-100 Hz; 1% strain), time
sweeps (1.0; 1% strain), strain sweeps (10 Hz; 0.05-250% strain), and continuous
flow experiments (linearly ramped: 0-0.5 s-1 and returned). For shear recovery
experiments, shear-thinning was performed at 100% strain with recovery at 1.0%
strain, each at 10 Hz. Compressive mechanics were performed on samples (n=3)
following crosslinking at pH 8.0 overnight at 37 ºC with a dynamic mechanical
analyzer (DMA, Q800 TA Instruments) at a strain rate of 10%/min. Moduli were
calculated at a strain of 10-20%.
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7.2.16 MRI Imaging and Analysis.
Cardiac explants were imaged using either a 3T or 9.4T MRI Scanner
(Siemens) to directly visualize material distribution and quantify retention.
Hydrogels injections were performed via syringe (28G ½” needle) at a depth of
approximately 4 mm from the epicardial surface of porcine myocardial explants.
Tissue samples were stored in PBS supplemented with Penicillin-Streptomycin
before initial imaging (<2 hours post-injection) and between subsequent
timepoints. Imaging at 3T was performed with submersion in PBS to minimize
dielectric artifacts near the tissue surface. A T2 weighted turbo spin echo pulse
sequence was used with the following parameters: echo time (TE) = 71 ms,
repetition time (TR) = 6000 ms, averages = 2, matrix size = 320 x 320 x 50, voxel
size = 0.3125 x 0. 3125 x 0.1 mm3. Imaging at 9.4T was performed in ambient
conditions. A T2 weighted spin echo pulse sequence was employed with the
following imaging parameters: TE = 40 ms, TR = 4000 ms, averages = 4, matrix
size = 256 x 256 x 128, voxel size = 0.14 x 0. 14 x 0.25 mm 3.
For all image analysis, segmentation and 3D reconstruction was performed in
ITK-Snap.35 Images were converted into NIFTI format using ImageJ software.
Reconstruction was carried out in ITK-SNAP by automated segmentation with
manual

edge

correction,

allowing

three-dimensional

quantification of retained hydrogel volumes.
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and

7.2.17 In Vitro Degradation.
Acrylamide molds were used to contain the hydrogels within a 5 mm diameter
6 mm high depression. Hydrogels were prepared as described and 30 μL of the
desired hydrogel loaded into the depression. Hydrogels were covered with 1 mL
PBS and allowed to erode at 37°C. The buffer was replaced twice weekly.
Following 28 days, hydrogels were degraded in 1mg/mL hyaluronidase to allow
determination of remaining hydrogel content necessary for data normalization.
Macromer release was quantified by uronic acid assay.

7.2.18 In Vivo Degradation.
To allow for degradation to be directly observed in vivo, CD-MeHA was labeled
by the near-IR dye Cy7.5 through preparation of the peptide GCKKG-Cy7.5 and
subsequent Michael-addition of the peptide to form the derivatized HA macromer.
After injection (25µL), degradation was assessed biweekly over 4 weeks (Pearl
Impulse, LI-COR). The fluorescence signal (λex/λem=785/820 nm) was integrated
over identically sized regions of interest centered over the injection site for all
animals. Values were baseline corrected to images of mice prior to injection
(n=11), and normalized to the peak intensity for the material group.

7.2.19 Myocardial Infarct Model.
MI was induced in adult male Wistar rats using an established and highly
reproducible model. Infarct induction and analyses were performed similar to that
previously described.36 Male Wistar rats weighing 250 to 300 g were obtained from
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Charles River Laboratories (Wilmington, MA) and housed with food and water
provided ad libitum. All experiments conformed to the Guide for the Care and Use
of Laboratory Animals, published by the US National Institutes of Health (Eighth
Edition, 2011). The protocol was approved by the Institutional Animal Use and
Care Committee of the University of Pennsylvania (protocol number 804952).
Rats were first anesthetized in an induction chamber (VetEquip, Pleasantville,
CA) by 3% isoflurane. A 16-gauge angiocatheter was used for endotrachial
intubation and connected to mechanical ventilation (Hallowell EMC, Pittsfield
Mass), allowing 1-3% isoflurane to be maintained throughout the operation. A
thoracotomy was performed through the left fourth intercostal space, the heart was
exposed, and a 7-0 polypropylene suture was placed around the left anterior
descending artery (LAD) 2 mm below the left atrium. The suture was briefly snared
to verify the size and location of myocardial ischemia based on color change and
was permanently tied down to produce a large anterolateral MI comprising ~20%
of the left ventricular wall, which was visually confirmed by color change resulting
from myocardial ischemia.36 The animals were randomized into 3 groups and
received 6-8 separate intramyocardial injections (75 µL per animal) of saline
(n=22), GH hydrogel (n=8), or DC hydrogel (n=8) into the border zone of the infarct.
Sham control procedures (n=14) followed an identical protocol to the saline group,
without ligation of the LAD. The thoracotomy was closed in multiple layers, and
tissue adhesive (VetBond; 3M, Minneapolis, MN) was applied over the incision.
Animals were allowed to recover with buprenorphine (0.5 mg/kg) administered for
postoperative pain control and subject to endpoint analysis at 28 days post-infarct.
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7.2.20 Echocardiographic and Hemodynamic Assessment.
LV geometry and function were evaluated preoperatively and at 4 weeks in all
animals.37 A Phillips Sonos 5500 revD ultrasound system (Philips Medical
Systems, Amsterdam ND) was used, with a 12-MHz transducer at an image depth
of 2 cm. LV parasternal short-axis 2-dimensional and M-mode images at the level
of the papillary muscle were used to obtain echocardiographic data. All analyses
were performed by a single investigator who was blinded to the treatment groups.
Four weeks after LAD ligation, animals underwent invasive hemodynamic
measurements with a pressure–volume conductance catheter (SPR-869; Millar
Instruments, Inc). Rats were anesthetized as above, and the catheter was
introduced into the LV using a closed-chest approach via the right carotid artery.
Measurements were obtained before and during inferior vena cava occlusion to
produce static and dynamic pressure–volume loops under varying load conditions.
Data were recorded and analyzed with LabChart version 8.0 software (AD
instruments). Finally, cardiac output was assessed by placing a 2.5-mm periaortic
Doppler flow probe (Transonic Systems, Ithaca, NY) around the ascending aorta.

7.2.21 Histological Analysis and Immunohistochemistry.
To assess infarct size and vascular density, hearts were explanted following
invasive hemodynamic assessment and flushed with PBS and then injected
retrograde with Tissue Tek optimum cutting temperature (OCT) compound
(Sekura, The Netherlands) through the aorta and pulmonary artery. Hearts were
submerged in OCT, frozen, and stored at −80°C. 10-μm-thick sections were
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prepared from each heart at the level of the papillary muscles and subject to
staining by hematoxylin and eosin (H&E) and Masson’s trichrome. Standardized
digital photographs were taken with a Nikon D5100 SLR camera (Nikon, Tokyo,
Japan). Photographs were uploaded to ImageJ (v1.46b) and the size of the infarct
assessed with digital planimetry. Two 10-μm-thick sections from each animal were
stained with antibodies directed against von Willebrand Factor (vWF) and
separately for alpha smooth muscle actin (αSMA) to quantify capillary and arteriole
densities, respectively. Sections were fixed with ice cold acetone, blocked in 10%
fetal bovine serum, and incubated with either rabbit anti-vWF (1:200 dilution;
Abcam) or mouse anti-αSMA (1:50 dilution; Thermo) for 2 hours. Donkey antirabbit antibody (Alexa Fluor 488, 1:200; Abcam) or donkey anti-mouse antibody
(Alexa Fluor 555, 1:50 dilution; Invitrogen) were used as secondary reagents and
incubated for 1 hour, after which sections were washed and counterstained with
4’,6-diamidino-2-phenylindole (DAPI) to visualize nuclei. Quantitative analysis of
capillary and arteriolar density within the borderzone was conducted under the 20x
objective of a Leica DM5000B microscope. Group blinded counts were averaged
over 4 fields per specimen with a minimum of 4 animals per group.

7.2.22 Statistical Analysis.
All data is reported as means ± standard error (SEM) or standard deviation
(SD), for in vitro data. For degradation studies, comparison between groups was
performed by Students t-test with two-tailed criteria and significance determined at
p<0.05. For the infarct model, statistical significance was determined by one-way
ANOVA with post hoc testing to compare between groups. Bonferroni correction
was used to account for multiple comparisons, with α=0.05.
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7.3 Results and Discussion
7.3.1 Guest-Host Hydrogels for Shear-Thinning Delivery.
β-Cyclodextrin is a macrocycle composed of 7 D-glucose units arranges in a
toroidal fashion through 1,4-glucosidic bonds, enabling it to include a range of
hydrophobic molecules in its interior cavity.38 Of these potential guest molecules,
adamantane is widely regarded as having one of the greatest affinities (Ka≈105 M1)12

due both to its hydrophobicity and complementary size. Together, the

molecules form a guest-host pair known to interact in a one-to-one fashion upon
mixing in aqueous conditions (Figure 7.11A). Hyaluronic acid (HA) is a linear
polysaccharide found in native ECM and is well suited to applications in
translational medicine, as it plays a role in embryogenesis, angiogenesis, cell
migration and scar reduction.39 Importantly, HA also provides carboxyl and
hydroxyl functionalities, useful as reactive handles for ease of modular chemical
modification. For assembly of guest-host (GH) hydrogels, HA was modified (Figure
11B) either by coupling of 1-adamantane acetic acid via esterification (guest, AdHA) or aminated β-cyclodextrin via amidation (host, CD-HA) as previously
described.15
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Figure 7.11. Guest-host hydrogel formation enables shear-thinning injection and
hydrogel retention. (A) Interaction of adamantane (Ad, guest) and β-cyclodextrin (CD,
host) in formation of a reversible guest-host (GH) complex crosslink, and corresponding
synthesis (B) for specific guest (Ad-HA) and host (CD-HA) macromers. (C) Schematic of
supramolecular hydrogel formation utilizing guest-host complexation. (D) Oscillatory time
sweeps of individual macromers and hydrogel formed at 3.5wt%; storage modulus (G’,
filled symbols) and loss modulus (G’’, empty symbols) at 1.0 Hz, 1.0% strain. (E-F) Shearthinning and recovery characterization, demonstrating shear yielding behavior at high
strain (E) for GH hydrogel (3.5wt%) and corresponding recovery under repeated
deformation (F) of 1.0 (low) and 100% strain (high, shaded) at 10Hz. (G) Short axis MRI
cross-section of an explanted porcine heart showing retention of injected hydrogels (left,
injection sites indicated), with corresponding 3D reconstruction (right) of nine 300μL GH
hydrogel injections (purple) in a porcine whole heart explant (red); imaged at 3T.

Guest-host complexation drives supramolecular assembly of a physically
crosslinked hydrogel. Owing to the linear polymer architecture and pendant
functionality of the guest and host groups, macromer components self-assemble
through the binary complexes, which act cooperatively to result in a net avidity
between polymer chains.15,40 These interactions were demonstrated by rheological
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measurements, showing that individual macromers were viscous solutions and
mixing resulted in a hydrogel composed of non-covalent bonds (Figure 7.11C,D).
Owing to the reversible nature of the guest-host complex, the networks formed are
dynamic. Hydrogels thus displayed stress relaxation at low frequency, indicative
of bond restructuring (Figure 7.12A); the relaxation behavior of these networks was
previously characterized.15

Figure 7.12. Rheological examination of guest-host hydrogel dynamics. (A)
Representative oscillatory frequency sweep showing storage modulus (G’, filled symbols)
and loss modulus (G’’, open symbols) of guest-host hydrogel (Ad20HA+CD20HA; 3.5wt%)
with bulk relaxation time (1/Frequency) indicated by the black arrow. (B) Continuous flow
experiment showing the shear stress (closed symbols) and viscosity (open symbols) of
guest-host hydrogel (Ad20HA+CD20HA; 3.5wt%) at increased shear rate.

As a result of the dynamic bonding structure, hydrogels are capable of shearinduced flow and rapid recovery. In particular, GH hydrogels exhibited yielding
behavior and transition to liquid-like flow under high strain (>35%, Figure 7.11E)
and displayed characteristic shear-thinning behavior under continuous flow
conditions (Figure 12B). Owing to the high valence of polymer modifications (>40
groups per HA chain) and moderate association constant of the guest-host
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complex, near-instantaneous reassembly of the networks was exhibited with >85%
recovery of G’ within 3s following shear-thinning (Figure 7.11F). As a direct result
of these flow and recovery characteristics, GH hydrogels are easily injectable, selfhealing, and readily re-form even upon injection into aqueous media.
Finally, we sought to demonstrate the capacity of GH hydrogels for injection
site retention. Towards this, magnetic resonance imaging (MRI) has been useful
to image HA hydrogels, as T2 relaxation behavior of the multiple hydroxyl moieties
enables ease of imaging both in vitro and in vivo.24,41 For this investigation,
hydrogels were injected into explanted porcine myocardium and subjected to T2
weighted MRI, allowing visualization of material in situ. The pattern of nine
injections was observed both in the tissue cross-section and corresponding 3D
reconstruction (Figure 7.11G). Hydrogel injections were quantitatively evaluated at
higher field strength and resolution to evaluate retained volumes and morphology
over time, demonstrating GH hydrogels were initially well retained (>98% in all
cases), and the hydrogel retention was independent of injection volume (50-300μL
examined; Figure 7.13A, Table 7.1). Hydrogels were sustained within the tissue
for greater than one week in vitro and exhibited minimal morphological changes
over time with the exception of modest swelling (Figure 7.13B, Table 7.1). In
summary,

the

guest-host

hydrogel

mechanism

developed

affords

a

supramolecular hydrogel through dynamic binary guest-host associations. The GH
hydrogel is capable of shear-yielding and rapid mechanical recovery, thus enabling
injectable delivery with high target site retention.
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Figure 7.13. MRI analysis of hydrogel retention. (A) Representative cross sections of
T2 weighted MRI for guest-host hydrogel injections of various volume, as indicated. (9.4T;
day 3 post-injection) (B) Representative 3D reconstructions of T2 weighted MRI for a
single guest-host hydrogel injection acquired at various times post-injection, as indicated.
(9.4T; 50μL)

Table 7.1. Volumes of guest-host hydrogels post-injection.

Calculated Volume (μL)

Injected
Volume (μL)

Day 0

Day 3

Day 7

50.0

55.9

64.8

67.8

150.0

149.2

161.7

169.6

300.0

297.8

327.7

337.6

199

7.3.2 Dual-Crosslinking Hydrogels with Controlled Michael Addition Kinetics.
Michael-addition (MA) crosslinking (Figure 7.14) occurs through the
condensation of a nucleophile, such as a thiol, and an activated olefin. Common
thiolated small molecule crosslinkers42 were avoided in material design, opting
rather for the modification of HA macromers to limit diffusion from the reaction site.
Initial attempts were made to functionalize HA with thiols (HA-SH) via cystamine
amidation; however, the product could not be isolated in soluble form following
disulfide bond reduction and lyophilization. This is presumably a result of
decreased pKa of the thiol due to regional chemical structure,43 leading to
accelarated generation of the thiolate anion and resultant interchain disulfide bond
formation. HA was thus modified by esterification of HA with 3,3’-dithiodipropionic
acid followed by reduction with DTT. The product was isolated by precipitation from
EtOH and subsequent lyophilization from acidified water (HCl, pH 3.5). The degree
of HA modification, determined by 1H-NMR, demonstrated complete reduction of
the disulfide bond with no change in modification before and after reduction.
Moreover, GPC analysis demonstrated that HA-SH was recovered without
degradation of the polymer or formation of interchain disulfide bonds.
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Figure 7.14. Michael-Addition hydrogel formation, tuning of crosslinking kinetics. (A)
Schematic of covalent crosslink formation via generalized Michael-addition reaction
between a thiol-modified HA macromer and Michael-acceptor (VSHA: vinyl sulfone HA,
AHA: acrylated HA, MeHA: methacrylated HA). (B-D) Real-time rheological observation
(storage modulus (G’), 1.0 Hz, 1.0% strain) of Michael-addition crosslinking with variations
in the Michael-acceptor reactivity (B), pH (C), and macromer concentration (D).

Reactants and reaction conditions were directly investigated through real-time
rheological observation to identify conditions with a range of gelation times from
minutes to hours. As addition reaction kinetics are highly dependent on the
structure and electrophilic activation of the Michael-acceptor, various Michaelacceptor modifications of HA were performed including the methacrylate (MeHA),
acrylate (AHA), vinyl sulfone (VSHA), and maleimide (MaHA) derivatives. Reaction
pH was also considered, as the thiolated anion (generated via deprotonation in
basic conditions) is the reactive species.26,43 Gel times were observed to decrease
with increasing reactivity of the Michael-acceptor (Figure 7.14B), pH (Figure
7.14C), and polymer concentration (Figure 7.14D). These trends were consistent
across the entirety of the parameter space investigated (Figure 7.15). From these
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results, MeHA was determined to be a viable Michael-acceptor for clinical use, as
it exhibited gel times greater than 45 minutes if the polymer concentration and pH
were properly controlled. Based on these trials in conjunction with guest-host
hydrogel behavior, we selected hydrogels of approximately 3.5wt% as optimal for
pursuit of subsequent in vivo applications.

VSHA > AHA > MeHA

pH 7> pH 6 > pH 5

pH 5

MeHA

pH 6

AHA

pH 7

VSHA

Figure 7.15. Real-time rheological observation of Michael-addition crosslinking with
variation in the Michael-acceptor reactivity (left: vinyl sulfone HA (VSHA), acrylated HA
(AHA), methacrylated HA (MeHA)) or pH (right) for all conditions examined showing the
storage modulus (G’) at 1.0 Hz, 1.0% strain. Maleimide modified HA (MaHA) was also
investigated, but crosslinking occurred too rapidly to allow rheological investigation,
independent of pH.
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To allow combination of physical and covalent crosslinking mechanisms for
dual-crosslinking (DC) hydrogels (Figure 7.16), thiolated Ad-HA and methacrylated
CD-HA were prepared by modular, sequential synthesis (Figure 7.16B). The
degree of HA modification was maintained at approximately 20% for all groups,
and sequential reactions were observed to be independent of prior modifications.
Despite the secondary polymer modification for Michael-addition, GH hydrogels
retained their native mechanical properties prior to liberation of the reactive
mercapto group by reduction with DTT (Figure 7.17) and were qualitatively
observed to have similar injectable properties. To demonstrate the necessity and
efficacy of the dual-crosslinking approach toward retention, hydrogel injections
were performed into explanted porcine myocardium followed by washing in PBS
for 24 hours. MRI imaging (Figure 7.16D) showed that MA gels alone did not have
sufficient initial mechanics for retention, even in a stationary tissue explant. Such
a crosslinking approach is therefore insufficient for therapeutic use, despite its
suitability for percutaneous injection. Conversely, the GH and DC gels were both
well retained at the injection site. Rheological time sweeps show that upon initial
formation, DC hydrogels have moduli similar to that of GH hydrogels, yet
subsequent crosslinking via the desired Michael-addition resulted in a more rigid
viscoelastic solid with increased shear modulus (Figure 7.16E). Following this
covalent crosslinking step, cessation of flow and bulk relaxation behaviors was
observed as evidenced by oscillatory frequency sweeps demonstrating the loss of
bulk relaxation behavior at low frequency (Figure 7.17). Allowing crosslinking to
proceed to completion, hydrogels with compressive moduli of 25.0±4.5kPa were
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obtained, whereas GH hydrogels did not have sufficient mechanics for unconfined
compression testing. In sum, secondary modification of HA to allow Michaeladdition was accomplished in a modular fashion, allowing in situ stabilization
without compromising the injectable behavior of the GH gel.

Figure 7.16. Dual-Crosslinking hydrogel formation, retention, and altered
biophysical properties. (A) Addition of thiol and methacrylate in formation of a covalent
crosslink (a), and corresponding synthesis (B) of guest Michael-donor (Ad-HA-SH) and
host Michael-acceptor (CD-MeHA) macromers. (C) Schematic of dual-crosslinking (DC)
hydrogel formation. (D) MRI cross-section of explanted porcine myocardium injected with
the Michael-addition (MA), guest-host (GH), and dual-crosslinking (DC) hydrogels; imaged
at 9.4T (for interpretation in color as well as histological confirmation, the reader is referred
to Figure 7.18 and 7.19). (E) Oscillatory time sweeps (1.0 Hz, 1.0% strain) of GH and DC
hydrogels immediately after mixing. (F) Cumulative in vitro erosion profiles (mean±SD;
n=3) for GH and DC hydrogels.
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Figure 7.17. Rheological examination of hydrogel properties prior and subsequent
to disulfide reduction. (A) Representative oscillatory frequency sweeps showing storage
modulus (G’, filled symbols) and loss modulus (G’’, open symbols) of the unmodified
guest-gost (GH) hydrogel (top left; Ad20-HA+CD20-HA; 5.0wt%), GH hydrogel including
secondary modifications (top right; Ad20-HA-DTPA20+CD20-Me25HA; 5.0wt%), and the
overlay of both plots (bottom). (B) Representative oscillatory frequency sweeps showing
storage modulus (G’, filled symbols) and loss modulus (G’’, open symbols) of the
unmodified guest-host (GH) hydrogel (top left; Ad20-HA+CD20-HA; 3.5wt%), dualcrosslinking (DC) hydrogel (top right; Ad20-HA-SH20+CD20-Me25HA; 3.5wt%), and the
overlay of both plots (bottom).

Figure 7.18. MRI reconstruction of hydrogel injection. (A) 3D reconstruction of
hydrogel injections: Michael-addition (blue, left), guest-host (purple, middle), and dualcrosslinking (green, right) into porcine myocardium (red). (B) Cross-section of injection
site with interpretation in color.
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Figure 7.19. Histological confirmation of hydrogel injections: Michael-addition (blue,
left), guest-host (purple, middle), and dual-crosslinking (green, right) into porcine
myocardium. Paraffin embedded sections were sectioned in the x-z plane of (Figure 7.18)
near the center of the injection site and subject to H&E staining. Hydrogel is stained
purple, indicated by “G.”

In addition to modification of the hydrogel stiffness, secondary covalent
crosslinking is expected to alter hydrogel degradation. Physically crosslinked
hydrogels, including the GH system, undergo mass loss dominated by surface
erosion through stochastically governed network disassembly.1,14,15 Rapid erosion
and release of encapsulated cargo, often on the order of hours to days, is exhibited
and known to be dependent on the affinity of the heterodimeric interactions and
their valence.1,14,22,44 The GH hydrogel system demonstrated surprising stability
toward erosion in vitro (65.6±1.9% remaining at day 28), likely owing to the high
valence of functional groups. Mass loss, however, was relatively rapid as
compared to the DC hydrogels, which exhibited a significant reductions in mass
loss at all observed time points beyond day 3 (Figure 7.16F). For DC hydrogels,
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mass loss was still observed, likely resulting from macromer surface erosion
preceded by the expected slow hydrolysis of thioether-ester bonds formed through
Michael-addition.45

Figure 7.20. In vivo degradation behavior modulated by dual-crosslinking. (A-C)
Near-IR fluorescence imaging of guest-host (GH) and dual-crosslinking (DC) hydrogels
after injection subcutaneously in the right flank of mice (A) and monitored over 28 days (B:
fluorescent images, C: normalized signal intensity (mean±SEM; n=3)). (D-F) Epicardial
injection and retention in a rat infarct model. Injections were performed in the infarct border
(D: schematic, E: visualization immediately after injection). (F) Fluorescence imaging of
hearts explanted at the terminal time point (top) and quantification of fluorescence signal
intensity (bottom, (mean±SEM; n>5)).

As established in vitro, the material systems described are intended to afford
physically crosslinked hydrogels with injectable capacity and optional in vivo
stabilization through covalent dual-crosslinking. However, in vitro degradation is
not always a reliable predictor of in vivo behavior.46,47 Our lab and others have
shown that near-IR fluorescent labeling has great utility in tracking material
degradation and release of biological factors in vivo.36,48,49 To examine the
potential for crosslinking and degradation in vivo, hydrogels were injected
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subcutaneously in mice (Figure 7.20A). An innovative approach was used to
provide fluorescence using a custom peptide sequence (GCKKG-Cy7.5). Standard
solid phase peptide synthesis allowed preparation of the fluorescent peptide in
high purity, where the amine terminus was capped by the free acid of Cyanine 7.5
during the synthesis. Despite harsh reaction conditions, absorbance and emission
spectra demonstrated the expected fluorescence properties (λmax abs/em = 800/808
nm). Subsequent reaction with CD-MeHA under basic conditions enabled fascicle
near-IR labeling of the macromer used to form the hydrogel. Upon injection, a
visible gel formed under the tissue, and degradation was monitored over 4 weeks
(Figure 7.20A,B). Over the time course, GH gels approached complete
degradation, while DC gels remained as visible and palpable solids until the
experiment endpoint (Figure 7.21). Quantification of fluorescence intensity (Figure
7.20C) again showed significant differences between groups for all time points
beyond day 3. Results are in qualitative agreement with in vitro degradation studies
and demonstrate the capacity of the material systems toward injectable delivery
as well as the ability to implement secondary crosslinking in vivo. In sum, both in
vitro and in vivo results clearly demonstrate the ability of the materials to form GH
hydrogels that flow for injectable delivery, rapidly recover for retention at the target
site, and which undergo optional secondary covalent crosslinking to modulate their
biophysical properties.
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Figure 7.21. Macroscopic images of subcutaneous hydrogel injections (guest-host
(GH) or dual-crosslinking (DC) hydrogels, as indicated) immediately after injection (A), at
14 days (B), and at 28 days (C) exposed by retraction of the dermal tissue following
sacrifice.

7.3.3 Therapeutic Potential: Mechanical Stabilization of Myocardial Infarct.
To demonstrate the therapeutic potential of the material systems developed,
they were investigated in the context of a preventative treatment for heart failure
(HF) resultant from myocardial infarction (MI). Heart failure is a clinical condition in
which the contractile functions of the heart have been impaired to a level where
normal bodily functions are compromised.50 In nearly 70% of cases, the condition
has been attributed to maladaptive left ventricular (LV) remodeling following
myocardial infarction (MI),51 making this the greatest cause of cardiovascular
related death.52 Extensive work has shown these remodeling events are a result
of initial expansion of the non-contractile and compliant infarct, altering normal
stress distributions and precipitating progressive remodeling.50,53,54 DC hydrogels
exhibit compressive moduli (25.0±4.5kPa) greater than that of native myocardium
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(5.8±1.5kPa),55 and comparable to that of materials shown to have efficacy in
attenuating remodeling through mechanical stabilization of the infarct. 23,41,55,56 A
combination of experimental and computational approaches has recently
demonstrated that this may be due to reduction in the local and global myofiber
stresses, related to anisotropic stiffening of the tissue.41 GH hydrogels are likewise
investigated, as soft materials injections have shown some efficacy in the
treatment of MI,57-60 though they may be limited in their ability to mechanically
restrain the infarct to resist initial expansion. Due to the inability of MA hydrogels
to be retained at the injection site in vitro, they were excluded from in vitro studies.
We used a rodent model of MI to establish the efficacy of these material platforms
in attenuating LV remodeling, as small animal models allow for relatively large
sample size and thus reliable data analysis.61

Figure 7.22. Epicardial GH injection in the infarct border zone. Macroscopic images
of epicardial guest-host (GH) hydrogel injections into the infarct border zone, as indicated
(A). Hydrogel injection (B) results in pockets of hydrogel that are well retained in the tissue
(C), indicated by green circles in expanded view for clarity. (D) Histological confirmation
of guest-host hydrogel injection, approximately 24 hours post-injection.
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Adult male Wistar rats underwent permanent ligation of the left anterior
descending artery (LAD) to induce MI, and a series of injections (6-8; 75uL total
per animal) was performed into the myocardium in the infract border zone region
(Figure 7.20D,E). Importantly, both GH and DC hydrogels were observed to be
well retained at the injection site despite the forces of myocardial contraction, with
continued retention at 1 day observed histologically (Figure 7.22). With respect to
long-term retention, near-IR imaging of the explanted tissue (Figure 7.20F) shows
diffuse fluorescence throughout the tissue for the GH hydrogel group, whereas DC
hydrogels remain localized, even at 4 weeks post-MI, with a nearly 4-fold greater
net retention. MI and sham groups showed similar, negligible background
fluorescence indicating that the signal is not dependent on inflammation or
remodeling of the myocardial tissue.
Histological, geometric, and functional outcomes were evaluated at 4 weeks
post-MI to assess the efficacy of treatments, with complete analysis provided in at
the end of the chapter in Table 7.2. Treatment of MI by hydrogel injections resulted
in desirable modulation of the tissue response. In particular, mechanical
stabilization of the infarct is expected to protect the border zone from altered stress
distributions and thereby reduce the infarct size. Histological evaluation revealed
a trend toward reduction in the infarct size for DC treatment relative to GH, as
quantified by fibrotic area (Figure 7.23A, Table 7.2). Importantly, a significant
increase in border zone vascular density, including both capillary and arteriole
densities, was observed for the DC relative to GH treatments (Figure 7.24).
Histological analysis is in agreement with prior observations of border zone
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protection by infarct stabilization and the angiogenic potential of HA.23,36,62
Progressive remodeling post-MI is also known to result in dilation of the left
ventricle,

negatively

affecting

its

contractile

function.

Echocardiographic

measurement of the LV inner diameter at end systole (LVIDs, Figure 23B) and end
diastole (LVIDd) showed significantly attenuated LV dilation relative to MI control
for both the GH and DC treatment groups. In sum, histological and geometric
outcomes demonstrate attenuation of infarct expansion through protection of the
border zone and resultant prevention of LV dilation.

Figure 7.23. Histological, geometric, and functional outcomes after hydrogel
injection. (A) Histological cross-sections of myocardial infarction controls (MI) or after
injection of either guest-host (GH) or dual-crosslinking (DC) hydrogels, demonstrating
reduced scar formation (purple color in images) with hydrogel treatment at 28 days postinfarction. (B-F) Geometric and functional outcomes of LV inner diameter at end systole
(B), end-systolic pressure volume relationship (C) fractional shortening (D, ejection
fraction (E), and cardiac output (F) for MI and sham controls, as well as after treatment
with GH and DC hydrogels. Values represent mean±SEM, with sham values indicated by
the shaded regions.
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Figure 7.24. Immunohistochemical (IHC) staining. Utilized for determination of capillary
density (A, von Willebrand factor: vWF, green) and arteriole density (B, α-smooth muscle
actin: αSMA, red), with co-staining of cell nuclei (DAPI, blue) treatment groups of guesthost (GH) or dual-crosslinking (DC) hydrogel injections. (B,C) Quantification shows
increased vascular density for DC injection, relative to both MI controls and GH injections
for determination of both capillary density (C) and arteriole density (D).

Continued contractile function of the LV is, however, the ultimate measure of
treatment efficacy. The end-systolic pressure volume relationship (ESPVR) is a
measure of contractility, valuable in hemodynamic analysis due to its
independence from load and heart rate.63 Determination of ESPVR (Figure 7.23C,
Figure 7.25) showed a trend toward increased contractility for both material
treatments, but was significant only for DC hydrogels. Examination of functional
outcomes, including fractional shortening (Figure 7.23D), ejection fraction (Figure
7.23E), and cardiac output (Figure 7.23F) likewise showed improved function over
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MI in both treatment groups, all with a consistent trend for stabilization by DC
hydrogels to improve outcomes relative to GH. Moreover, the functional
assessments of DC hydrogel treatments approached those of sham controls and
were not statistically different for any measure performed (p>0.28), with the
exception of ejection fraction, which was improved over MI but was statistically
different than sham controls. Analysis of outcomes demonstrates the attenuation
of adverse LV remodeling for both GH and DC hydrogels, with distinct histological
and functional improvement afforded DC hydrogel treatment capable of
mechanically stabilizing the infarct border zone.
100

MI

80

Sham

LV Pressure (mmHg)

LV Pressure (mmHg)

ESPVR: Pes = 2.666 * Ves - 247.07, r² = 0.9915

80

60
40

60

40

20

20
0
100

110 120 130 140 150 160 170 180 190 200

110

LV Volume (µL)

GH

130

140

DC
100

LV Pressure (mmHg)

LV Pressure (mmHg)

100

120

LV Volume (µL)

80
60
40
20

0

80
60
40
20
0

180

190
200
LV Volume (µL)

210

140

150

160
170
LV Volume (µL)

180

Figure 7.25. Response of pressure-volume (PV) relationships to varying load. Endsystolic pressure volume relationship (ESPVR) was determined by linear fit to the
maximum volume of each cardiac cycle during inferior vena occlusion by linear fit to the
maximum pressure of each PV loop (example provided for Sham). ESPVR values
reported represent the slope of the linear fit, often regarded as the end-systolic
elastance. Comparison between groups shows an increase in elastance for Sham
relative to MI as well as DC relative to GH, though only improvements in elastance for
the DC group were significant over MI control (p<0.05).
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Table 7.2. Complete geometric, functional, and histological outcomes of infarct
model. Treatments include infarct controls (MI), guest-host (GH) or dual-crosslinking (DC)
hydrogel treatments, and sham surgeries.
Category/
Metric

MI

GH

LV Inner Diameter,
Diastole(cm)

0.79±0.02

0.55±0.03

LV Inner Diameter,
Systolic(cm)

0.64±0.03

0.38±0.02

Fibrotic Area (%)

-

9.97±1.79

8.34±0.92

-

Stroke Work (mmHg/uL)

977.5±156.2

1359.7±178.7

1356.0±88.6

1692.6±337.7

dP/dt max (mmHg/sec)

2702.7±174.2

3014.6±225.7

3284.4±272.7

3306.2±115.3

dP/dt min (mmHg/sec)

2217.8±170.4

2278.6±173.6

2457.9±194.7

2390.3±136.1

End-Systolic Pressure
Volume Relationship

1.23±0.08

1.77±0.30

2.52±0.22

*

3.74±0.93

End-Diastolic Pressure
Volume Relationship

0.22±0.04

0.21±0.06

0.19±0.02

0.21±0.07

Ejection Fraction (%)

41.0±2.6

49.6±3.9

Fractional Shortening
(%)

19.75±1.64

30.11±3.08

Cardiac Output (mL/min)

25.57±1.43

37.00±5.21

51.00±3.07

20.00±3.32*

28.55±3.94*

8.21±1.20*

13.00±1.40*

DC

Sham

Geometric
*

0.65±0.03

*,†

*,†

0.41±0.04

*

0.49±0.04
0.29±0.03

*

*

Functional

†

59.4±3.2
*

*,†

37.46±3.21

84.1±2.6
*

*

*

42.0±3.61

59.18±6.95

Immunohistochemical
-2

Capillary Density (mm )
-2

Arteriole Density (mm )

4.8±2.8
1.4±1.2

†
†

Data provided as mean±SEM.
* p<0.05 relative to MI
†
p<0.05 relative to Sham
‡
p<0.05 DC relative to GH
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,‡
,‡

*

16±2.7*
9.7±3.5*

*

7.4. Conclusion
In conclusion, the material system developed harnesses the beneficial features
of both supramolecular assembly and addition reaction crosslinking in an
orthogonal and complementary fashion to create a materials system with unique
properties. Namely, the utilization of a physically crosslinked hydrogel enables
initial retention at the injection site through shear-thinning delivery. This retention
ability facilitates the employment of slow covalent crosslinking for stabilization in
vivo, occurring on timescales that enable ease of clinical application. In recent
years, there has been a significant drive toward percutaneous delivery of materials
for both cosmetic and therapeutic purposes, with significant attention given to
material retention as well as appropriate control of biophysical properties. Indeed,
the material concept developed herein is a generalizable approach which
addresses a fundamental challenge in percutaneous delivery: the ability to
maintain hydrogel presence despite clinically required slow covalent crosslinking.
The approach may be of great utility in many applications, including soft tissue
reconstruction as well as toward therapeutic needs including nucleus pulpous
replacement or treatment of MI.
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CHAPTER 8

Injectable Shear-Thinning Hydrogels for Minimally Invasive
Delivery to Infarcted Myocardium to Limit Left-Ventricular
Remodeling

Adapted from: Rodell CB, M.E. Lee, H. Wang, S. Takebayashi, T. Takayama, T.
Kawamura, J.S. Arkles, N.N. Dusaj, S.M. Dorsey, W.R.T. Witschey, J.J. Pilla, J.H.
Gorman, J.F. Wenk, J.A. Burdick, R.C. Gorman. Injectable Shear-thinning
Hydrogels for Minimally Invasive Delivery to Infarcted Myocardium to Limit LeftVentricular Remodeling. (In Review).

8.1 Introduction
In the United States, an estimated 785,000 acute myocardial infarctions (MIs)
occur annually, and the speed of treatment and use of percutaneous coronary
interventions have improved the in hospital survival rate by nearly 40% in recent
decades.1-3 However, there remain downstream consequences for these patients,
as MI is known to be a major contributor to the development of chronic heart failure
(HF), which affects an estimated 5.7 million Americans, has been cited as a
contributor to 1 in 9 deaths, and imposes an estimated financial burden of $30.7
billion annually.1 Transplantation remains the only definitive treatment for HF,
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motivating the development of preventative therapies to mitigate this morbidity,
mortality, and financial burden through understanding and treatment of the
underlying etiology.
In the case of ischemic HF, loss of LV function is the result of LV remodeling
(Figure 8.1A,B) through a deleterious cascade of biological and mechanical
events, which ultimately result in geometric reshaping of the LV and loss of
contractile function.4-6 It has been recognized in recent years that infarct
compliance plays a major role in this process, as loss of infarct contractility results
in increased systolic compliance, creating an energy sink which increases
workload on the remaining healthy tissue.5 Moreover, passive mechanical
properties of the infarct are reduced for as long as 6 weeks,7 largely as a result of
a spatiotemporal imbalance of matrix metalloproteinase activity favoring
proteolysis.8,9 Owing to these changes, the infarct is susceptible to energetic
losses, thinning, and planar expansion in early stages post-MI, contributing to
abnormal stress distributions and continued detriment to the borderzone
contractility,10-12 which perpetuate ventricular dilation.
In addition to these primary remodeling events, HF is complicated by additional
maladaptive changes to myocardial function. Primary among these is ischemic
mitral regurgitation (MR), wherein dysfunction of the mitral valve allows retrograde
systolic flow from the LV to the left atrium (LA) (Figure 8.1B, expanded). Notably,
MR is observed in nearly 20% of patients post-MI and in greater than 50% of
patients in congestive HF.13,14 Patients with moderate-to-severe MR have 50%
mortality at 3 years, even following revascularization,15 and mortality is graded with
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MR severity.16 The combined prevalence and mortality of MR have motivated
continued therapeutic investigation, where direct augmentation of the valve
leaflet17 as well as surgical correction18,19 of the subvalvular apparatus position
(i.e., papillary and associated chordae) have exhibited positive results. Similar to
such approaches, annuloplasty seeks to restore the valve geometry to correct MR
and remains the preferred clinical treatment in conjunction with revascularization.20
Despite these efforts, relapse of MR occurs in a portion of the treatment population,
indicating

continued

ventricular

remodeling

may

compromise

treatment

durability.21 Indeed, the pathological basis of MR reveals that MR develops due to
ventricular dilation, displacing the papillary and thereby distorting the valve via
tethering.22-24 Ischemic MR is therefore a ventricular and not solely a valvular
condition, motivating the prevention of MR by of intercepting the LV remodeling
process.
To counter the effects of infarct expansion, mechanical interventions early postMI have proven to be of great utility, including such devices as affixed patches or
wraps that act as restraints and biomaterial injection to stabilize the infarct 25 Such
restraints, including myocardial patches,26 have also proven effective in reducing
MR. These therapies are most effective when applied at early stages post-MI prior
to extensive LV remodeling. While effective in preclinical studies, therapeutic
approaches that require thoracotomy for the application of restraints will likely not
achieve widespread application due to the high risk associated with thoracic
surgery early after MI. Thus, the use of biomaterials to mechanically stabilize the
infarct is attractive, in part, because of the potential for minimally invasive
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percutaneous delivery. Numerous injectable hydrogels have been investigated,
spanning a wide range of material properties and methods of delivery27 and prior
studies have demonstrated the importance of the material mechanical properties 28
and prolonged degradation29 on remodeling outcomes. In the use of biomaterials
to stabilize the infarct (Figure 8.1C,D), reduced wall thinning and dilation have
been demonstrated. Moreover, prevention of papillary displacement by these
dilation processes, coupled with myocardial bulking, are anticipated to reduce
maladaptive remodeling of the subvalvular apparatus thereby correcting MR
(Figure 8.1D, expanded).

Figure 8.1. Schematic long-axis representation of LV remodeling. Posterolateral
infarct (i) at baseline (A) and following left-ventricular (LV) remodeling (B) where wall
thinning, ventricular dilation, and associated posterior papillary displacement (ii) result in
asymmetric tethering (iii, expanded). Corresponding treatment (C) by hydrogel injection
(iv) to minimize LV remodeling (D) and prevent tethering (expanded).
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Despite the need for minimally invasive techniques for hydrogel delivery, few
currently availability hydrogels (e.g., decellularized ECM, alginate) have the
properties that permit their delivery via intracoronary or intramyocardial injection.3032

While they have proceeded to clinical trials, the modest stiffness of these

materials (10 Pa for decellularized ECM)33 make them unsuitable for mechanical
stabilization of the infarct and they have not yet observed attenuation of MR. It has
been demonstrated that supraphysiological moduli of approximately 40kPa are
required to effectively attenuate LV remodeling.28 To address this need, we have
developed an injectable hydrogel system – based on guest-host (GH) interactions
that present dynamic physical bonds that exhibit shear-thinning (i.e., flow easily
through a syringe or catheter) and rapid re-assembly (i.e., localize at the injection
site). The hydrogel includes an optional secondary crosslinking (DC) that occurs
in situ to enhance mechanical properties (approximately 40kPa moduli, motivated
by prior results) and prolong degradation of the hydrogel within the infarct region.
Herein, we demonstrate the utility of these material systems toward attenuating
the LV remodeling response post-MI and demonstrate the feasibility of
percutaneous hydrogel delivery in an ovine model.

8.2 Methods
8.2.1 Hydrogel Synthesis and Preparation.
Hyaluronic acid (HA, 90kDa) was purchased from Lifecore (Chaska, MN). βcyclodextrin (CD) and 1-adamantane acetic acid (Ad) were purchased from TCI
America. All other reagents were purchased from Sigma, unless otherwise
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indicated. Modified hyaluronic acid (HA) polymers were prepared by methods
previously described.34,35 These included HA modified with adamantane (Ad-HA)
or β-cyclodextrin (CD-HA) to form guest-host (GH) hydrogels, as well as HA
modified with both adamantane and thiols (Ad-HA-SH) or both β-cyclodextrin and
methacrylates (CD-MeHA) to form dual-crosslinking (DC) hydrogels. Following
modification, modified hyaluronate was purified by dialysis (and vacuum filtration,
where necessary to remove insoluble impurities) and recovered by lyophilization.
Polymer modifications were determined by 1H NMR acquired at 360MHz (Bruker).
Disaccharide modifications were approximately 25% of repeat groups; Ad-HA
utilized in percutaneous delivery had a 50% modification.
GH hydrogels were formed under sterile conditions by dissolution of the two
modified HA polymers in PBS at the desired concentration (4.5wt%), mixing of the
two solutions, centrifugation to remove entrapped air, and loading into syringes for
injection. Formulations were designed such that adamantane (guest, Ad) and βcyclodextrin (host, CD) were present in equimolar ratios, and the concentration
denotes the combined weight percent of both polymers in solution. DC hydrogels
were prepared similarly to GH hydrogels, with the pH of dissolution buffers
adjusted to obtain a desired final pH of 5.

8.2.2 In vitro hydrogel evaluation.
To assess hydrogel mechanical properties, oscillatory shear rheology (AR2000,
TA Instruments) was performed using a 20 mm diameter cone and plate geometry
(59 min 42 s cone angle, 27 μm gap) maintained at 37 ºC. GH hydrogel mechanics
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were determined by frequency sweeps (0.01-100 Hz; 1.0% strain) and strain
sweeps (1.0 Hz; 0.1-500% strain). Compressive mechanical analysis (Q800, TA
Instruments) of DC hydrogels was performed serially on samples (n = 6) following
overnight crosslinking at 37ºC with a compression rate of 10% strain/min (moduli
were calculated from 10-20% strain).
To examine hydrogel degradation, 30 μL hydrogels (n = 5) were contained
within a 5 mm diameter 6 mm high depression in acrylamide molds. Hydrogels
were submerged in 1 mL PBS and stored at 37°C. At set time points, the buffer
was collected and replaced. At study completion, hydrogels were degraded in
hyaluronidase (1 mg/mL) to allow determination of remaining hydrogel content.
Degradation was quantified via a uronic acid assay and data was normalized to
the cumulative release for each sample.

8.2.3 Finite-Element (FE) modeling.
To evaluate the effects of hydrogel injections on myocardial wall stress, FE
modeling of end-diastolic myocardial thickness and corresponding myofiber stress
distributions was conducted by adaptation of a method similar to those previously
described.36 The LV geometry was approximated by an ellipsoidal model, where
dimensions at end-systole were based on measurements performed in ovine
hearts; images were acquired via TrueFISP CINE sequences. The wall thickness
was 1.3 cm, the inner diameter of the endocardial wall near the equator was 4.0
cm, and the distance from base to apex was 6.4 cm. To simulate hydrogel injection,
the base model was modified to include 16 injections in a 4-by-4 array within the
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free wall (Figure 8.2). The size and shape of the hydrogel injections were based
on MR images of injected explant tissue (Figure 8.3, Table 8.1), where the
injections were approximated as ellipsoids where the volume is given by the
equation:
𝑉=

4
3

𝜋(𝑎 ∗ 𝑏 ∗ 𝑐)

(eq. 8.1)

The spacing between injections was determined to be 1.5 cm from center-tocenter, based on expected anatomical measures. Each injection was 0.3 mL,
resulting in a total volume of 4.8 mL added to the model. To account for volumetric
addition, the myocardial wall thickness throughout the injection regions was
increased to 1.5 mm, thus preserving the total volume of myocardium. The
longitudinal dimensions were unaltered, as was were dimensions in remote
regions, away from the injection site.

Figure 8.2. Depiction of finite element model geometry. (A) Finite element model of
ovine LV with 16 hydrogel injections in the free wall. The injections were modeled as
ellipsoids, which caused the LV wall to thicken. (B) Short axis view of LV wall. (C) Long
axis view of LV wall.

230

Figure 8.3. Reconstruction of hydrogel geometry based on MRI data of injections
embedded in myocardial wall. Note that the shape is approximately ellipsoidal and a
volume of 0.298mL was directly determined from the reconstruction in ITK-Snap.
Table 8.1. Ellipsoid dimensions of a 0.3 mL
hydrogel injection, based on MRI data.

a

6.60mm

b

3.94mm

c

2.73mm

The material response of the myocardium was represented using a nearly
incompressible, transversely isotopic, hyperelastic constitutive law, which was
defined using the strain energy function:
𝑊𝑚𝑦𝑜𝑐𝑎𝑟𝑑𝑖𝑢𝑚 =

𝐶
2

2

2

2

2

2

2

2

2

2

(𝑒 𝑏𝑓𝐸𝑓𝑓+𝑏𝑡(𝐸𝑠𝑠+𝐸𝑛𝑛 +𝐸𝑛𝑠+𝐸𝑠𝑛)+𝑏𝑓𝑠(𝐸𝑓𝑠+𝐸𝑠𝑓+𝐸𝑓𝑛+𝐸𝑛𝑓) − 1) +

𝜅
2

(𝐽 − 1)2

(eq. 8.2)

where 𝐸𝑖𝑗 are the deviatoric components of the Green-Lagrange strain tensor
relative to the myofiber coordinate system (f = fiber direction, s = cross-fiber inplane direction, n = transverse-fiber direction) and J is the determinant of the
deformation gradient. The diastolic material parameters were assigned to be 𝐶 =
0.51 kPa, 𝑏𝑓 = 22.84, 𝑏𝑡 = 3.45, and 𝑏𝑓𝑠 = 12, while the bulk modulus was 𝜅 = 1x103
kPa.36 Since the model was intended to mimic the initial time frame after infarction,
it was assumed that the properties would be unchanged during this timeframe. 5.
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Hence, the model was created such that the myocardial material properties around
the hydrogel injections were the same as in remote regions. The myofiber
orientation was assigned to vary linearly from epicardium to endocardium using
the angles of -37 degrees to 83 degrees, respectively. The material response of
the hydrogel injections was represented using a nearly incompressible, isotopic,
hyperelastic constitutive law, which was defined using the strain energy function:
𝑊𝑖𝑛𝑗𝑒𝑐𝑡𝑖𝑜𝑛 =

𝐸
2(1+𝜈)

𝐸

tr(𝐄𝟐 ) + 6(1−2𝜈) ln(𝐽)2

(eq. 8.3)

where E is the deviatoric Green-Lagrange strain tensor, tr() is the trace operator,
and ln() is the natural log operator. The material parameters for Young’s modulus
(E) were assigned based on the experimental measurements of the GH and DC
hydrogels, while the Poison ratio (𝜈) was assigned a value of 0.499. A pressure of
10 mmHg was assigned as a boundary condition on the endocardial wall in each
of the FE models, simulating end-diastolic loading conditions and and
corresponding regional examination of myofiber stress was performed.

8.2.4 Ovine infarct model.
All animals in this study were provided care in compliance with the National
Institute of Health’s guidelines for the care and use of laboratory animals (NIH
Publication 85-23, revised 1996) with protocol approval by the University of
Pennsylvania’s Institutional Animal Care and Use Committee. Twenty-two adult
male Dorset sheep, approximately 45 kg, were subject to infarction and study up
to 8 weeks (Table 8.2).24 For MI induction, sheep were induced by ketamine (25
mg/kg), intubated for mechanical ventilation, and maintained under anesthesia by
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inhaled isoflurane (1.0-2.0%). A left thoracotomy was performed and a
posterolateral infarct comprising approximately 20% of the LV was induced by
selective ligation of the obtuse marginal (OM) branches (Figure 8.5A). Thirty
minutes following ligation, sixteen injections (0.3 mL ea. via a 1/2cc syringe, with
27G ½ in needle) were performed in the infarct region, which consisted of saline
(MI control), GH hydrogel, or DC hydrogel (Figure 8.5B, C). The infarct was
surrounded by MRI compatible markers sutured to the epicardium to aid in locating
the infarct in MRI and post-mortem examination. The incision was closed in layers
and the animal recovered under supervision with postoperative pain control by
fentanyl (25-75 µg, transdermal).

8.2.5 Echocardiography.
MR was monitored throughout infarct induction, including baseline (preligation), 30 minutes post-ligation, immediately post-injection, and at the terminal
timepoint of 8 weeks. For each timepoint, both real-time two-dimensional (2D)
Doppler flow and three-dimensional (3D) and echocardiography of the mitral valve
were performed.37 Severity of MR was graded using a standardized, semiquantitative scale based upon the area of the regurgitant jet observed in 2D
Doppler flow echocardiography.38 Analysis of mitral valve geometry was performed
by techniques previously described, where analysis was performed at mid-systole
in Echo-View (TomTec Imaging Systems) through interactive segmentation of the
valve.17,39
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Table 8.2. Animal usage and assessment of gross cardiac geometry.
Category/
Metric

MI

GH

DC

Number Included

7

7

6

Weight (kg), Baseline

39.7 ± 1.1

44.4 ± 1.8

43.7 ± 2.0

Weight (kg), 2 WK

38.9 ± 0.8

42.0 ± 2.3

43.0 ± 1.9

Weight (kg), 8 WK

46.6 ± 1.0

51.4 ± 1.7

51.3 ± 1.3

Heart Mass (g)

274.99 ± 16.20

306.42 ± 13.53

300.63 ± 18.43

RV Mass (g)

71.03 ± 14.01

58.20 ± 3.59

62.18 ± 4.64

LV Mass (g)

141.00 ± 18.78

166.84 ± 4.02

169.88 ± 9.02

19.4 ± 0.6

18.6 ± 0.7

19.3 ± 0.7

19.35 ± 0.78

18.36 ± 1.22

17.25 ± 1.34

Final Infarct Area (cm )

98.56 ± 5.96

98.85 ± 3.85

103.58 ± 4.41

Final Infarct Size (% LV)

19.31 ± 1.97

18.15 ± 1.43

17.93 ± 1.81

Animal Usage

Heart Size, 8 WK

Infarct Geometry
Initial Infarct Area (% LV)
2

Final LV Area (cm )
2

Data provided as mean±SEM.
No differences observed between groups (P > 0.05 by ANOVA).

8.2.6 Magnetic resonance imaging and analysis.
Image acquisition was performed at 3T (Tim Magnetom Trio Scanner;
Siemens, Inc.). For visualization of the hydrogel distribution following in vivo
injection, the explanted heart was submerged in saline and imaged via a T2
weighted turbo spin echo pulse sequence (matrix size = 320 x 256 x 65, voxel size
= 0.3125 x 0. 3125 x 1.0 mm3, repetition time = 1128 ms, echo time = 71 ms, 4
signal averages). Examination of hydrogel distribution in explanted tissue was
performed by 3D reconstruction of the hydrogel and myocardial segments (ITK234

Snap40).For longitudinal analysis of myocardial geometry and function in vivo,
imaging was performed at baseline (immediately prior to infarct), as well as at 2
and 8 weeks post-infarct. Anesthesia was maintained throughout the procedure
and cardiac gating was performed by placement of a pressure catheter (Millar
Instruments, Inc.) into the LV. Two-dimensional TrueFISP CINE images were
acquired for primary assessment of myocardial geometry (field of view =
280x166.25 mm, acquisition matrix = 256 x 152 pixels, repetition time = 27.52 ms,
echo time = 1.46 ms, BW = 930 Hz/pixel, slice thickness = 4 mm). Late gadolinium
enhancement (LGE) imaging was performed approximately 15 minutes following
bolus intravenous injection gadobenate dimeglumine (0.1mmol/kg; MultiHance;
Bracco Diagnostics, Inc.) by a spoiled gradient echo sequence to confirm the size
and location of fibrotic tissue (field of view = 218 x 350, acquisition matrix = 256 x
160, repetition time = 5.50 ms, echo time = 2.42 ms, BW 244 Hz/pixel, slice
thickness = 4 mm, 2 signal averages.).
Longitudinal analysis of infarct thickness was performed from CINE MRI. Three
consecutive short axis images were isolated at end-diastole from the infarcted
region, immediately sub-papillary where possible. The infarct was confirmed from
corresponding LGE images, and the location was maintained across all time
points. For each image, 5 radial lines were drawn from epicardium to endocardium
and measured (ImageJ; Figure. 8.4) and reported values represent the average of
all 15 measurements for each animal. Analyses were repeated in the remote
region along the contralateral LV wall.
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Toward assessment of LV dilation and function, volumetric analysis was
performed. CINE images were sorted and cropped using customized programming
(MATLAB).

Through

all

acquired

planes

and

phases,

semi-automated

segmentation of the intraventricular space was performed with manual correction
as necessary (ITK-Snap). Repartitioning of the images into the time-space and
corresponding volumetric reconstruction enabled determination of the LV volume
as a function of time, from which the minimum volume (LVESV), maximum volume
(LVEDV), SV, and EF were determined.
To allow assessment of MR volumes, planar magnitude and phase images
were acquired orthogonal and immediately superior to the mitral valve (field of view
= 300 x 243.75 mm, acquisition matrix = 192 x 117 pixels, slice thickness = 4 mm,
repetition time = 41.35 ms, echo time = 3.41 ms, BW = 389 Hz/pixel, flip angle =
25 degrees). Semi-automated contouring of the mitral valve as well as
quantification of the net regurgitation volume was performed (Argus, Siemens).
The long-axis dimension (LAD) and posterior chordae length (PCL) were
evaluated from CINE data. End-systolic were isolated, rotated, and re-sliced
(ImageJ) to provide long-axis sections through the posterior papillary, apex, and
mitral valve. The LAD was measured as the length from the base (plane bisecting
the LV-LA and Septal-RA junctions) to the endocardial wall of the apex. The PCL
was measured and the length from the most prominent point of the posterior
papillary (that affected by infarction) and the center of the mitral valve.
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Figure 8.4. MRI based determination of myocardial thickness over time. Red and
green arrows indicate infarct and remote thickness, respectively, as assessed for MI (left),
GH (middle), and DC (right) treatment groups. Measurements were performed (3 slices,
n = 5 measurements per slice) at baseline, 2 weeks, and 8 weeks, with delayed contrast
enhancement (DCE) used to confirm measurements were made within the infarcted region
(myocardial wall in white contrast).
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8.2.7 Post-mortem analysis.
Following evaluation at 8 weeks, animals were sacrificed, the hearts harvested,
and long-axis sections were taken through the infarct region (adjacent to the
posterior papillary) and from remote sections (adjacent to the anterior papillary).
From these samples, myocardial thickness was directly measured and reported as
the average of three measurements from the base, infarct (approximately
equatorial), and apex for each animal. Subsequently, sections from these regions
were fixed in formalin, paraffin embedded, and stained with Masson’s Trichrome
and hematoxylin and eosin (H&E). To evaluate the distribution of the hydrogel in
vivo, tissue was analyzed in one GH and one DC hydrogel injected animal within
the first 24 hours post-MI.

8.2.8 Percutaneous intramyocardial injection.
GH hydrogels were evaluated for delivery to the myocardium via endocardial
injection. Two healthy adult male Dorsey sheep were utilized, allowing
investigation of two separate procedural approaches, both utilizing a delivery
system comprised of an AgilisTM NxT steerable introducer, a BRKTM transseptal
needle (4 Fr, 90 cm; St. Jude Medical) pre-loaded intraoperatively with sterile
hydrogel, and a 1 mL syringe containing the desired injection volume (0.3 mL
each). Injection position was monitored by fluoroscopy and directly visualized by
simultaneous intracardiac echocardiography (ICE; AcuNav 8 Fr, Siemens). In the
first approach, the introducer was inserted through the internal jugular and passed
into the right ventricle (RV) over wire. The sheath was deflected to reach various
locations and the needle advanced 4-5mm into the tissue for injection and
subsequently retracted. Four injections were performed into the septal wall. In the
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second approach, the introducer was similarly passed into the LV with access via
the right carotid, and five injections were performed into the inferior and anterior
walls. Following the procedure, injection was confirmed by MRI of the explanted
tissue, as described above.

8.2.9 Statistical analysis.
Data is presented as mean ± standard deviation (SD, for in vitro data) or as
mean ± standard error of the mean (SEM, for in vivo data). Statistical significance
was determined by ANOVA, using repeated measures where appropriate, in
conjunction with post hoc Student’s two-tailed t-tests with Bonferroni correction to
account for multiple comparisons. Significance was determined at P = 0.05. For
volumetric quantification, outliers were identified within groups by Grubb’s test (p
< 0.05) and excluded from further analysis.

8.3 Results
8.3.1 Development of Injectable Hydrogels with Controlled Biophysical
Properties.
Guest-host (GH) hydrogel precursors were prepared with 25% of HA repeat
units modified with either Ad or CD. Upon mixing solutions of Ad-HA with CD-HA,
GH hydrogels (Figure 8.5B) rapidly formed through interactions between polymer
chains. The elastic modulus (E) of GH hydrogels was estimated at 1.6 Hz
(corresponding to a heart rate of 100 BPM) to be 799.2 Pa (Figure 8.6A). GH
hydrogels are known to exhibit shear-thinning (during injection) and self-healing
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(after injection into tissue) properties34,41,42 necessary for delivery into myocardial
tissue (Figure. 8.5D); yet, shear-yielding was not observed at physiological
myocardial strains (Figure 8.6B), indicating stability after reaching the tissue.

Figure 8.5. MI model and therapeutic groups. (A) Infarct generation by selective obtuse
marginal ligation and injection with saline (MI control), guest-host hydrogel (GH), or dualcrosslinking hydrogel (DC) which were longitudinally assessed by MRI. (B) GH hydrogels
were composed of adamantane modified hyaluronic acid (Ad-HA, blue) and cyclodextrin
modified hyaluronic acid (CD-HA, red) which form physical associations (purple). (C) DC
hydrogels were composed of thiolated Ad-HA (Ad-HA-SH) and methacrylated CD-HA
(CD-MeHA), and resulted in additional covalent crosslinks (green). (D) Both GH and DC
hydrogels were injected into the infarcted region. (E) DC hydrogel elastic moduli over time
(mean ± SD; n = 6; *P < 0.01 relative to day 0). (F) Hydrogel degradation (mean ± SD; n
= 5; *P < 0.05 relative to DC for all timepoints beyond day 1).
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Figure 8.6. Rheological examination at physiological conditions. (A) Frequency
sweep (1.0 % strain, 37○C) showing frequency dependence of GH hydrogel shear
moduli (G’). Relevant moduli were estimated at 1.6 Hz, corresponding to a heart rate of
approximately 100 BPM. Elastic moduli (E) estimated assuming an incompressible solid
whereby E = 3*G’. (B) Strain sweep (1.0 Hz, 37○C) showing strain dependence of GH
hydrogel shear moduli (G’). Shear-induced loss of GH mechanics and corresponding
flow is not observed below strains of ~40%. Approximate physiological range (maximum
strain of 10-15%)43,44 is indicated (shaded regions).

Dual-crosslinking (DC) hydrogels were developed to introduce additional
covalent crosslinks into the GH hydrogels to increase their mechanical properties
(Fig. 1C). Thus, they are likewise injectable via shear-thinning but with increased
mechanical strength. DC hydrogels possessed an elastic modulus of 41.4 ± 4.3
kPa when measured at 48 hours after mixing. Subsequent softening, significant
beyond 2 weeks, was observed due to hydrogel degradation (Figure 8.5E). GH
and DC hydrogel degradation was monitored for 8 weeks under static conditions
(Figure 8.5F). Rapid degradation of the GH hydrogel was observed (>50%
cumulative erosion), in contrast to the DC hydrogel, which remained stable up to
8 weeks (5.1 ± 0.2% degradation).
In vivo examination of hydrogel retention was performed at 24 hours following
infarct induction and intramyocardial injection. Both the GH and DC hydrogels were
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well retained as solid, discrete hydrogels within the myocardium (Figure 8.7A,B).
MRI of excised tissue for the DC hydrogel injection (Figure 8.7C) demonstrated
dispersion of injections throughout the tissue with a measured volume of 5.1mL, in
agreement with the estimated 4.8mL volume injected. Excised DC hydrogels
exhibited moduli of 30.3 ± 2.6 kPa, coinciding with measured in vitro moduli at
these times and demonstrating the ability for dual-crosslinking to occur in vivo.

Figure 8.7. Material retention in vivo. Histological image of GH (A) and DC (B) hydrogels
(indicated, *) within infarct tissue by H&E staining at 1 day post-MI. (C) MRI reconstruction
of retained DC hydrogel (purple) within the myocardium (red) following initial injection in
vivo.

8.3.2 Finite Element Assessment of Myofiber Stress and LV Wall Deformation.
Finite element simulations were conducted to evaluate anticipated myocardial
bulking and altered distribution of end-diastolic myofiber stress throughout the LV
wall at early time points post-MI. The average respective wall thickness within the
injected regions at end-diastole for the control, GH, and DC cases were 1.0, 1.08,
and 1.23 cm. The myofiber stress distributions throughout the LV were differentially
altered by GH (Figure 8.8A) and DC (Figure 8.8B) hydrogel injections. The average
myofiber stress in the myocardium surrounding the DC injection was 2.5 kPa (27%
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reduction relative to control), while the stress around the GH injection was 3.4 kPa
(Figure 8.8C). Through the transmural dimension, DC injection reduced the
myofiber stress by 46% at the epicardium, 23% at mid-myocardium, and 51% at
the endocardium compared to the control case (Figure 8.8D). Circumferentially,
near the edge of the injection region, hydrogels reduced the myofiber stress
(Figure 8.8E) by a maximum of 27% for GH and 60% for DC, relative to controls.

Figure 8.8. Finite element analysis of hydrogel injection. End-diastolic myofiber stress
distribution for an LV with either (A) GH hydrogel injection or (B) DC hydrogel injection.
Note that only a portion of the model is shown in order to visualize the distribution within
the myocardium. Myofiber stress in elements adjacent to the material (C), or distributed
along a transmural (D) or circumferential (E) path in the edge of the injection region.
Corresponding regions are indicated for the material region (i) or transmural (ii) and
circumferential (iii) paths.
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8.3.3 Assessment of Myocardial Thickness.
Wall thickness was measured following excision at 8 weeks. Examination of
myocardial long-axis segments (Figure 8.9A) clearly showed thinning of the infarct
region after MI, relative to remote regions. Qualitatively, thinning was attenuated
by hydrogel injection and remaining DC hydrogel was observed post-mortem in all
cases, as indicated by black arrows. Histological examination at 8 weeks (Figure
8.10) indicated integration of the DC hydrogel into the tissue, which was not
apparent at early timepoints (Figure 8.7), with minimal chronic inflammation (i.e.
foreign-body giant cell localization, fibrous encapsulation). Histologically, GH
materials were not observed at the 8 week time point, consistent with the observed
rapid erosion (Figure 8.5F) and prior in vivo examination.35 Quantitatively (Figure
8.9B, Table 8.3), hydrogel injection demonstrated increased infarct thickness,
significant for DC injection, as well as a tendency to increase adjacent basilar and
apical thickness. Temporal assessment of end-diastolic thickness by CINE MRI
(Figure 8.9C) revealed significant differences between infarct tissue thickness at
both 2 and 8 weeks, with minimal differences observed in remote thicknesses
(Table 8.4). Notably, DC hydrogel injection was observed to maintain wall
thickness at 2 weeks, in contrast to the observed drastic thinning in both MI and
GH groups.
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Figure 8.9. Myocardial wall thickness. (A) Macroscopic images of remote or infarcted
regions with hydrogel indicated (▼) for DC treatment. (B) Corresponding thickness
quantification. (C) Temporal assessment of infarct thickness by CINE MRI. Measurements
are normalized to the thickness of corresponding remote sections ( mean ± SEM; n≥6; *P
< 0.05 relative to MI; #P < 0.05 relative to GH).

Figure 8.10. Histological examination 8 weeks post-MI. Myocardial sections from the
infarct region in control (MI), guest-host (GH), and dual-crosslinking (DC) groups with
remote section provided for reference. (A) H&E (top) and trichrome (bottom), with the
expanded region indicated for DC injection. (B) Expanded view, with DC hydrogel visible
by H&E staining (dark purple) and trichrome (light blue) integrated with viable tissue. Other
groups demonstrate fibrosis (trichrome, dark blue) without indication of remaining
hydrogel.
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Table 8.3. Direct measurement of myocardial thickness at 8 weeks post-MI.
Treatment Group/
Region

Base
Thickness (mm)

Infarct
Thickness (mm)

Apical
Thickness (mm)

Infarcted Region

11.11 ± 0.96

3.90 ± 0.48

8.49 ± 1.08

Remote Region

13.31 ± 1.04

12.39 ± 1.13

10.51 ± 0.49

Infarcted Region

11.25 ± 0.27

5.79 ± 0.96

8.66 ± 0.42

Remote Region

12.38 ± 0.85

11.13 ± 0.50

9.69 ± 0.74

Infarcted Region

11.92 ± 0.20

9.92 ± 0.24*,#

9.08 ± 0.84

Remote Region

11.75 ± 0.21

11.10 ± 0.25

9.82 ± 0.32

MI

GH

DC

Table 8.4. MRI assessment of myocardial thickness over time.
Treatment Group/
Timepoint

Infarct
Thickness (mm)

Remote
Thickness (mm)

Baseline

9.44 ± 0.14

9.81 ± 0.28

2 Weeks

4.39 ± 0.43

9.94 ± 0.34

8 Weeks

3.56 ± 0.19

10.31 ± 0.22

Baseline

8.92 ± 0.24

9.32 ± 0.18

2 Weeks

6.98 ± 0.46*

9.76 ± 0.40

8 Weeks

5.51 ± 0.23*

9.70 ± 0.22

Baseline

10.90 ± 0.44*,#

10.79 ± 0.48

2 Weeks

11.39 ± 1.16*,#

10.78 ± 0.31

8 Weeks

10.02 ± 0.79*,#

11.21 ± 0.41*

MI

GH

DC

Data provided as mean±SEM.
* P < 0.05 relative to MI
# P < 0.05 relative to GH
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8.3.4 LV Dilation and Functional Assessment.
MRI was utilized to assess temporal changes in LV volume and function. The
LV progressively dilated over time, as indicated by a greater than two-fold increase
in LVEDV and LVESV in MI controls. At end-diastole (Figure 8.11A), hydrogel
treatment reduced dilation at 8 weeks; however, significant differences were
observed between DC and MI at 2 weeks, and between DC and both GH and MI
groups at 8 weeks at end-systole (Figure 8.11B). While not significant, SV (Figure
8.11C) was increased with DC hydrogel injection. EF (Figure 8.11D) showed a
consistent, progressive loss of function following MI, which was moderately
attenuated by GH injection and significantly attenuated by DC hydrogel injection
at both 2 and 8 weeks. Additional significance was noted for DC relative to GH
hydrogels at 2 weeks.

Figure 8.11. MRI assessment of cardiac geometry and function. CINE MRI
determination of LVEDV (A), LVESV (B), SV (C), and EF (D) (mean ± SEM; n≥6; *P <
0.05 relative to MI; #P < 0.05 relative to GH).
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8.3.5 Mitral Regurgitation Severity.
Both echocardiography and MRI were used to assess progression and severity
of MR. 2D Doppler echocardiography demonstrated MR (Figure 8.12A). At the time
of infarct induction, there was no significant difference in MR grade between
treatment groups, including at baseline, post-MI, or post injection (Figure 8.12B),
and no significant change in MR occurred within groups between these points in
the procedure (Figure 8.12C,D). There was significant reduction in MR between
MI and DC groups at 8 weeks (Figure 8.12B). At 8 weeks, four animals in the MI
group developed 2+ MR and one developed 3+ MR; two animals in the GH
treatment group developed 2+ MR and one developed 3+ MR; in the DC treatment
group, three animals exhibited 1+ MR (two of which were 1+ as baseline) and
remaining animals had no detectable MR. MR progressed from infarct induction to
the 8 week timepoint in MI controls (Figure 8.12E). Severity of the progression was
reduced by hydrogel treatments, significant of DC treatment (p = 0.013).
Retrograde flow in the left atrium (LA) was detected by flow velocity magnitude
scans superior to the mitral valve (Figure 8.12F). The lateral location of the MR jet
(indicated) was consistent across animals in which MR was observed by these
methods and was consistent with that expected for posterolateral infarct.
Quantification of the cumulative regurgitation volume per cardiac cycle (Figure
8.12G) showed increased prevalence of high volumes (>5 mL) in the MI group (2
of 7 cases, compared to 1 in the GH and 0 in the DC treatment groups).
Regurgitation volumes were as high as 17.3 mL. Differences between group
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means were not significant, likely due to variation in the location of the acquired
plane resulting in false negative measurements.

Figure 8.12. Assessment of mitral regurgitation severity. (A) Representative 2D
Doppler echocardiography at 8 weeks post-infarct for an MI control (MR jet indicated in
red) and corresponding graded MR quantification (B). Change in MR resultant from MI
(C), injection (D), and progression of LV remodeling post-MI to 8 weeks (E). (F)
Representative short axis magnitude scan transecting the LA superior to the mitral valve;
regurgitation jet indicated (▼). (G) Corresponding regurgitation volume quantification. *P
< 0.05 relative to MI. Indicated in images: left ventricle (LV), left atrium (LA), aorta (Ao),
and pulmonary artery (PA).
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8.3.6 Geometric Remodeling of the Mitral Valve and Subvalvular Apparatus.
Direct assessment subvalvular apparatus was performed by CINE MRI, where
long-axis views of the LV at end-systole allowed direct quantification of the LAD
and PCL (Figure 8.13A,D). Ventricular dilation resulted in progressive increase in
LAD (Fig 8.13B), which was a correlated with an increase in PCL (𝛥𝑃𝐶𝐿 =
0.64(𝛥𝐿𝐴𝐷) + 0.89; 𝑅 2 = 0.63). Change in the LAD and PCL dimensions were
attenuated by hydrogel treatments, significant for DC at 8 weeks (ΔLAD) and 2 and
8 weeks (ΔPCL). At 8 weeks, both assessments of ventricular elongation were
correlated with the observed MR grade (R2 > 0.71), with treatment dependent
clustering (indicated, Figure 8.13C,F).
Direct assessment the mitral valve geometry was performed by 3D
echocardiography. Deviation from the baseline geometry was observed; annular
height (AH), commissural width (CW), and their ratio (AHCWR) all increased in MI
controls, with changes attenuated by hydrogel treatment (not significant, Figure
8.13H). Assessment of tethering of the anterior (A1, A2, A3) and posterior (P1, P2,
P3) leaflets was performed (Figure 8.13I) and strongly indicated tethering of the
posterior leaflet in MI controls—moderately reduced in GH and significantly
reduced (P1) or absent in DC treatments. The location of strongest tethering in MI
controls (P2, P3) is consistent with the observed location of the MR jet via flow
velocity magnitude scans (Figure 8.12F) and indicative of asymmetric ischemic
MR. Notably, increase in the circumference of the posterior leaflet, leaflet length,
and coaptation area were observed in the MI group with relative reduction by
hydrogel treatments (Table 8.5), though not significant.
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Figure 8.13. Valve-associated Geometric Changes due to LV remodeling. Long axis
dimension (LAD, A) and posterior chord length (PCL, D) were determined from CINE MRI.
(B,E) Corresponding quantification for change (∆,relative to baseline measurement for
each case) in LAD and PCL, separated by treatment groups. (C,F) MR grade (8 WK)
dependence on ∆LAD and ∆PCL, where treatment group clustering is indicated (MI: black,
solid; GH: purple, dashed; DC: green, dotted line). (H) Saddle shape geometry was
assessed by geometric change in annular height (AH), commissural width (CW), and the
annular height to commissural width ratio (AHCWR). (I) Leaflet angle (α), indicative of
tethering, was regionally assessed within the anterior and posterior leaflet. *P < 0.05
relative to MI unless otherwise indicated. Indicated in images: right atrium (RA), left
ventricle (LV), left atrium (LA), aorta (Ao), long axis dimension (LAD), and posterior chord
length (PCL).
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Table 8.5. Mitral Valve Geometry.

MI

GH

DC

Time
Point

Posterior
Circumference
(mm)

Leaflet Length
(mm)
Anterior /
Posterior

Coaptation Area
2
(mm )

Post-MI

60.71 ± 1.50

44.06 ± 3.74
/ 49.07 ± 4.71

138.62 ± 19.20

Terminal

67.53 ± 2.85

53.86 ± 5.73
/ 58.15 ± 5.33

219.98 ± 51.54

Change

6.82 ± 2.75

9.80 ± 4.27
/ 9.07 ± 4.43

81.36 ± 47.87

Post-MI

63.68 ± 2.09

58.07 ± 5.65
/ 57.14 ± 3.91

129.09 ± 13.38

Terminal

68.59 ± 2.12

64.19 ± 7.33
/ 63.96 ± 6.84

197.46 ± 44.15

Change

4.91 ± 1.98

6.12 ± 7.63
/ 6.82 ± 5.81

68.37 ± 43.19

Post-MI

65.81 ± 2.58

40.86 ± 1.24
/ 43.11 ± 1.53

122.23 ± 7.73

Terminal

69.43 ± 1.84

41.62 ± 1.03
/ 45.82 ± 0.61

147.52 ± 13.01

Change

1.87 ± 1.57

0.95 ± 1.60
/ 1.18 ± 0.22

25.23 ± 11.24

Data provided as mean±SEM.
* No difference between groups determined by ANOVA

8.3.5 Percutaneous Hydrogel Delivery.
The potential for percutaneous injection of the shear-thinning GH hydrogel was
examined using equipment and methods amenable to adaptation in the majority of
interventional cardiology units. Hydrogels were prepared as described, and the
injection volume (0.3 mL) was loaded into 1 mL Luer-Lock syringes. The desired
injection location (i.e., septal for RV approach, anterior and posterior wall for LV
approach) were positively identified by fluoroscopy, the introduction sheath
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positioned accordingly, and ICE used to allow visualization of the needle location
(Figure 8.14A,D). The injection catheter was filled with hydrogel prior to insertion
into the introduced sheath and injections were performed by insertion of needle
into the LV wall, as visualized by ICE (Figure 8.14A, inset). Following sacrifice and
excision of the heart, hydrogel injections were visualized by MRI. As with direct
injection via left thoracotomy, discrete hydrogel injections were located along the
long axis (Figure 8.14B,E) and short axis (Figure 8.14C,F) of the myocardium.

Figure 8.14. Percutaneous hydrogel injection. (A) Internal jugular approach toward RV
injection, with alignment of the steerable introducer (i), intracardiac echocardiograph
probe (ICE, ii), and deployment of needle assembly (iii). Inset: corresponding ICE view of
deployed needle (indicated, white arrow) entering the myocardial wall (indicated, dashed
red line). (B-C) Long axis (B) and short axis (C) images of hydrogel injection (indicated,
white arrows). (D) Right carotid approach toward LV injection, including steerable
introducer (i), ICE (ii), and deployment of needle assembly (iii) into the midwall of the LV.
(E-F) Long axis (E) and short axis (F) images of hydrogel (indicated, white arrows).
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8.4 Discussion
Toward abating the LV remodeling process post-MI, epicardial placement of
devices, including both mechanical restraints25 and therapeutic-containing
patches45,46 have demonstrated great efficacy in pre-clinical studies. However, the
clinical application of such therapies will most likely be limited due to their inherent
requirement for open surgical approaches. To address this important
consideration, therapeutics that may be delivered via catheter have been
investigated (i.e., cell therapy).47 In addition to such approaches, our group and
others have utilized a combination of experimental and computational tactics to
explore the capacity for injectable hydrogels to directly alter the mechanical
environment both in and around the infarcted region.11,28,29,36,48
The ability of material injection to reduce myofiber stress within the infarct
region and its borderzone is critical, as rapid geometric changes within the infarct
(i.e. infarct expansion) and progressive dysfunction of the borderzone myocardium
have been repeatedly implicated in progression of LV remodeling, as previously
discussed. GH and DC hydrogels are both shear-thinning and self-healing to
permit hydrogel localization in the myocardium (Figure 8.7); however, the DC
hydrogel exhibits stiffening (>40-fold change) to increase the delivered hydrogel
mechanical properties. FE modeling of the LV was utilized to examine the potential
for the two distinct material systems to reduce potentially damaging stresses in the
myocardium. At representative end-diastolic conditions, DC injection showed the
greatest reduction in myofiber stress relative to MI controls. Stress reduction was
driven by the preservation of LV shape in the case of DC injections; the increased
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material stiffness allowed the LV wall to maintain a near normal thickness, which
reduced myofiber stress. In contrast, GH injections deformed under loading,
elongating circumferentially (Figure 8.8A). Although only an initial snapshot into
this mechanism, these results indicate that the hydrogel stiffness is important
because it enables reduction in fiber stress through stiffness-induced bulking of
the myocardium. While progressive DC degradation results in moduli decline and
hydrogel integration with the host tissue, the therapy is intended to intercept the
remodeling process by reducing myofiber stress to prevent early infarct expansion
and thinning within a temporal window where remodeling proceeds rapidly — prior
to endogenous infarct stiffening which occurs in progressive remodeling due to
collagen deposition.49
Myocardial bulking predicted by FE modeling was consistent with in vivo
observations, as the thickness of the myocardium was better maintained with
hydrogel injection. Notably, DC injection maintained baseline measurements at 2
and 8 weeks, with thickness at 2 weeks consistent with FE model predictions.
Importantly, recent analyses have highlighted myocardial thinning as a dominant
feature of LV remodeling, consistent across species, making it an attractive
therapeutic target.50 In addition to bulking, the FE model predicted alterations in
myocardial loading which translated to attenuation of LV remodeling events in vivo,
with DC treatment resulting in significant reduction in LVESV and improvement in
EF at both 2 and 8 weeks. Moreover, the hydrogel treatments demonstrated the
capacity to reduce progression and severity of MR as a result of attenuated
remodeling. These metrics have been shown to be valuable clinical predictors for
255

survival post-MI.51,52 While decreased LV volume, resulting from tissue
displacement by hydrogel, may contribute minimally to changes in EF, the injection
volumes alone (4.8 mL) cannot account for the disparity in LV volumes between
control and treatment cases (44 mL at end-systole, 8 wk) and consistent
improvement in SV was demonstrated, indicating genuine preservation of both
ventricular geometry and function.
To enable formation of injectable hydrogels in vivo, both physical and covalent
crosslinking have been individually leveraged, and a myriad of such hydrogels
have been injected into the myocardium after MI. 27 Yet, exceedingly few have
demonstrated feasibility for percutaneous delivery, largely owing to procedural
complications that place restrictions upon the material system.53 To date, only soft
physically crosslinked hydrogels have been delivered percutaneously via
catheters. Specifically, alginate has been delivered via intracoronary infusion, 30
decellularized extracellular matrix has been delivered via intramyocardial
injection,31,54 and pH responsive assembly of poly(ethylene glycol) hydrogels in
situ has been demonstrated via intramyocardial injection as a vehicle for local
growth factor delivery.55 For such physically assembling systems, the range of
attainable elastic moduli limit their applicability toward mechanical restraint. 56 Yet,
positive results have been demonstrated in porcine models, possibly attributable
to biological effects,57 and these material systems have advanced to clinical trials
(AUGMENT-HF, VentriGel) with outcomes pending.
While physically assembling systems have demonstrated percutaneous
delivery with some positive effects on LV remodeling, they have failed to exploit
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mechanical stabilization in their mechanism of action. As an alternative, covalent
crosslinking of hydrogels has been utilized to achieve mechanical restraint of the
infarcted region, with factors such as increasing stiffness and prolonged
degradation correlated with improved functional outcomes. 28,29 However, gelation
of these systems relies on the mixing of several components, which can be
challenging with a catheter where rapid gelation can clog the catheter and slow
gelation can lead to material dispersion in the tissue, compromising hydrogel
formation.35,58 This challenge has prevented covalently crosslinking hydrogels
from being delivered in a percutaneous approach.
To address these limitations, we have leveraged physical interactions (i.e.,
formation of complexes between guest and host molecules) to enable formation of
a soft hydrogel which exhibited fluid-like behavior within the needle or catheter to
allow injection. Importantly, the guest-host system allowed rapid re-assembly
within the tissue and thus high local retention. Secondary covalent crosslinking,
via thiol-ene addition reaction, has been tuned to provide crosslinking on the order
of hours under controlled conditions (i.e., pH 5), to enable ease of use in a clinical
setting.35 The resulting DC hydrogel mechanics were sufficient to provide tissue
bulking to thicken the myocardium, reduce myofiber stress, and attenuate LV
remodeling processes. Similar to the previously mentioned soft materials (e.g.,
alginate, decellularized extracellular matrix), there was some positive outcome
even with the soft GH hydrogel. This is likely due to the biological effect of injection
a foreign material into the myocardium, which can lead to changes in collagen
production and thus preservation of tissue thickness. Taken together, we have
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demonstrated, for the first time, the development of a catheter-deliverable material
system with the ability to mitigate LV remodeling through mechanical restraint.
The present study has demonstrated that hydrogels can effectively assuage LV
remodeling after MI without the need for added biological therapeutics (i.e. cells,
drugs) through modulation of the myocardial stresses. The study also
demonstrates the feasibility of delivering these materials via catheter-based
techniques, owing to the independently designed mechanisms for material
retention and stiffening. Such materials will facilitate the development of clinically
relevant approaches, owing to the relative ease of preparation and potential for
minimally invasive delivery.25,27,59 Moreover, the primary constituents (i.e., HA and
CD) have been certified as generally recognized as safe (GRAS) by the US Food
and Drug Administration, and many of their chemically modified forms are
industrially well represented, including in the pharmaceutical and medical device
industries.60-62 The defined material formulations therefore constitute a medical
device that holds potential to rapidly progress toward clinical use.

8.5 Conclusion
For the first time, we have developed shear-thinning hydrogels with
therapeutically relevant properties for delivery via percutaneous intramyocardial
injection. Such shear-thinning delivery enabled local hydrogel retention, while
secondary covalent crosslinking enhanced mechanically advantageous bulking of
the infarct tissue. Importantly, the stiffening reaction occurred autonomously in situ
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on clinically relevant timescales and further enhanced treatment efficacy through
bulking and mechanical stabilization of the infarct. The dual-crosslinking hydrogel
system represents the first engineered material designed to specifically and
simultaneously address the needs of localized retention, mechanical stabilization,
and percutaneous delivery for treatment of MI. The present study establishes the
efficacy of the material system as a therapeutic approach toward moderating LV
remodeling.
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CHAPTER 9

Injectable and Cytocompatible Tough Double-Network
Hydrogels Through Tandem Supramolecular and Covalent
Crosslinking

Adapted from: C.B. Rodell, N.N. Dusaj, C.B. Highley, J.A. Burdick. Injectable and
Cytocompatible

Tough

Double-Network

Hydrogels

Through

Tandem

Supramolecular and Covalent Crosslinking. (In Review).

9.1 Introduction
Hydrogels are an invaluable class of materials for biomedical applications,
owing to their utility as structural, bioinstructive, and cell-laden implants1,2. Despite
their many positive attributes, covalently crosslinked hydrogels are typically brittle,
and supramolecular assemblies often exhibit pseudoplastic deformation with low
resistance to loading. Thus, each individually fails to recapitulate biological tissue’s
resilience toward repeated loading. Addressing these limitations, double network
(DN) hydrogels3, a subset of specifically structured interpenetrating networks that
exhibit resistance to mechanical failure, have evolved to produce desirable
mechanical properties for biomedical applications4-6. Canonically, the primary
network (formed first) is highly crosslinked and brittle to dissipate energy and
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protect the ductile secondary network from rupture.7,8 Remarkably, this mechanism
has recently enabled the formation of hydrogels with strengths approaching those
of synthetic rubbers and connective tissues5,6,8-10.
Despite their improved mechanical properties, DNs are susceptible to the
Mullins effect11,12, a loss of mechanical strength upon loading, due to permanent
rupture of covalent bonds. Physical networks, including those based on ionic
crosslinking (e.g., polyampholytes13, alginate14,15, and chitin16) as well as hydrogen
bonding17, have been introduced to attain recoverable primary networks within DN
hydrogels. However, recovery remains poor, requiring long timeframes (>30min)
or excessive heating (>50○C) to approach initial properties. Moreover, the
processing techniques common to the fabrication of DN hydrogels require lengthy
sequential polymerizations where often toxic secondary network components are
swollen into the first network3 or secondary ionic crosslinking is similarly
induced13,16,17. Some efforts have been taken to overcome these limitations and
encapsulate viable cells within IPN‘s, such as by orthogonal click reactions18 or
multistep photopolymerization16,19-23; however, such methodologies preclude
injection.

9.2 Methods
9.2.1 Material Synthesis.
Hyaluronic acid (HA, Lifecore) was converted to methacrylated HA (MeHA) by
esterification (Figure 9.1) with methacrylic anhydride (MA)24. HA with 25%
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(Me25HA) or 100% (Me100HA) of disaccharides modified were prepared by reaction
with 6 eq MA (pH 8.0-8.5, 3 hr) or 25 eq MA (pH 9-10, 4 hr; repeated without
purification), respectively. To enable anhydrous reaction in DMSO, HA and a
portion of Me25HA were converted to their respective tetrabutylammonium salts
(HA-TBA and Me25HA-TBA) by exchange against Dowex-100 (3.0 g per 1.0 g HA)
and neutralization by tetrabutylammonium hydroxide. Adamantane modified HA
(Ad-HA) and β-cyclodextrin (CD) modified HA (CD-HA) were formed by methods
previously reported (Figure 9.2)25, having respective modifications of 33% and
31% of disaccharide repeats. Briefly, HA-TBA (1 eq) was dissolved in anhydrous
DMSO (2 wt%) and modified by esterification with 1-adamantane acetic acid (3.0
eq) via Boc2O (0.67 eq)/DMAP (0.5 eq) catalysis or separate amidation with
aminated CD (0.8 eq) by reaction with BOP (0.8 eq). Methacrylated Ad-HA (AdMeHA) and CD-HA (CD-MeHA) were identically prepared (Figure 9.3), starting
with Me25HA-TBA (1 eq). Modification by Ad and CD were determined to be 33%
and 30%, respectively. All final gel precursors were purified by extensive dialysis,
recovered by lyophilization, and modifications determined by 1H NMR (Bruker,
DMX 360 MHz).
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Figure 9.1. Methacrylate modifications. (A) Preparation of methacrylated hyaluronic
acid (MeHA) with both high and low modifications, designated Me100HA (y = ~1.0) and
Me25HA (B, y = 0.26). Methacrylate modification was determined by integration of the vinyl
singlets (1H ea., shaded green) relative to the sugar ring of HA (10H, shaded gray).

Figure 9.2. Guest-host polymer modifications. (A) Preparation of guest-host polymers,
including hyaluronic acid (HA) with pendant modification by adamantane (Ad-HA; x = 0.33)
or β-cyclodextrin (CD-HA; z = 0.30). (B) Modification of Ad-HA was determined from 1H
NMR spectra by integration of the ethyl multiplet (12H, shaded blue) of adamantane
relative to the sugar ring of HA (10H, shaded gray). (C) Modification of CD-HA was likewise
determined from 1H NMR spectra by integration of the hexane linker (12H, shaded yellow)
of 6-(6-aminohexyl)amino-6-deoxy-β-cyclodextrin relative to the N-acetyl singlet of HA
(3H, shaded gray).
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Figure 9.3. Methacrylated guest-host polymer modifications. (A) Preparation of
methacrylated guest-host polymers, including hyaluronic acid (HA) with pendant
modification by adamantane and methacrylate (Ad-MeHA; x = 0.33 y = 0.26) as well as βcyclodextrin and methacrylate (CD-MeHA; z = 0.30, y = 0.26). Reaction proceeded as for
Ad-HA and CD-HA modifications, with prior methacrylation to product Me 25HA (Scheme
2). (B) Modification of Ad-MeHA was determined from 1H NMR spectra as described for
both MeHA and Ad-HA polymers. (C) Due to considerable spectral overlap of pendant
modifications with both the sugar ring and N-acetyl group of HA, modification of CD-MeHA
was determined from 1H NMR spectra by assuming the methacrylate modification to be
conserved throughout the reaction (25%, vinyl protons 1H ea., shaded green) with
integration of the hexane linker (12H, shaded yellow) of 6-(6-aminohexyl)amino-6-deoxyβ-cyclodextrin.

9.2.2 Hydrogel Formation.
For single networks composed of guest-host networks alone (GH), Ad-HA and
CD-HA were dissolved in equal volumes of PBS such that their combination
resulted in the combined overall concentration desired (5.0 wt%, unless otherwise
specified). For single networks composed of covalent crosslinks alone (MeHA),
Me100HA was dissolved in triethanolamine buffer (TEOA buffer: PBS,
supplemented with 50 mM TEOA, pH 8.5). Dithiothrietol (DTT) was added at 20x
270

concentration, such that the ratio of thiol/methacrylate (ΧDTT) was that specified
and the overall weight percent of Me100HA in solution was 3.0 wt%, unless
otherwise specified. For guest-host double networks (GH DNs), hydrogels were
formed as stated for single network formation, using TEOA buffer. CD-HA and
Me100HA were dissolved together, and DTT thoroughly mixed with Ad-HA
immediately before hydrogel formation. For methacrylated guest-host double
networks (MethGH DNs), hydrogels were prepared as described for GH DNs, with
substitution of Ad-MeHA and CD-MeHA.

9.2.3 Mechanical Testing: Shear Rheology.
Hydrogels were cast between the geometry (1○ cone angle, 20 mm diameter)
and Peltier plate (37○C) of a stress controlled rheometer (TA Instruments,
AR2000); examination was performed by oscillatory frequency sweeps (0.01-100
Hz, 0.5% strain), time sweeps (1.0 Hz, 0.5% strain), and strain sweeps (1.0 Hz,
0.5-500% strain). For hydrogels undergoing covalent crosslinking, crosslinking
was observed in situ via time sweeps (1.0 Hz, 0.5% strain). Analyses were
performed in a minimum of duplicate and results are reported as representative
samples.

9.2.4 Mechanical Testing: Compressive Dynamic Mechanical Analysis.
Immediately following the mixing of hydrogel components, 50 µL of hydrogel
was cast into 5 mm diameter cylinders, sealed to prevent dehydration, and
crosslinked at 37○C overnight prior to compression testing (TA Instruments, Q800).
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Samples (n ≥ 3) were secured via a preload (0.01 N) and compression performed
(0.5 N min-1) for determination of elastic moduli (slope from 10-20% strain), failure
strain, and failure stress. Additionally, moduli were determined for a single sample
at 5, 10, 100, and 500 % strain min-1 to demonstrate strain rate dependence.
Hysteresis testing was performed at 0.5 N min-1 with repeated loading and
unloading cycles to 70% or 80% strain. Similar cyclic testing, with maximum strain
progressively increased by 10% per cycle was also performed. For all repeated
loading, a minimum of 5% strain was utilized to maintain sample contact with the
instrument. Stress-strain profiles were integrated by geometric approximation
(MATLAB) to determine hydrogel toughness, strain energy, and relaxation energy.

9.2.5 Mechanical Testing: Tensile Analysis.
Utilizing similar fabrication methods to compression samples, hydrogels (n ≥ 4)
were cast using PDMS molds into dog-bone shaped samples (3.0 mm thickness,
5.0 mm width at center). Samples were secured in custom clamps, pre-tension
applied (0.01 N), and subjected to extension at 5.0 mm sec -1 (Instron, 5848, 10 N
load cell). Elastic moduli (slope from 40-50% strain), failure strain, and failure
stress were measured. Toughness was determined by methods analogous to
compressive testing.

9.2.6 Cell Encapsulation and Viability.
Human mesenchymal stem cells (hMSCs, Lonza) were expanded under
standard culture conditions in MSC growth media (α-MEM, 16.7% FBS, 1% L272

glutamine, penicillin streptomycin) and encapsulated between passage 3 and 7 at
a density of 5x106 cells per mL, maintained in culture for 24 hours (day 0) or an
additional 14 days, and stained for live/dead following manufacturer’s instructions
(Molecular Probes). For encapsulation, hydrogels were prepared as described,
with 10% of the total volume reserved to account for addition of a concentrated cell
suspension to the components immediately before onset of gelation. For all cases,
crosslinking was performed in Media 199 (Gibco) supplemented with 2.5 mM
TCEP, 25 mM HEPES, and with the pH adjusted such that final gelation occurred
at pH 8-8.5 under culture conditions. Images were acquired (Olympus, BX51) at
10x magnification using epifluorescent filters for both live (calcein AM labeled) and
dead (ethidium homodimer labeled) cells. Viability is reported as the percentage
of cells with positive calcein staining, n ≥ 3 per group. To examine hMSC
distribution within the hydrogels, representative images were obtained by confocal
microscopy (Zeiss, LSM 510, 10x objective) with maximum projections and 3D
rendering performed (ImageJ). To assess metabolic activity, hMSCs were
encapsulated and serially examined at set timepoints by incubation with Alamar
blue (Fisher; 1:10 dilution with growth media, 4 hr incubation) and quantified by
fluorescence (Tecan, Infinite M200, λabs/em=530/590 nm), which was normalized to
baseline for each sample (n = 4).

9.2.7 Injection.
Hydrogels were prepared using supplemented Media 199. Ex vivo injections
were performed subcutaneously (rat, 300 µL ea.) and intramyocardially (ovine left
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ventricle, 200 µL ea.). Articular cartilage defects (bovine tibia, 5 mm) were filled by
injection of hydrogels, contacted with the meniscus throughout crosslinking, and
subsequently washed. All were incubated (37○C, 2 hrs) prior to excision and/or
imaging. For subcutaneous injection, samples were collected (n ≥ 4, 4 mm
diameter) and subjected to compressive analysis.

9.2.8 Statistical Analysis.
All data are reported as mean ± standard deviation (SD). Statistical significance
was determined by ANOVA with post hoc Tukey HSD to compare between groups
unless otherwise stated. In all cases, significance was determined at P ≤ 0.05.

9.3 Results and Discussion
9.3.1 Hydrogel Design and Network Properties.
To simultaneously address the need for rapid self-healing, injectable delivery,
and cytocompatibility, we have established a novel and generalizable methodology
for formation of DN hydrogels by tandem supramolecular interactions and
secondarily formed covalent crosslinks. Supramolecular guest-host assembly26,27
was utilized

to develop a rapidly self-healing primary network, where β-

cyclodextrin (CD, host) was chosen as the host macrocycle due to its
demonstrated biocompatibility, ease of chemical modification28, and high affinity
guest-host complexation (Keq ~ 105 M-1)29 with adamantane (Ad, guest). Standard
anhydrous esterification and amidation reactions (Figure 9.2) were utilized to
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couple 1-adamantane acetic acid and aminated CD to hyaluronic acid (HA), used
due to its long history of use in biomedical applications and potential for functional
modification30. Upon mixing of the separate polymer solutions (5.0 wt% overall), a
guest-host (GH) hydrogel formed (Figure 9.4A) that exhibited expected frequency
dependent moduli due to the dynamic bond structure (Figure 9.4B) and yielded at
high strain (>75% reduction in G‘) with recovery (>95%) within 6 seconds of
removal of high strain conditions (Figure 9.4C). Thus, GH complexation was
successfully leveraged in construction of a primary network that formed upon
simple mixing, was shear-yielding, and underwent rapid self-healing.
The secondary network was formed through an orthogonal covalent
crosslinking reaction. Specifically, methacrylated HA (3.0 wt% Me 100HA, Figure
9.1) was reacted with dithiothreitol (DTT) to form a covalently crosslinked hydrogel
under basic conditions (50 mM TEOA, pH 8) via Michael addition between
methacrylates and thiols (Figure 9.4D). Addition crosslinking enabled facile
changes in the covalent crosslink density by adjusting the ratio of thiol to
methacrylate (ΧDTT), resulting in a network with tunable properties. Failure strains
and elastic moduli were achieved ranging from 45.5±0.5 to 86.5±7.6 % and 2.2±0.2
to 85.7±4.5 kPa, respectively (Figure 9.4E,F). All subsequent analyses utilized
ΧDTT = 20%, due to requisite ductility of the secondary network.
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Figure 9.4. Properties of single network hydrogels and schematics of hydrogels
examined. (A) Schematic of adamantane (Ad-HA, blue) and β-cyclodextrin (CD-HA,
yellow) modified hyaluronic acid crosslinked through guest-host (GH) complexation. (BC) GH hydrogels (5.0 wt%) were examined by frequency sweeps (B; 0.01-100 Hz, 0.5%
strain) and strain sweeps (C; 1.0 Hz, 0.5-500% strain) with yield point indicated (▼, 64%
strain) and subsequent rapid recovery (shaded; 1.0 Hz, 0.5% strain). (D-F) Schematic of
Michael addition crosslinking (D) of methacrylated hyaluronic acid (MeHA) by dithiothreitol
(DTT, red), where crosslink density was controlled through the thiol:methacrylate ratio
(ΧDTT) and altered failure strains (E) and compressive elastic moduli (F). (p < 0.05, except
where no difference (n.d.) is indicated). (G) Network architectures examined included a
guest-host (GH) hydrogel, covalently crosslinked (MeHA) hydrogel, guest-host double
network (GH DN), and methacrylated guest-host double network (MethGH DN). Local
stress under loading (red) dissipated through reversible GH complex rupture (i) within the
primary GH network; increased stress led to covalent bond rupture (ii) within the
secondary covalent network, whereas energy dissipation from the GH network reversibly
protected the secondary MeHA network from bond rupture within the double networks (iii),
a mechanism which was enhanced through network tethering to enable stress
transference (iv).
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The combination of supramolecular and covalent chemistries enabled the
engineering and investigation of DN hydrogels with unique and desirable
properties (Figure 9.4G), including injectability and self-healing (due to reversible
guest-host crosslinking) and easily tunable properties (due to covalent
crosslinking). The guest-host double network (GH DN) was readily formed upon
one-pot mixing of the polymer solutions, owing to simultaneous and orthogonal
crosslinking mechanisms, with interpenetration of the two networks resulting in
stress transference primarily through network entanglement 31.

Since network

tethering may enhance overall network properties32, the polymers were modified
(Figure 9.3) to incorporate methacrylates into the GH network (MethGH DN),
enabling coupling of the two interpenetrating networks.

9.3.2 Double Network Mechanical Characterization
Under compressive loading (Figure 9.5A) MeHA hydrogel controls with only
covalent crosslinking exhibited dramatic and sudden failure, attributed to
unhindered propagation of covalent rupture points11,33; GH DN hydrogels exhibited
ductile and unrecoverable failure, attributed to covalent bond rupture and
subsequent sliding of entanglement points and GH complexes 12; MethGH DN
hydrogels demonstrated exceptional recovery with only minor and localized
defects observed, likely arising from imperfections created during sample
preparation. Due to the pseudoplastic behavior of GH single networks, they were
not suitable for testing.
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Compressive stress-strain relationships (Figure 9.5C) illustrated increased
moduli for DNs (inset), as well as substantially increased failure stresses for
MethGH DN hydrogels. While properties were investigated at a nominal rate (0.5N
min-1), compressive strain rate dependence was observed (Figure 9.6) due to
stochastic and forcefully induced GH complex yielding27,34, indicating shock
absorbing capacity reminiscent of many load bearing tissues. Elastic moduli were
dependent on polymer concentration of the GH network (Figure 9.5E). Since no
significant improvements were observed with GH polymer concentrations greater
than 5.0 wt%, this concentration was used in subsequent analyses. Hydrogel
properties were highly tunable through modulation of covalent crosslink density
(Figure 9.5F). MethGH DN moduli exhibited approximately a fivefold and threefold
amplification at ΧDTT = 20% and 100%, respectively, far exceeding summation of
network properties where the elastic moduli of GH and MethGH single network
hydrogels were <1kPa (1.0 Hz, 0.5% strain, where 𝐸 = 3(𝐺’)). Enhancement of
MethGH DN moduli resulted in greater failure stresses and toughness, despite
similar failure strains (Figure 9.7). Enhanced mechanical properties required an
interpenetrating structure, but did not result from entanglement alone, as indicated
by controls with perturbed polymer composition (Figure 9.8).
Under tensile loading (Figure 9.5B,D) all hydrogels exhibited substantial elastic
elongation with high failure strains (>150%, Figure 9.9). Elastic moduli increased
with GH DN formation and further improved with tethering in the MethGH DN
(Figure 9.5D). For both DNs, failure stresses were also significantly improved over
MeHA controls. As a result of these changes, both DNs exhibited drastic increases
in toughness (Figure 9.5G, > 8.5 fold increase for MethGH DN).

278

Figure 9.5. Dependence of double network properties on structure and composition.
(A) Differing modes of compressive failure were observed between the hydrogels following
compression to 90% strain (unconfined, 0.5 N min-1): brittle (MeHA: 3.0 wt% Me100HA,
ΧDTT = 20%; left), ductile (GH DN: 3.0 wt% Me100HA, ΧDTT = 20%, 5.0 wt% GH, middle),
and recoverable (MethGH DN: 3.0 wt% Me100HA, ΧDTT = 20%, 5.0 wt% MethGH, right).
Scale bar: 5.0 mm. (B) Tensile testing of identically composed samples demonstrated a
high degree of elasticity, where starting position of the top member is indicated (dotted
line). Scale bar: 1.0 cm. (C-D) Corresponding compressive (C, 0.5 N min-1) and tensile (D,
5 mm sec-1) stress-strain relationships. (E-G) Networks demonstrated tunable properties.
(E) Compressive elastic moduli with varied supramolecular guest-host density (3.0 wt%
Me100HA, ΧDTT = 20%, 0-7.5 wt% GH), where MeHA groups contained soluble HA to
account for contributions by polymer entanglement. (p < 0.01, within and between groups
for both DNs except where no difference (n.d.) is indicated). (F) Compressive elastic
moduli with varied covalent crosslink density modulated by the ratio of thiol to methacrylate
(3.0 wt% Me100HA, ΧDTT = 20-100%, 5.0 wt% GH). (p < 0.01, for all comparisons except
where indicated: *, p < 0.05; n.d., no difference). (G) Tensile toughness for DNs and MeHA
controls (*, p < 0.05; ***, p < 0.005,).
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Figure 9.6. Dependence of compressive elastic moduli on strain rate. Moduli were
examined at various strain rates (0.5-500% strain min-1 compression as shown: inset, left)
for MeHA (A, 3.0 wt% Me100HA, ΧDTT = 20%), GH DN (B, 3.0 wt% Me100HA, ΧDTT = 20%,
5.0 wt% GH) and MethGH DN (C, 3.0 wt% Me100HA, ΧDTT = 20%, 5.0 wt% MethGH)
hydrogels, which demonstrated moduli dependence on strain rate only for networks
containing supramolecular crosslinks.

Figure 9.7. Dependence of compressive hydrogel properties on covalent crosslink
density. Failure strain (A), failure stress (B), and corresponding hydrogel toughness (C)
were investigated as a function of covalent crosslink density (ΧDTT = 20-100%), including
for MeHA (3.0 wt% Me100HA), GH DN (3.0 wt% Me100HA, 5.0 wt% GH) and MethGH DN
(3.0 wt% Me100HA, 5.0 wt% MethGH) hydrogels. (ǂYield point not observed due to ductile
failure).
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Figure 9.8. Dependence of compressive mechanical properties on double network
composition and architecture. Investigated groups include 3.0 wt% Me100HA (MeHA),
3.0 wt% Me100HA + 5.0 wt% HA (MeHA + HA), 3.0 wt% Me100HA + 5.0 wt% GH (MeHA +
GH), 3.0 wt% Me100HA + 5.0 wt% MethGH (MeHA + MethGH), 3.0 wt% Me100HA + 5.0
wt% Me25HA (MeHA + MeHA (25%)) and 5.0 wt% MethGH alone (MethGH). In all cases,
ΧDTT = 20% and loading was performed at a strain rate of 0.5 N min -1 to determine
compressive elastic modulus (A), failure stress (B), and failure strain (C). (ǂYield point not
observed due to ductile failure. Significance relative to MeHA shown: *, p < 0.05; **, p <
0.01, ANOVA with post hoc HSD). Results demonstrate the inability of entanglement with
or without tethering (MeHA + HA and MeHA + MeHA (25%), respectively) to account for
changes in hydrogel mechanics. Moreover, the necessity of a double network, utilizing two
separate polymers rather than covalent stabilization of MethGH alone, is demonstrated by
the failure of MethGH only to recapitulate the high failure mechanics of the MethGH DN.

Figure 9.9. Dependence of tensile hydrogel properties on network structure.
Dependence of tensile (5.0 mm sec-1 elongation) failure strain (A), elastic modulus (B),
and failure stress (C) on hydrogel network structure, including for MeHA (3.0 wt%
Me100HA, ΧDTT = 20%), GH DN (3.0 wt% Me100HA, ΧDTT = 20%, 5.0 wt% GH) and MethGH
DN (3.0 wt% Me100HA, ΧDTT = 20%, 5.0 wt% MethGH) hydrogels. (*, p < 0.05; ***, p <
0.001, ANOVA with post hoc HSD).

281

9.3.3 Supramolecular Self-Healing
In addition to enhancing mechanical strength, a distinctive and advantageous
feature of supramolecular interactions is their ability to undergo repeated
association to endow macrostructural and microstructural (i.e., internal) selfhealing (Figure 9.10). Cut hydrogel fragments exhibited cohesion in aqueous
conditions, which was disturbed only for MeHA hydrogels following mechanical
agitation (Figure 9.10A). Cohesion likewise occurred between GH DN and MethGH
DN hydrogel fragments, due to their identical guest-host composition. Notably,
binding occurred rapidly (~1 sec), allowing near-immediate resistance to
separation by repeated mechanical loading.
To quantitatively investigate internal self-healing of DNs, repetitive loading was
examined. Stress-strain profiles under ramped cyclic compressive strain (20-70%,
Figure 9.10B, Figure 9.11) demonstrated synchronization of the loading curves
with no appreciable change in moduli between loading cycles, indicating elastic
recovery below critical strains. An appreciable increase in the strain energy (i.e.,
the energy required to induce deformation) was observed for MethGH DN
hydrogels (Figure 9.10C) with successive cycles. Moreover, the hysteresis energy
(i.e., the energy consumed due to internal bond failure11) demonstrated a notable
increase for MethGH DN hydrogels, relative to MeHA and GH DN groups,
indicating energy dissipation due to forcefully induced GH complex failure. With
repeated application of 80% maximum strain, Mullins-type softening (i.e., loss of
moduli and strain energy) was observed in MeHA and GH DN hydrogels, which
was not observed at subcritical (<70%) strains (Figure 9.12) or in MethGH DNs
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(Figure 9.10D,E). Thus, MethGH DNs effectively leverage the primary
supramolecular network to prevent internal rupture of covalent bonds and maintain
their moduli, even without lengthy recovery times that are needed with other types
of crosslinking (e.g., ionic DNs)13,15,16. Taken together, results indicate that
supramolecular bonds within DNs immediately self-heal between loading cycles
and contribute substantially to energy consumption throughout loading, enabling
supramolecular DNs to undergo repetitive loading in rapid succession, such as that
which occurs in biological tissues.

Figure 9.10. Supramolecular self-healing at macroscopic and molecular scales. (A)
Macroscopic images of self-healing between fragments of MeHA (blue, 3.0 wt% Me100HA,
ΧDTT = 20%), GH DN (green, 3.0 wt% Me100HA, ΧDTT = 20%, 5.0 wt% GH), and MethGH
DN (orange, 3.0 wt% Me100HA, ΧDTT = 20%, 5.0 wt% MethGH) hydrogels before (top) and
after (bottom) mechanical agitation, which demonstrated a lack of self-healing between
MeHA samples only. Scale bar: 1.0 cm. (B-C) Compressive stress-strain profiles (B) for
ramped loading (8 cycles at 0.5 N min-1 as shown, inset) of MethGH DN and strain energy
of all groups (C). (D-E) Compressive stress-strain profiles for repeated loading to 80%
strain (5 cycles at 0.5 N min-1 as shown, inset) of MethGH DN (D) and normalized strain
energy of all groups (E).
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Figure 9.11. Evaluation of network energy throughout loading and unloading cycles.
Ramped strain loading (20-70% strain at 0.5 N min-1 compression as shown, inset) for
MeHA (A, 3.0 wt% Me100HA, ΧDTT = 20%), GH DN (B, 3.0 wt% Me100HA, ΧDTT = 20%, 5.0
wt% GH) and MethGH DN (C, 3.0 wt% Me100HA, ΧDTT = 20%, 5.0 wt% MethGH) hydrogels
with determination of strain energy during loading (D), relaxation energy during unloading
(E), and the hysteresis energy as the difference in strain and relaxation energy (F).

Figure 9.12. Evaluation of network recovery from cyclic compressive loading.
Loading (5 cycles at 0.5 N min-1 compression) was maintained below the yield strain,
including to 70% strain (A-C) and 80% strain (D-F) for MeHA (A, D; 3.0 wt% Me100HA,
ΧDTT = 20%), GH DN (B, E; 3.0 wt% Me100HA, ΧDTT = 20%, 5.0 wt% GH), and MethGH DN
(C, F; 3.0wt% Me100HA, ΧDTT = 20%, 5.0 wt% MethGH) hydrogels with determination of
compressive moduli for successive cycles (insets, right). Hydrogels exhibited elastic
recovery at 70% strain, but successive Mullins-type losses in moduli at 80% strain for
MeHA and GH DN samples, not observed for MethGH DNs.
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9.3.4 Double Network Cytocompatibility
For biomedical applications, the encapsulation or delivery of cells is often
desirable; however, these processes remain challenging with many types of
crosslinking. Towards this, we developed cytocompatible crosslinking conditions
(< 20 min, pH 8.5, 37○C) that supported tandem DN formation (Figure 9.13), using
a phosphine Michael addition catalyst (TCEP: tris(2-carboxyethyl)phosphine,
2.5mM). These conditions were informed by previous reports that showed TCEP
to be a water soluble and highly efficient Michael addition catalyst under mildly
basic conditions35, as well as recent utilization of Media 199 in nucleophilic
addition36. These crosslinking conditions and cell inclusion did not impact hydrogel
mechanics (Figure 9.14).

Figure 9.13. Development of cytocompatible crosslinking conditions. Real-time
rheological examination of MeHA crosslinking kinetics (A-C, 1.0 Hz, 0.5% strain. MeHA:
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Me100HA, ΧDTT = 20%) and metabolic assay (D) Alamar blue) were used to identify
conditions suitable for rapid Michael addition catalysis while maintaining cell viability. Upon
probing relevant catalytic conditions in Media 199, the speed of crosslinking was observed
to be greatly dependent on pH variations (A, pH 8.0 – 9.5, 25 mM TCEP, 37 ○C), nearly
independent of variations in TCEP concentration (B, pH 8.5, 2.5 mM – 25 mM TCEP, 37
○
C), and highly dependent on temperature (C, 2.5 mM TCEP, pH 8.5, 4 – 37 ○C), where
no increase in moduli was observed at 4○C within 1 hour. (D) Alamar blue assay was
conducted according to manufacturer’s instructions following exposure of MSCs (seeded
25x103 cells/well, 24 well plate) to conditions which replicated hydrogel encapsulation,
including exposure to the prescribed buffer conditions (100 µL/well) for 30 min followed
be dilution with 1.5 mL MSC growth media and overnight culture. Buffers included MSC
growth media (Media), MSC growth media adjusted to pH 8 by NaOH (Media pH 8), 50
mM TEOA in MSC growth media at pH 8 (TEOA, pH 8), Media 199 supplemented with
TCEP (TCEP 2.5-125 mM, pH 7.5), and Media 199 supplemented with TCEP at various
pH (TCEP 2.5 mM, pH 7.5-9.0). Significant differences relative to standard media
conditions are designated (*, p < 0.01, ANOVA with post hoc HSD). We observed a
notable decrease in metabolic activity in the presence of TEOA (TEOA, pH 8), which likely
resulted in part from TEOA toxicity rather than pH alone, as Media pH 8 showed a lesser
effect. Toxicity of TCEP was observed only at concentrations greater than 2.5 mM. At a
concentration of 2.5 mM TCEP, no differences were observed in metabolic activity from
pH 7.5 – 9.0. Based on these observations, suitable crosslinking conditions for cell
encapsulation were determined by be 2.5 mM TCEP, 37 ○C, pH 8.5 where serum free
Media 199 was utilized and pH was maintained in the CO2 environment by addition of 25
mM HEPES.

Figure 9.14. Mechanical characterization of cell laden double network hydrogels. To
examine the capacity for cytocompatible crosslinking conditions to fully crosslink materials
without detriment to established mechanical properties, including in the presence of cells,
mechanical characterization was performed in TEOA buffer (TEOA), Media 199
supplemented with 2.5 mM TCEP, 25 mM HEPES, pH 8.5 (M199), and in the presence of
MSCs (5x106 cells per mL, M199 + MSC). Regardless of catalysis conditions or cell
presence, similar trends were observed between groups in elastic compressive moduli
(A), failure stress (B), and failure strain (C). No significant differences were observed
between TEOA and M199 + MSC conditions with the exception of moderate reductions in
failure strain (*, p < 0.05).
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At 24 hours following hydrogel formation (day 0), all hydrogels exhibited
homogenous cell distributions, assessed by confocal microscopy (Figure 9.15A,
Figure 9.16) and high viability (>95%, Figure 9.15B). Throughout 14 days in
culture, metabolic activity (Figure 9.15C) remained similar between all hydrogel
groups (p > 0.67, ANOVA) and increased over time, significant for GH DN beyond
7 days and for MethGH DN beyond 3 days, relative to group baseline.
Corresponding temporal examination of hydrogel moduli, swelling, and
degradation (Figure 9.17) revealed that MethGH DN moduli were higher than that
of the MeHA and GH DN hydrogels throughout the study and that DN groups
exhibited reduced degradation. All hydrogels exhibited a nearly four-fold increase
in mass due to swelling by day 1, which was maintained thereafter; such high water
content (> 97%) likely helped overcome diffusive limitations that hindered longterm viability in other tough IPN and DN hydrogels19-21,23. At day 14, high viability
(> 98%) and uniform cell distribution was maintained (Figure 9.16).
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Figure 9.15. Cell encapsulation, distribution, and long-term viability. (A) Confocal
microscopy maximum projections of encapsulated mesenchymal stem cells (MSCs;
calcein & ethidium staining) 24 hours after encapsulation within single (GH: 5.0 wt%;
MeHA: 3.0 wt% Me100HA, ΧDTT = 20%) and double network (GH DN: 3.0 wt% Me100HA,
ΧDTT = 20%, 5.0 wt% GH; MethGH DN: 3.0 wt% Me100HA, ΧDTT = 20%, 5.0 wt% MethGH)
hydrogels. Of note, GH hydrogels exhibited a high degree of swelling, which reduced MSC
density. Scale bar: 200 µm. (B) High viability (> 95%) was observed for all hydrogels 24
hours after encapsulation (day 0), determined via quantification of epifluorescent images,
and did not vary between groups (p > 0.95). (C) Metabolic activity was similar across
groups at all timepoints (p > 0.69) and increased over 14 days of culture (*p < 0.05 relative
to baseline, repeated measures ANOVA with post hoc Student’s t-test). GH hydrogels are
not included, as they were not maintained in long-term culture.
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Figure 9.16. Cell distribution within single and double network hydrogels. Oblique
perspectives of confocal microscopy images of cell laden hydrogels at day 0 (A) and day
14 (B). GH hydrogels demonstrated apparent reductions in density at day 0 due to the
relatively high degree of swelling and could not be maintained in culture through day 14.
Covalently crosslinked hydrogels, including MeHA, GH DN, and MethGH DN exhibited
relatively homogenous cell distributions throughout the culture period. Oblique projections
through the hydrogel edge (not shown) did not show proliferation on the gel surface at day
14. Scale bar: 200 µm.

Figure 9.17. Temporal characterization of material properties. To understand the bulk
properties and behavior of the hydrogels over the time-course of cell culture,
characterization of compressive elastic moduli (A), hydrogel degradation (B), and swelling
(C) was performed for MeHA (3.0 wt% Me100HA, ΧDTT = 20%), GH DN (3.0 wt% Me100HA,
ΧDTT = 20%, 5.0 wt% GH), and MethGH DN (3.0 wt% Me100HA, ΧDTT = 20%, 5.0 wt%
MethGH) hydrogels in the absence of cell inclusion. All hydrogels showed a high degree
of swelling within the first 24 hours, moderate loss of moduli, and concurrent hydrogel
degradation and HA release.
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9.3.5 Double Network Injectability
In addition to endowing DNs with the ability to withstand repeated loading, rapid
self-healing of supramolecular bonds enabled hydrogel injection, which is crucial
for minimally invasive delivery in biomedical applications. As demonstrated
rheologically (Figure 9.4C), GH complexation enabled yielding and flow of GH
single network hydrogels under application of high strain with subsequent rapid
recovery. This unique quality was harnessed to enable injection, where upon
injection into aqueous media (TEOA buffer; Figure 9.18A) GH DN and MethGH
DN hydrogels exhibited near-instantaneous supramolecular re-assembly following
injection, resulting in retention of the interpenetrating MeHA polymer which
subsequently crosslinked to form a highly elastic DN (Figure 9.18B). Conversely,
MeHA single networks rapidly diffused prior to crosslinking.
Translation toward gelation in situ, such as for therapeutic in vivo injection, was
evaluated through injection into various tissues post-mortem (Figure 9.18C). In all
cases, including subcutaneous injection in rats, intramyocardial injection in ovine
tissue, and filling of cartilaginous defects, MeHA hydrogels were notably absent
from the delivery location as a result of slow crosslinking kinetics; however, DN
hydrogels were successfully retained at the injection locations. The mechanical
properties of DNs following injection and in situ crosslinking were evaluated after
harvesting of subcutaneous implants. GH DN and MethGH DN samples exhibited
moduli of 5.83 ± 0.95 kPa and 11.17 ± 3.21, respectively, that were similar (p >
0.79) when compared to in vitro controls. Likewise, failure mechanics of MethGH
DN samples were similar to in vitro controls, including failure stress (264.00 ± 48.38
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kPa, p = 0.08), failure strain (86.63 ± 4.05% strain, p = 0.51), and toughness
(311.33 ± 54.00 kJ/m3, p = 0.41). Thus, developed supramolecular DN hydrogels
retained desirable mechanical properties, including after injection and in situ
crosslinking within tissue.

Figure 9.18. Hydrogel injectability. (A-B) Macroscopic images of hydrogels following
injection into TEOA buffer (A), demonstrating diffusion of MeHA (3.0 wt% Me100HA,
ΧDTT = 20%) prior to crosslinking and rapid supramolecular re-assembly of double
network formulations (GH DN: 3.0 wt% Me100HA, ΧDTT = 20%, 5.0 wt% GH; MethGH
DN: 3.0 wt% Me100HA, ΧDTT = 20%, 5.0 wt% MethGH), which maintained elasticity (B,
GH DN) following covalent crosslinking. (C) Hydrogel placement within tissues including
subcutaneous (i) and intramyocardial (ii) injection, where approximate injection locations
are indicated (▼), and filling of articular cartilage defects (iii, control empty defect shown
at bottom left). GH DN and MethGH DN hydrogels formed highly localized implants,
encircled by dashed lines, while MeHA alone rapidly diffused from the sites prior to
hydrogel formation. Scale bars: 5 mm.
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9.4 Conclusions
Supramolecular

interactions,

including

ionic13,15,16,37,

and

hydrogen

bonding17,38, and engineered binary associations39-41, are essential in the
development of tough materials. Yet, these methods have failed to deliver
hydrogels that rapidly self-heal to enable sequential repetitive loading. We have
harnessed the rapid association of supramolecular macrocycles to enable nearimmediate internal self-healing of DN hydrogels, where concurrent and substantial
amplification of the hydrogel toughness and elastic moduli were simultaneously
achieved through tethering of the single networks to enable stress transfer during
loading. In contrast to conventional DN formation, hydrogels were composed of
orthogonal supramolecular and covalent bonding schemes, which enabled single
step (one-pot) preparation without detriment to encapsulated cells and enabled
maintenance of high cell viability in culture — features not observed in other DNs.
Autonomy of the reactions, in combination with shear-yielding behavior of the
supramolecular bonds, enabled injectability with in situ DN formation. Due to their
unique

load-bearing,

injectable,

and

cytocompatible

properties,

hybrid

supramolecular-covalent DNs are promising materials scaffolds for biomedical
applications.
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CHAPTER 10

Summary, Limitations, and Future Directions

10.1 Overview
The work presented in this dissertation has illustrated the development,
characterization, and utility of hydrogels formed through guest-host (GH) directed
assembly. Specifically, supramolecular hyaluronic acid (HA) hydrogels were
developed that undergo dynamic assembly, directed by the GH complexation of βcyclodextrin (CD) and adamantane (Ad). Owing to the dynamic nature of these
bonds, GH hydrogels underwent shear-thinning and re-assembly — desirable
properties for injectable materials. Through extensive in vitro and in vivo
characterization, an understanding of the material properties was developed,
including the mechanical properties, dynamic rearrangement into supramolecular
microstructures, and degradation behaviors, which were altered through both
hydrogel composition and external triggers (e.g., enzymatic degradation). The
hydrogel development and characterization served as a basis of understanding
towards their utility in biomedical applications.
Subsequent studies focused on altering the material properties of these
physical hydrogels through additional covalent crosslinking, to improve their
mechanical properties toward specific or general biomedical application. In the first
approach, GH hydrogels were modified to undergo secondary covalent
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crosslinking (of the same polymer) in order to improve their mechanical strength.
These dual-crosslinking (DC) hydrogel systems were applied to both small and
large animal models, where they demonstrated promise as an injectable
therapeutic to assuage maladaptive left-ventricular (LV) remodeling precipitated
by myocardial infarction (MI). Toward development of tough hydrogels, secondary
covalent crosslinking was introduced through interpenetrating double networks
(DNs) with the GH hydrogel. These hydrogels were injectable, self-healing, and
cytocompatible — properties that are useful for widespread biomedical
applications. The remainder of this chapter summarizes primary conclusions and
limitations of each specific aim, as well as future directions.

10.2 Specific Conclusions, Limitations, and Future Directions
Specific Aim 1: Develop and characterize guest-host (GH) hydrogels capable
of injection.
Conclusions: Through anhydrous esterification and amidation reactions, host
(CD-HA) and guest (Ad-HA) polymers were prepared. Polymer conjugation did not
impact the guest or host affinity, relative to unconjugated controls (K a ≈ 500 M-1).
Individual components were non-viscous solutions, which resulted in physical GH
hydrogels when mixed with tunable moduli (G’ ≈ 200 Pa – 20 kPa at 1.0 Hz, 1.0%
strain) and bulk relaxation behaviors (τ ≈ 0.1 – 100 sec) through modulation of
polymer concentration, adamantane:cyclodextrin ratio, and modification of Ad-HA.
Moreover, GH hydrogels were shear-thinning with rapid subsequent recovery
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(>80% G’ within 1.33 sec). GH hydrogels were therefore concluded to be a
mechanically tunable physical hydrogel system with desirable properties for use
as an injectable hydrogel.
GH hydrogels were stable is aqueous environments (20-80% mass loss at 60
days, dependent on formulation) and permitted sustained diffusive protein release
(bovine serum albumin, >60 days). Further modification of this system
incorporated an enzymatically degradable peptide linker between HA and Ad,
which enabled accelerated hydrogel degradation either through collagenase or
matrix metalloproteinases (MMP-2) in vitro. Hydrogel erosion was likewise
accelerated in vivo, relative to non-degradable controls. The GH hydrogel system
is therefore a promising drug delivery system, enabling injectable delivery of
therapeutic reservoirs which can be made responsive to native biological signals.
Dynamic supramolecular assembly of GH hydrogels also resulted in a
hierarchical structure in vitro. Visible turbidity arose following GH hydrogel
formation and incubation, indicative of light diffraction due to microscale
heterogeneity. The porous structure was observed by microscopic methods in the
hydrated state and evolved temporally with void fractions (~8.5 - 94%) and pore
diameters (~2.1 – 1025 µm) that were tunable through polymer concentration and
Ad-HA modification. Micromechanical analysis via atomic force microscopy and
microparticle tracking analysis revealed the evolution of hollow pores. Thus, a
tunable microstructure was achieved through guest-host directed polymer
assembly.
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Limitations & Future Directions: Taken together, the extensive synthesis and
characterization employed resulted in diverse hydrogel features; though, several
experimental variables remain unexplored. Toward tailoring of the GH hydrogels
at the polymeric level, only pendant modification of hyaluronic acid was explored.
Additional polymers may be of interest, including cationic or neutral polymers as
well as those with star, dendrimeric, or branched structures. Moreover, only βcyclodextrin and adamantane were examined as the guest-host pair. As discussed
in Chapter 3, an array of possible host macrocycles and corresponding guest
moieties are available, which enable alterations in binding constants and even
stimuli-responsive behaviors. These variations in hydrogel composition may
enable further implementation of the GH hydrogel for cell and drug delivery or use
as model cell culture substrates.
Toward the utilization of these materials as bioerodible hydrogels for delivery
of therapeutic cargo, we have demonstrated here the long-term stability of these
hydrogels as well as concurrent release of an inert model protein (albumin). The
investigation of therapeutic delivery has not been observed in vivo through the
studies presented herein. Though, continuing work beyond the scope of this
dissertation has utilized these materials for localized peptide and protein delivery,
including for applications in kidney1,2 (IL-10 and anti-TGF β delivery) and
myocardial disease (SDF-1α and cathelicidin-related antimicrobial peptide), both
with positive outcomes. Longitudinal analysis of release behavior and related
activity in vivo, rather than in vitro examination alone, would improve upon such
studies. Moreover, supramolecular interactions also perpetuate controlled delivery
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though the guest-host interaction of CD with small molecule therapeutics or
polymer charge interactions to electrostatically control release of charged
therapeutics (i.e., proteins, RNA). These mechanisms have not been explored
here, but remain a focus of continuing efforts.
While a microscale structure was shown to evolve in this hydrogel system, it
has not yet been generalized to include the assembly of alternative binding pairs.
Likely, the choice of binding pair will greatly alter the timescale for evolution and
feature size. Additionally, alterations to the polymer may result in interesting
changes, including by reduction in electrostatic repulsion for neutral polymers that
would enable polymer condensation with greater density (i.e., higher moduli). The
modulus of the hydrogel phase was not determined in the absence of secondary
photopolymerization, and it therefore remains ambiguous if hydrogel stiffening
occurred (due to polymer compaction) or if swelling in the surrounding aqueous
environment resulted in softening. These questions warrant further investigation,
as they are relevant toward the development of these and related adaptable
materials as three-dimensional cell-culture substrates,3 and may greatly influence
hydrogel permeability relevant to drug delivery applications.
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Specific Aim 2: Develop dual-crosslinking (DC) hydrogels capable of both
guest-host assembly and secondary covalent crosslinking in situ on
clinically relevant timescales.
Conclusions: Separate thiolation of Ad-HA (Ad-HA-SH) and methacrylation of
CD-HA (CD-MeHA) resulted in a dual-crosslinking (DC) hydrogel that was
injectable prior to covalent crosslinking. Onset of secondary covalent crosslinking
occurred with sufficient time (>2 hours) for clinical application. Elastic moduli (~25
kPa) were increased over GH hydrogels and hydrogel erosion was significantly
reduced over time both in vitro and in vivo. When GH and DC hydrogels were
delivered to the heart through multiple injections in the infarct border zone in rats,
mechanically-dependent alterations in left-ventricular (LV) geometry and function
were observed. Both GH and DC hydrogels improved LV wall thickness, LV inner
diameter, and fractional shortening, relative to MI controls. Though, only the endsystolic pressure volume relationship, ejection fraction, and cardiac output were
significantly improved by DC treatment. Geometric and functional outcomes were
typically improved by DC treatment, relative to GH treatment. We conclude that
the guest-host crosslinking mechanism enabled hydrogel injectability with
retention at the target site, while secondary covalent crosslinking mechanisms
stiffened the hydrogels in vivo to improve attenuation of adverse LV remodeling in
a rat model of MI.
Limitations & Future Directions: While the materials concept presented provided
immediate development towards cardiac applications, efforts focused only on
optimization of secondary crosslinking on clinically useful timescales and
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achieving moduli of > 20 kPa. No efforts were made to explore additional
crosslinking mechanisms, such as dynamic covalent chemistries, which may
confer additional advantages such as self-healing capacity. Moreover, materials
were not yet optimized to produce catheter-deliverable formulations — as
formulations had high viscosity that prevented their flow through conventional
catheter tubing. These issues were later addressed in Aim 3 through the use of a
non-conventional injection catheter coupled with formulations which exhibited
properties (i.e., lower viscosity, injection force) more amenable to catheter
injection.
Additionally, the animal model provided strong proof-of-concept that the
materials system had desirable features and efficacy for myocardial application,
though the methodology was limited by technical aspects and experimental design.
First, it is noted that injections were performed immediately following infarct due to
challenges in a second thoracotomy for two surgical procedures. These timescales
of delivery would likely not be clinically feasible, and further discussion toward this
point is provided in the following section. Secondly, neither longitudinal evaluation
of function or myocardial mechanical properties were assessed. With hydrogel
therapy to restrict expansion, DC hydrogels were necessarily stiffer than the
myocardium, which may have imposed diastolic dysfunction (i.e., ventricular
under-filling due to restriction of wall motion). While the end-diastolic pressure
volume relationship (a measure of myocardial elasticity) showed no change with
hydrogel injection, further investigation (e.g., evaluation of diastolic myocardial
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properties and wall motion by finite element analysis of SPAMM tagged MRI) is of
general interest toward injectable materials as infarct restraints.

Specific Aim 3: Assess the therapeutic potential of guest-host and dualcrosslinking hydrogels to attenuate LV remodeling in an ovine infarct model.
Conclusions: GH and DC hydrogels of similar formulation to Aim 2 were
employed in an ovine model of MI, where the GH hydrogels (<1 kPa moduli)
enabled injection and localized retention with subsequent stiffening (41.4±4.3 kPa
moduli) after injection for the DC system. Finite element modeling, predictive of
early myocardial stress distributions, projected myofiber stress reduction within the
infarct region for DC but not GH hydrogel treatments. Infarct thickness, LV end
systolic volume, and ejection fraction were improved with both GH and DC
hydrogels, with results graded according to material stiffness — consistent with
results from Aim 2 and with predicted myocardial stress reductions. Furthermore,
ischemic mitral regurgitation (MR) was attenuated by hydrogel therapies, with no
significant increase in MR grade observed at 8 weeks. Across all treatment groups,
MR grade was correlated (R2 > 0.71) with increases in the LV long-axis dimension
as well as posterior chord length. Echocardiographic analysis revealed significant
posterior leaflet tethering, which was attenuated in the DC treatment arm.
Percutaneous delivery of GH hydrogels was accomplished through endocardial
injection, using fluoroscopic and echocardiographic guidance. Successful delivery
was visualized by MRI. We conclude that a percutaneous delivered hydrogel
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system was developed, and hydrogels with increased stiffness were most effective
in ameliorating LV remodeling, preserving LV function, and attenuating MR.
Limitations & Future Directions: While the mechanical analysis of hydrogels
conducted herein demonstrated that DC hydrogel moduli following in vivo injection
were comparable to those measured in vitro, mechanical analysis of GH hydrogels
could not be performed as a result of hydrogel dispersion throughout the tissue,
and temporal analysis of GH hydrogel mechanics was not performed due to the
inability to accurately assess these hydrogels rheologically following swelling. For
both GH and DC hydrogel injection, the spatiotemporal mechanical properties of
the hydrogel-tissue composite are an important consideration and their
understanding would enable further development of the finite element analysis
techniques employed. Indeed, improving upon these mechanical analyses is a
point of consideration already being explored. Measurement of the mechanical
properties would be improved through examination of the hydrogel-tissue
composite (rather than hydrogel alone) coupled with the ability to discern both
compressive, tensile, and shear loading conditions that better representing the
mechanical complexity of the myocardial environment. Such analysis may be
accomplished through multipoint triaxial loading, and collaborative efforts to
explore these avenues are being initiated.
Toward development of injectable material systems as a clinically translatable
methodology, further scrutiny of two primary safety considerations is necessary.
First, it is recognized that percutaneous endocardial injection is accompanied by
the risk of embolism—either through leaking of the material or thrombotic response
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within the ventricle.4 It is anticipated that shear-thinning of hydrogels within the
circulation may prevent embolism, but direct investigation (such as by ventricular
lumen injection) is needed to substantiate such claims. While HA is inherently nonthrombogenic, examination of the synthetically modified forms used here is worthy
of further investigation. Secondly, the injection of discrete hydrogel regions into the
myocardium has the potential to impair electrophysiological conductivity, resulting
in increased risk of arrhythmia. While hydrogel therapies would be performed
through injection tissue that is already minimally conductive (scar tissue or tissue
that will transition into a scar), systematic investigation of conductivity following
injection and prevalence of arrhythmia may be warranted.
Intervention with hydrogel injection was performed at the time of infarct
induction. Such timing is likely not achievable clinically, with intervention in the 3
to 7 day range or later being more feasible.5 The results of this study therefore
demonstrate the capacity for the material systems developed to act as a
preventative therapy to alter LV remodeling, as well as introduce a delivery
approach that could expand the feasibility of injection at later times. While efficacy
of material injection at later time points has been demonstrated in some small
animal,6-8 large animal,4,9 and clinical studies10, the optimization of injection time
for both clinical applicability and efficacy remains an important issue in need of
direct examination and likely the optimal material formulation will be dependent on
this treatment time. Indeed, these efforts are already initiated through the
development of ischemia/reperfusion MI models that do not require a thoracotomy
and then injection through minimally invasive approaches. These efforts may be
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aided by percutaneous injection procedures that are accompanied by necessary
myocardial and infarct mapping. Lastly, animals were only studied out to 8 weeks
post-MI; longer studies will be required to assess the durability of the therapeutic
response at time points beyond the in vivo lifetime of the DC materials. Ultimate
clinical translation of the materials described here will be dependent on future
studies that will be focused on timing, dosing, and addressing essential safety
concerns.

Specific

Aim

4:

Develop

injectable,

cytocompatible,

and

tough

supramolecular double network (DN) hydrogels through tandem guest-host
and covalent crosslinking reactions.
Conclusions: In order to form interpenetrating double networks (DNs) of
supramolecular and covalently crosslinked polymers, GH hydrogels were used in
conjunction with highly methacrylated HA (MeHA, 100% modification). Guest-host
double networks (GH DNs) were formed with interpenetration of MeHA,
crosslinked through Michael addition with dithiothreitol (DTT). Additionally, the two
networks were tethered by methacrylation (25%) of Ad-HA and CD-HA, yielding
methacrylated guest-host double networks (MethGH DNs). Compressive and
tensile mechanical analyses demonstrated toughening (> eightfold increase) and
high strength (~0.25 MPa moduli) when compared to covalent networks alone.
Guest-host

interactions

exhibited

rapid

self-healing

(<6

sec,

observed

rheologically), which allowed hydrogel injection prior to covalent crosslinking as
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well as immediate recovery of DNs between repeated loading cycles. Mild
crosslinking conditions were developed which permitted the encapsulation of
viable cells (>95% viability at day 0 and day 14), as well as DN formation following
injection into tissue — both without loss of mechanical properties. We conclude
that the novel combination of guest-host and covalent crosslinking (on separate
polymers) results in a material system that balances injectability, cytocompatibility,
and tough mechanical properties.
Limitations & Future Directions: The material preparations examined here
enabled drastic increases in moduli and toughness relative to covalently
crosslinked hydrogels alone. Yet, neither of these yet attain the properties of soft
connective tissues (e.g., cartilage and tendon). While compressive moduli
approached 0.25 MPa moduli, these remain marginally below that of native
cartilage (~1 MPa). To improve upon these properties, further alteration of the
materials system may be explored—including increasing the concentration of
MeHA, therefore increasing the covalent crosslink density above that achieved
here. These changes, however, are likely to over-emphasize the covalent hydrogel
characteristics and thereby remove self-healing properties and yield more brittle
materials. Alternatively, it has been demonstrated that the properties also depend
upon

supramolecular

crosslink

density

(through

guest-host

polymer

concentration). As increases beyond 5.0 wt% yielded little change, other
modifications to the supramolecular crosslinking may prove useful. These may
include deviation from the cyclodextrin macrocycles (as previously discussed) to
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leverage the improved binding affinity of other guest-host complexation or
increases in the guest and host polymer modification may be explored.
A promising avenue for continued exploration is the development of mechanical
properties through stimulation of cells encapsulated within the gel to produce their
own extracellular matrix (ECM). It is realized that hydrogels do not have to initially
match the exact mechanical properties of native tissues. Rather, encapsulated
cells (e.g., chondrocytes, mesenchymal stem cells) may be encouraged to produce
ECM through mechanical or cytokine (e.g., TGF-β) stimulation, resulting in
improved mechanical performance of the ECM-hydrogel composite. Owing to high
viability in long-term culture and the ability to undergo repetitive loading without
detriment to mechanical properties, it is envisioned that these unique DNs have
the capacity to undergo such examination. Injectability and in vivo formation of
these systems perpetuate a regenerative medicine approach to engineering of
mechanically durable tissues.

10.3 Conclusions
The body of work presented throughout this dissertation builds-up a class of
material systems centered upon the design, synthesis, and characterization of a
supramolecular hydrogel uniquely designed and optimized for injection. In
particular, this base system has been well characterized to develop an
understanding of its native characteristics, including mechanical properties,
microstructure, erosion, and molecule release behaviors. Through engineered
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modification of this base material, either through changes in formulation or varied
synthetic modifications, adaptations toward enzymatic response as well as
mechanical reinforcement have been demonstrated. Such material systems are
highly relevant as biomedical scaffolds for therapeutic use, as they enable ease of
application in a clinical setting through simple injection. Such utility has been
demonstrated in specific application toward treatment of myocardial infarct, though
these same principles apply toward the application of these hydrogel systems as
general biomedical materials, where highly localized delivery of mechanically
robust materials is desired or where hydrogels may be used for their capacity as
therapeutic (i.e., cell, drug) delivery vehicles. Collectively, these materials hold
promise as adaptable biomaterials for widespread use in conventional therapeutic
and regenerative medicine approaches.
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